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 The maintenance of metabolic homeostasis presents a major challenge to animal 
biology. Dysregulation of this process is central to the etiology of diabetes and obesity, 
which have placed an ever-increasing burden on global human health. Nuclear receptors 
are a family of ligand-regulated transcription factors that play important roles in 
preventing metabolic dysfunction by coordinating downstream transcriptional programs 
to support physiological homeostasis. This dissertation is focused on one of these nuclear 
receptors, Hepatocyte Nuclear Factor 4A (HNF4A), which acts as a critical regulator of 
systemic glucose homeostasis. Mutations in HNF4A were established 20 years ago as the 
monogenic cause of an inherited form of diabetes called Maturity-Onset Diabetes of the 
Young 1 (MODY1). The mechanistic link between HNF4A dysfunction and diabetes 
onset, however, remains unclear. In this dissertation, I present work that provides new 
insights into the mechanisms by which HNF4 supports physiological homeostasis and 
prevents diabetes.   
 The fruit fly Drosophila melanogaster provides an ideal system for studies of 
metabolism and physiology that can guide our understanding of these pathways in 
mammals. We developed and optimized methods for studies of metabolism in Drosophila 
to further advance its utility in these efforts. Using these techniques, I investigated 
potentially conserved roles for Drosophila HNF4 (dHNF4) in supporting development 
and metabolic homeostasis. Through this work, I discovered that dHNF4 mutants 
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recapitulate hallmark features of MODY1, including hyperglycemia and impaired 
glucose-stimulated insulin secretion (GSIS). dHNF4 functions in the adult insulin 
producing cells and the fat body to support GSIS and peripheral glucose clearance during 
adulthood. These functions are linked to a role for dHNF4 in promoting mitochondrial 
activity in the mature animal through up-regulation of both nuclear and mitochondrial-
encoded genes involved in oxidative phosphorylation (OXPHOS).  
 By extending my analysis to mammals through a collaborative effort with several 
labs, we uncovered evidence suggesting that the role for HNF4 in supporting 
mitochondrial function has been conserved through evolution. Taken together, my work 
has identified HNF4 as an important regulator of mitochondrial activity, and suggests that 
this function has been conserved through evolution to support normal development, 
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 Animal biology fundamentally relies on the ability of organisms to maintain 
metabolic homeostasis. As physiological and environmental conditions vary, these 
complex networks of biochemical reactions must be properly coordinated to meet cellular 
and organismal needs. The regulation of systemic nutrient supply is central to this 
process. In many metazoans, simple carbohydrates such as glucose are maintained at 
abundant levels in circulation to provide a dependable source of fuel for vital organs. 
Systemic glucose homeostasis must therefore be tightly regulated to support normal 
physiology. Hypoglycemia, for example, can result in acute neuronal dysfunction, stroke, 
and even death. Persistent excess of serum glucose is also detrimental, leading to chronic 
defects in tissue integrity and organ function. As a result, diabetes mellitus represents a 
major cause of adult blindness, lower-limb amputation, end-stage renal failure, heart 
attack, stroke, and death (Centers for Disease Control and Prevention, 2014). The 
alarming rise in the prevalence of diabetes has therefore placed a major burden on global 
healthcare, prompting increased efforts to better understand metabolic systems and how 





HNF4A in development, metabolism, and disease 
Nuclear receptors are a family of ligand regulated transcription factors that play 
critical roles in the regulation of development and metabolic homeostasis. More than 
10% of all drugs approved by the US Food and Drug Administration act on nuclear 
receptors, highlighting their utility in providing treatment options and insight into human 
diseases (Overington et al., 2006). Hepatocyte Nuclear Factor 4A (HNF4A) represents 
one of the most ancient members of this family, with identifiable homologs present in all 
animals examined to date (Sladek, 2011). Mutations in HNF4A have also been implicated 
in several human diseases including diabetes, hemophilia, hepatocellular carcinoma, 
kidney dysfunction, and disorders of the intestinal tract. As a result, significant efforts 
have been made to better understand the complex functions of HNF4A in development, 
physiology, and disease. 
The Hnf4a nuclear receptor was first discovered through its association with 
regulatory elements for expression of several hepatocyte-specific genes in rodents (Costa 
et al., 1989; Sladek et al., 1990). Extensive studies have since proven Hnf4a to be a 
critical player in the transcriptional control of various developmental and metabolic 
processes, both in hepatocytes and elsewhere. In mice, complete loss of Hnf4a causes 
early embryonic lethality due to defects in gastrulation, revealing an essential 
requirement in mammalian development (Chen et al., 1994). Accordingly, tissue-specific 
approaches have been employed to investigate its regulatory activities during later stages 
of development and in adulthood.  
Loss-of-function studies in the mouse liver have established Hnf4a as a master 
regulator of hepatic identity. Consistent with this, liver-specific deletion leads to 
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dedifferentiation and over proliferation of hepatocytes, along with steatosis, reduced 
glycogen storage, and early lethality (Bonzo et al., 2012; Hayhurst et al., 2001; Walesky 
et al., 2013a; Walesky et al., 2013b). As part of this differentiation, hepatocytes require 
extensive and specific metabolic programming to support liver function. Hnf4a 
contributes to this by regulating the expression of select metabolic genes involved in lipid 
metabolism and transport, gluconeogenesis, glycolysis, drug detoxification, and bile acid 
synthesis. 
 Although the liver represents the region of highest Hnf4a expression, it is also 
found in the intestine and proximal tubules of the kidney, and at lower levels in the 
pancreas. Loss of Hnf4a in the fetal colon causes defects in epithelial differentiation and 
crypt formation, along with an increased inflammatory response (Ahn et al., 2008; 
Chahar et al., 2014; Garrison et al., 2006). Consistent with these findings, mutations in 
human HNF4A are linked to intestinal disorders such as ulcerative colitis and pediatric 
Crohn’s disease (Babeu and Boudreau, 2014). While functional studies of Hnf4a in the 
kidney have been limited, ex vivo organ culture of rat kidney with an Hnf4a antagonist 
(BI6015) suggests a role in differentiation of the proximal tubules and expression of drug 
metabolizing enzymes (Martovetsky et al., 2013). In line with these findings, patients 
with mutations in HNF4A have been reported to display defects in kidney function, 
manifested in the form of Fanconi syndrome (Hamilton et al., 2014). 
 Finally, the most well-established link between HNF4A dysfunction and human 
disease is the monogenic form of diabetes called Maturity Onset Diabetes of the Young 1 
(MODY1). Although MODY1 is considered to be a disorder caused solely by defects in 
β-cell function, deletion of Hnf4a in this cell type does not produce overt diabetes in mice 
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(Gupta et al., 2005; Miura et al., 2006). Nonetheless, these mice do display defects in 
glucose tolerance and glucose-stimulated insulin secretion (GSIS). The mechanisms by 
which Hnf4a regulates this process, however, remain unresolved.  
 
Maturity onset diabetes of the young (MODY) 
 
The genetic and environmental insults leading to diabetes onset are often complex 
and unclear. Monogenic forms of diabetes, however, display clear patterns of heritability 
mapped to causative mutations in single genes. To date, mutations in thirteen genes have 
been identified that lead to autosomal dominant inheritance of diabetes, classified as 
Maturity Onset Diabetes of the Young (MODY1-13). MODY patients typically present 
with hyperglycemia and reduced glucose-stimulated insulin secretion (GSIS) by young 
adulthood, while lacking signs of β-cell autoimmunity and obesity (Fajans and Bell, 
2011).  
The monogenic nature of this disease has highlighted MODY genes as critical 
regulators of systemic glucose homeostasis. Indeed several of these loci encode well-
known factors for insulin secretion and glucose uptake, including Insulin (INS, 
MODY10) and the glycolytic enzyme, Glucokinase (GCK, MODY2). Although GCK 
mutations are amongst the most common cause of monogenic diabetes, MODY2 patients 
display a relatively mild disease phenotype without the need for treatment (Fajans and 
Bell, 2011). In contrast, mutations in the transcription factors HNF4A (MODY1), HNF1A 
(MODY3), and HNF1B (MODY5) represent the most common forms of MODY that 
require clinical intervention due to their more severe and progressive disease 
complications. Despite this, the precise functions of these transcription factors in 
preventing diabetes onset remain unclear.  
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The genetic basis for the first form of MODY was mapped to mutations in the 
HNF4A locus twenty years ago (Yamagata et al., 1996). HNF4A, like many other 
MODY-related genes, is expressed in several organs that are important for systemic 
glucose homeostasis, including the liver, pancreas, kidney, and intestine. The 
development of MODY, however, is solely attributed to β-cell dysfunction. Accordingly, 
efforts to model MODY1 in mice have focused on tissue-specific deletion in pancreatic 
β-cells. Using this approach, two separate groups reported glucose intolerance and 
aberrant GSIS in adult mice, however overt diabetes was not observed (Gupta et al., 
2005; Miura et al., 2006). Several discrepancies were also noted between these studies, 
including conflicting reports on the basal levels of circulating glucose and insulin. 
Furthermore, no consensus was reached as to the molecular function of Hnf4a in the β-
cell to support GSIS. As a result, we still have a limited understanding of where and how 
HNF4A functions to prevent hyperglycemia.  
 
Drosophila as a model system for genetic studies of diabetes 
 For more than a century, genetic studies using the fruit fly, Drosophila 
melanogaster, have provided important insights into conserved aspects of animal 
development and cell biology. More recently, investigations of metabolic homeostasis in 
flies have also demonstrated a high degree of conservation with mechanisms regulating 
systemic metabolism in mammals (Alfa and Kim, 2016; Alfa et al., 2015; Diop and 
Bodmer, 2015; Owusu-Ansah and Perrimon, 2014; Padmanabha and Baker, 2014; 
Teleman et al., 2012). This includes pathways for intermediary metabolism, along with 
hormonal signaling mechanisms to support metabolic homeostasis between feeding and 
fasting cycles.  
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The insulin-signaling pathway represents a highly conserved hormonal response 
to the fed state, helping to control the balance of circulating and stored nutrients. In 
humans, defects in insulin signaling are central to the pathogenesis of diabetes, 
characterized by chronic hyperglycemia. Flies display a similar reliance on insulin 
signaling for regulation of circulating sugars and prevention of diabetes-like phenotypes. 
In Drosophila, the insulin-producing cells (IPCs) are made up of a cluster of 
neuroendocrine cells in the brain that express three Drosophila insulin-like peptides 
(DILP2, 3, and 5). Functionally analogous to mammalian β-cells, the IPCs respond to 
nutrient signals for release of DILPs into circulation. Unlike mammals, however, which 
encode separate receptors for insulin and insulin-like growth factor (IGF) signaling, 
DILPs act through a single insulin receptor (InR) to promote growth during larval 
development and to maintain metabolic homeostasis throughout the life of the animal. As 
a result, ablation of the IPCs leads to reduced body size and hallmarks of diabetes, 
including elevated levels of circulating carbohydrates (Haselton et al., 2010; Rulifson et 
al., 2002). Consistent with the highly conserved nature of this pathway, DILPs are 
capable of lowering blood glucose in rats, and mammalian insulin can also activate the 
Drosophila InR to decrease circulating sugar levels (Haselton and Fridell, 2011; Sajid et 
al., 2011).  
Counter to the functions of insulin, the peptide hormone glucagon is secreted 
from mammalian pancreatic α-cells in response to low serum glucose to prevent 
hypoglycemia during fasting. The Drosophila adipokinetic hormone (AKH) is similarly 
secreted from the corpora cardiac (CC) in response to fasting, and disruption of this 
pathway leads to reduced circulating carbohydrates, establishing AKH as a functional 
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homolog of mammalian glucagon (Isabel et al., 2005; Kim and Rulifson, 2004; Lee and 
Park, 2004). Taken together, the CC and IPCs represent physiological equivalents of the 
mammalian endocrine pancreas.  
 Despite the extensive conservation of intermediary metabolism and mechanisms 
regulating physiological homeostasis between flies and mammals, some discrepancies are 
worth noting. In mammals, elevations in circulating glucose act as the primary stimulus 
for insulin release from β-cells. Drosophila larvae, in contrast, do not respond to either 
glucose or sucrose for DILP release from the IPCs (Geminard et al., 2009) (Figure 1.1). 
Rather, dietary amino acids are sensed by the fat body, an organ functionally equivalent 
to mammalian liver and white adipose tissue, to remotely trigger DILP release (Geminard 
et al., 2009). Furthermore, free glucose is largely absent from the larval circulating fluid 
(Figure 1.1). Instead, the glucose disaccharide trehalose represents the primary 
circulating sugar (Tennessen et al., 2014). Although a recent report has demonstrated that 
trehalose is capable of stimulating secretion of a single DILP (DILP3) from the IPCs, the 
proposed pathway does not follow canonical mechanisms for glucose sensing in 
mammals (Kim and Neufeld, 2015). 
 More recent studies in adult Drosophila, however, have revealed notable 
differences with larval DILP secretion and glucose homeostasis. Electrophysiological 
measurements and calcium imaging of isolated IPCs from adult flies have demonstrated 
responsiveness to free glucose, suggesting that IPCs in the adult may employ similar 
pathways to mammalian GSIS (Kreneisz et al., 2010). Consistent with this, these cells 
also express the sulfonylurea receptor (Sur) and are responsive to the anti-diabetic 
sulfonylurea drug Glibenclamide, unlike larval IPCs (Fridell et al., 2009; Kreneisz et al., 
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2010) (Figure 1.1). Subsequent studies have further confirmed the presence of GSIS in 
adult Drosophila in vivo using a recently developed sandwich ELISA assay for DILP2 
secretion (Park et al., 2014). In line with these developmental changes in IPC physiology, 
my studies have uncovered differences in the basal levels of circulating glucose between 
larvae and adults, which are discussed further in Chapters 2 and 3. Taken together, these 
findings suggest that insulin secretion and glucose homeostasis are differentially 
regulated during Drosophila development, with the adult stage representing a more 
accurate context for studies relating to diabetes in humans (Figure 1.1).  
 
Studies of Drosophila HNF4 (dHNF4) 
 In addition to studies of diabetes, fruit flies provide an ideal context for 
investigating physiological functions of nuclear receptors. In contrast to mice, which 
encode 48 nuclear receptor genes, the Drosophila genome contains 18, with many 
representing an entire subclass in mammals (King-Jones and Thummel, 2005). The 
predominant lack of paraologous nuclear receptor genes in flies prevents issues of genetic 
redundancy when performing loss-of-function studies. In line with this, D. melanogaster 
express a single highly conserved member of the HNF4 family, dHNF4. In mammals, 
two paralogs of HNF4 are present, HNF4A and HNF4G, with Drosophila HNF4 most 
closely related to HNF4A, showing eighty-nine percent amino acid identity at the DNA-
binding domain and sixty-one percent at the ligand-binding domain.  
 Previous studies of dHNF4 revealed an essential requirement for Drosophila 
development, where null mutants die during the transition to adulthood (Palanker et al., 
2009). During larval development, dHNF4 mutants display starvation sensitivity and 
defects in lipid catabolism. These defects are linked to a critical role for dHNF4 in 
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promoting expression of genes involved in lipid mobilization and mitochondrial 
oxidation of fatty acids (Palanker et al., 2009). As a result, dHNF4 mutants display 
elevated levels of stored triacylglycerol (TAG) and reduced levels of the stored 
carbohydrate glycogen, similar to loss of Hnf4a in the mouse liver (Walesky et al., 
2013b). Analysis of the tissue distribution of dHNF4 in larvae has also demonstrated an 
analogous expression pattern to that of mammalian HNF4A, with dHNF4 protein and/or 
transcript detectable in the larval fat body (liver/white adipose tissue), oenocytes 
(hepatocyte-like cells), intestine, and malpighian tubules (kidney-like organ) (Palanker et 
al., 2006; Palanker et al., 2009; Wilk et al., 2013). Taken together, these studies highlight 
the potential overlap in physiological functions for Drosophila and mammalian HNF4.  
 
Coordination of metabolism with development 
Studies of insect physiology nearly two centuries ago provided early findings that 
development and metabolism are tightly coordinated (Newport, 1836). This included 
observations of differential rates of respiration throughout the life cycle, showing a U- or 
J-shaped curve between larval, pupal and adult stages. Although the mitochondrion was 
not discovered until over fifty years later, extensive work has since demonstrated that the 
differential activity of this organelle is a principal feature of developmental metabolism.  
The mitochondrion acts a central hub for cellular metabolism, with pathways for 
carbohydrate, lipid, and amino acid metabolism all converging on this organelle. The 
bulk of ATP production also occurs within mitochondria through oxidative 
phosphorylation (OXPHOS). OXPHOS is facilitated by the electron transport chain 
(ETC), which resides within the inner mitochondrial membrane and establishes the 
proton gradient that drives the ATP synthase machinery.  
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While differentiated cells tend toward higher rates of OXPHOS, growing and 
proliferative cells have a greater demand for biosynthesis and predominantly employ 
aerobic glycolysis (Figure 1.2). Proliferating cells still depend on mitochondrial function 
for their survival, however, due to a reliance on mitochondria for aspartate biosynthesis 
(Birsoy et al., 2015; Sullivan et al., 2015). Nonetheless, the differential regulation of 
mitochondrial respiration and glycolytic flux is a broadly observed strategy to 
accommodate differential metabolic needs during cellular development (Figure 1.2). 
Although the importance of coordinating metabolism with development has 
gained more attention in recent years, the mechanisms by which this occurs remain 
largely uncharacterized. Early studies of this phenomenon, however, have highlighted 
nuclear receptors as major players in this process. This is evident in the mammalian heart, 
where the nuclear receptors PPARα and ERRγ support a postnatal metabolic switch 
towards increased oxidative metabolism. Studies in Drosophila have also highlighted the 
importance of nuclear receptors in developmental metabolism. Drosophila ERR, for 
example, acts as a master transcriptional regulator at the embryo-to-larva transition to 
induce a metabolic switch towards aerobic glycolysis. This metabolic program is critical 
to support the robust growth phase of larval development. Drosophila neuroblasts have 
also been characterized to undergo a metabolic switch during development, transitioning 
from aerobic glycolysis to increased OXPHOS upon differentiation. This metabolic shift 
is critical for proper neuronal development and is mediated by the nuclear receptor EcR.  
Although studies of such phenomenon have been limited, fruit flies have proved to be a 
valuable system for uncovering the mechanisms by which metabolism is coordinated 
with developmental progression. Growing evidence has also demonstrated that a failure 
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to achieve this coordination can have major consequences for animal health.   
 
Dissertation summary 
 In this dissertation, I present my work investigating the functions of the nuclear 
receptor HNF4 in animal physiology and development. In Chapter 2, I present a 
collaborative effort detailing methods for studies of metabolism in Drosophila, including 
assays for metabolite quantitation, dietary manipulations, and developmental differences 
in assay utility and circulating glucose abundance.   
In Chapter 3, I discuss the role of dHNF4 to regulate metabolic homeostasis 
during development to prevent adult-onset diabetes. Here I report my discovery that 
dHNF4 mutants provide an animal model of MODY1. These findings were initiated by 
my observation that dHNF4 mutants are sensitive to dietary sugar levels, such that 
rearing on a low sugar diet suppresses dHNF4 mutant lethality at eclosion and supports 
adult survival. At the transition to adulthood, dHNF4 mutants develop hallmark features 
of MODY1, including impaired GSIS, glucose intolerance, and hyperglycemia. This is 
due in part to a critical role for dHNF4 to maintain mitochondrial function for glucose 
uptake by the fat body and GSIS from adult IPCs. dHNF4 supports these functions 
through the regulation of both nuclear and mitochondrial-encoded genes involved in the 
TCA cycle and ETC. As a result, dHNF4 mutants display a range of mitochondrial 
defects including fragmented morphology, reduced membrane potential, and impaired 
TCA cycle metabolism. During the pupal-to-adult transition, dHNF4 transcript levels 
increase along with both nuclear and mitochondrial target genes involved in OXPHOS. 
These findings reveal a developmental switch in metabolism whereby dHNF4 promotes 
increased mitochondrial function and GSIS in adulthood to support systemic glucose 
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homeostasis and the energetic needs of the mature animal.  
Lastly, in Chapter 4, I further examine the role for dHNF4 in regulating 
mitochondrial activity and the potential conservation of these functions in mammals 
through collaborative efforts. In contrast to dHNF4 mutant adults, which display 
fragmented mitochondrial morphology and impaired activity of ETC complexes I and IV, 
mutant larvae display normal morphology and ETC function. Interestingly, this defect in 
complex I activity is linked to a direct role for dHNF4 to promote expression of a 
nuclear-encoded acyl-CoA enzyme, CG7461, in addition to supporting mtDNA gene 
expression. CG7461 is the Drosophila homolog of mammalian ACAD9, which functions 
in both fatty acid oxidation and complex I activity. In fact, mutations in ACAD9 are a 
common cause of complex I deficiency in humans (Nouws et al., 2014). Consistent with 
this, knockdown of CG7461 impairs complex I activity to a similar level as disruption of 
a known complex I assembly factor, CIA30. Analysis of publically available ChIP-seq 
data for Hnf4a genomic localization in mouse hepatocytes showed significant enrichment 
at the ACAD9 promoter. Additionally, loss of Hnf4a in the adult liver results in reduced 
ACAD9 expression under metabolic stress, in the form of cold exposure. Hnf4a was also 
found associated with a number of other important mitochondrial genes including genes 
involved in mtDNA gene expression, such as Tfam and Polrmt, as well as Pink1, a 
critical gene involved in mitochondrial quality control. Consistent with this, Hnf4a 
mutant livers show significantly reduced expression of mtDNA-encoded genes. Although 
immunostaining for Hnf4a in hepatocytes failed to show appreciable mitochondrial 
subcellular localization, these data suggest that the role for HNF4 to support 
mitochondrial function has been conserved through evolution.  
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In addition to the mouse liver, we also examined HNF4A subcellular localization 
in the human pancreas. Surprisingly, HNF4A shows distinct mitochondrial localization in 
pancreatic islets and no observable nuclear staining. Although intriguing, the absence of 
nuclear signal and lack of available mutant tissue to validate the specificity of this 
staining makes it difficult to assess the significance of this finding. Nonetheless, a direct 
role for HNF4 within mitochondria is consistent with my findings in Drosophila and 




















Figure 1.1. Drosophila display developmental differences in glucose homeostasis and 
insulin secretion 
Left panel- Larval insulin-producing cells (IPCs) are unresponsive to glucose for 
secretion of DILPs. Trehalose, a glucose disaccharide, represents the predominant 
circulating sugar in larvae, while glucose is almost undetectable. Right panel- Adult IPCs 
are responsive to glucose for DILP secretion and express the sulfonylurea receptor (Sur). 
Consistent with this, adult IPCs, also depolarize in response to the sulfonylurea, 
Glibenclamide. Adult flies also display abundant levels of circulating free glucose, in 








Figure 1.2. General differences in mitochondrial metabolism during cellular 
development    
Left panel – Proliferative and/or rapidly growing cells require high levels of biosynthesis 
and exhibit elevated rates of glycolysis and low OXPHOS, even in the presence of 
oxygen. This metabolic program is referred to as aerobic glycolysis, where pyruvate is 
predominantly converted to lactate rather than entering the TCA cycle within the 
mitochondrial matrix. Right panel – Differentiated cells generally display higher levels of 
mitochondrial respiration, with the bulk of pyruvate oxidized through the TCA cycle 
within the mitochondrial matrix. This generates high-energy electron donors in the form 
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a b s t r a c t
Recent research using Drosophila melanogaster has seen a resurgence in studies of metabolism and
physiology. This review focuses on major methods used to conduct this work. These include protocols
for dietary interventions, measurements of triglycerides, cholesterol, glucose, trehalose, and glycogen,
stains for lipid detection, and the use of gas chromatography-mass spectrometry (GC-MS) to detect major
polar metabolites. It is our hope that this will provide a useful framework for both new and current
researchers in the field.
! 2014 Elsevier Inc. All rights reserved.
1. Introduction
Metabolism and physiology provided a major focus for
Drosophila research in the middle of the last century [1]. This work
included fundamental studies of biochemical genetics, starting
with classic work on eye pigment biosynthesis and the one gene-
one enzyme hypothesis [2], as well as detailed characterization
of basic energy physiology [e.g. Ref. [3–5]]. Although the advent
of recombinant DNA technology shifted the Drosophila field toward
studies of developmental biology, recent efforts have refocused on
metabolism, with a particular emphasis on the mechanisms that
maintain energy homeostasis and the use of Drosophila as a model
for studies of diabetes and obesity [6–10]. In this review, we high-
light methods that have been developed to conduct current genetic
studies of metabolism in Drosophila, with a focus on energy
homeostasis and physiology. We begin with an overall discussion
of the challenges facing researchers in the field, given the contribu-
tions of both environmental and genetic factors to metabolic
control. We then move on to review protocols for dietary interven-
tion in Drosophila, followed by widely used assays to quantify basic
metabolites in the animal. We end with protocols for metabolomic
profiling by gas chromatography–mass spectrometry (GC-MS). Our
goal is not to be comprehensive in our coverage of metabolic
protocols, since that is beyond the scope of one article, but rather
to focus on some major methods currently being used, with the
hope that this will provide a useful framework for both new and
current researchers in the field.
2. Experimental design
The profound interplay between environment and genetics
requires that metabolic studies be undertaken with careful atten-
tion to genetic background, diet, stock maintenance, and statistical
analysis of data. Particular concern should be directed toward the
selection of control strains and the establishment of an appropri-
ately matched genetic background for the mutant being studied.
Outcrossing mutants to the control strain provides a good way to
achieve this goal, as does confirming results with more than one
control line. Matching the genetic background becomes more diffi-
cult, however, when GAL4 drivers and UAS transgenes are included
in the genotype, although a uniform whitemutant background and
controls with the driver and/or responder alone can be included.
Tissue-specific RNAi provides an invaluable and widely used tool
for functional studies of metabolism. In addition to the standard
concerns with off-target effects, however, RNAi can have nonspe-
cific effects on physiology [e.g. Ref. [11]]. Finally, some care should
be taken when using commercial kits for quantifying specific
metabolites. Although these kits may be widely used in mamma-
lian research, most have not been validated in Drosophila. As dis-
cussed below for quantifying simple metabolites such as glucose,
glycogen, and triglycerides, protocols need to be adapted to the
system. A good way to achieve this for a new assay is to use known
mutants in the pathway being studied, and score for the predicted
changes in metabolite levels. Alternatively, methods such as
GC-MS can be used to confirm the changes in metabolite levels de-
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tected by an enzymatic kit. In general, the more labile the
metabolite (such as ATP), the more care that is needed for its
quantification.
3. Starvation and dietary paradigms
The metabolic state of an animal is intimately linked with its
diet. Accordingly, dietary conditions must be carefully controlled
when performing metabolic studies. Often this will require the
lab making special batches of media to maintain both breeding
and experimental stocks. This point becomes particularly impor-
tant when considering the recent evidence that parental diet can
influence the metabolic state of offspring, as has been well docu-
mented in mammals [12,13]. While carefully controlled dietary
conditions are essential, dietary manipulation also provides one
of the most useful approaches for studies of metabolism and
animal physiology. For example, enrichment or restriction of par-
ticular nutrients can often evoke robust metabolic phenotypes in
mutants that may otherwise appear normal under ideal dietary
conditions [14–17].
Starvation provides an important dietary stress that tests the
animal’s ability to mobilize stored nutrients for survival. This can
be achieved by transferring larvae or flies to either water or PBS.
Although moist filter paper is employed for larvae, studies of adult
starvation should use 1% agar as a substrate, as it provides a more
uniform moist environment for long-term studies (>12 h).
Alteration of dietary sugar levels is a useful method for investi-
gating potential defects in carbohydrate homeostasis. This can be
easily achieved by using an 8% yeast and 1% agar medium to serve
as the dietary foundation for manipulating sugar concentrations. A
range from 3–15% dietary sugar (ratio of 2:1 glucose to sucrose, by
weight) represents the low-to-high spectrum found within a rela-
tively normal diet for Drosophila (Table 1). In our studies, altering
the sugar concentration of this media has proven to be an effective
tool for both enhancing and suppressing diabetic phenotypes. For
example, several Drosophila mutants that are sensitive to dietary
sugar can maintain euglycemia on a 3% sugar diet but display
increasingly severe hyperglycemia as dietary sugar is increased
(W. Barry, D. Bricker, and R. Somer, unpublished results).
Very high sugar diets have been developed for studies of type 2
diabetes in Drosophila. These diets consist of either 1% agar, 3.4%
yeast, 8.3% cornmeal, and 30% sucrose [15] or 1% agar, 8% yeast,
2% yeast extract, 2% peptone, and 34.2% sucrose [18] (Table 1).
These diets lead to hallmarks of type 2 diabetes in wild-type
Drosophila, including hyperglycemia, insulin resistance, obesity,
and cardiac dysfunction [15,18,19]. High lipid diets have also been
developed for studies of diet-induced obesity in Drosophila. These
can be achieved by supplementation of standard growth media
with either soy lipids [20] or coconut oil [21,22], which has been
most widely used for this purpose.
Although the above media allow the researcher to crudely
manipulate the overall levels of carbohydrates and lipids in the
diet, precise addition or removal of dietary components is often
desirable. Fortunately, two labs have recently developed chemi-
cally defined diets that support Drosophila development and
growth (although at a reduced rate), and are well suited for the
study of adult physiology and aging [23,24]. The advent of these
defined diets provides a level of control not possible in past work,
and should greatly facilitate nutritional and metabolic studies in
Drosophila.
3.1. Measuring feeding rate
It is often important to assess whether changes in feeding rate
contribute to an observed metabolic phenotype. The use of dietary
dyes can provide a crude yet simple method to visually assess food
consumption [25]. This approach is particularly useful when ana-
lyzing responses to an acute feeding bout, by ensuring that only
animals that have consumed the food are analyzed. Dietary dyes
are not well suited for quantitative analysis, however, and cannot
be used to accurately assess feeding rate over extended periods
of time. In contrast, adding radioactive material to the food pro-
vides a more quantitative measurement of consumption based on
ingested radiation after a fixed period of time [26]. This can be
achieved for individual flies by adding 108 counts/min/ml (final
volume) a-32P dCTP (or any other nucleotide) to the diet and
permitting the animals to feed for 2 h. Lower levels of radiation
can be used if multiple flies are measured. Labeled animals are
transferred to unlabeled food for several hours to allow them to
clear radioactivity that is nonspecifically bound to the cuticle. They
are then subjected to Cerenkov counting in a scintillation counter
to quantify food uptake [27,28]. Scintillation fluid can be used if
the animals are sacrificed and lower levels of radiation are
employed in the diet.
The Capillary Feeder (CAFE) assay has been developed as a
means to directly quantify food consumption by making use of a
capillary feeder containing a liquid medium [29]. While this
technique allows for direct and precise analysis of ingested food
quantities, some researchers have raised concerns that the diet
and its method of delivery might not represent a natural feeding
scenario [29,30]. This led to an alternate technique that measures
the number of times an animal extends its proboscis to feed in a
fixed time period [30]. A more detailed description of these tech-
niques can be found in a recent review on Drosophila feeding
behavior [31].
4. Methods to measure basic metabolites: lipids
Under normal feeding conditions, dietary triglycerides (TAG)
and cholesterol esters are broken down into free fatty acids,
monoacylglycerols, and free sterols in the intestine. These digested
lipids can then be absorbed by the intestinal cells, where TAG is
resynthesized and packaged together with cholesterol, cholesterol
esters, and carrier proteins to form lipoprotein particles that are
trafficked throughout the body. These lipids can be either utilized
by cells or deposited in storage tissues. Most lipids reside in the fat
body, although some are also present in the gut and oenocytes of
both larvae and adults. Two different types of assays can be used
to detect lipids – either specific assays to quantify TAG or sterols
from whole animals or dissected tissues, or lipophilic dyes to visu-
alize neutral lipids within cells. Taken together, these provide a
valuable indication of the lipid distribution within the animal.
4.1. Colorimetric quantification of triglycerides
Overall quantification of TAG is often a first step in a metabolic
study, along with measurements of basic carbohydrates and pro-
tein. An accurate, although insensitive means of measuring TAG
is to use Bligh and Dyer lipid extraction followed by thin layer
chromatography (TLC) [32,33]. This allows fractionation and detec-
tion of total fatty acids, diacylglycerol (the major circulating form
of lipid in insects), and TAG. The most widely used assay for detect-
ing triglycerides, however, is a coupled colorimetric assay that
detects free glycerol levels after cleaving TAG with lipoprotein
lipase [32,34,35]. Although a few studies have suggested that
this approach does not provide an accurate assessment of stored
fat in insects [36,37], both TLC and the colorimetric assay produce
similar results [32]. It is, however, worth noting that the colorimet-
ric assay releases glycerol from mono- and diacylglycerides [38]
in addition to TAG and, therefore, conclusions regarding any
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particular form of glycerolipid should be validated by TLC. The
presence of eye pigment in adult samples could also interfere with
accurate absorbance measurements at certain wavelengths; how-
ever, assay kits designed to measure absorbance at 540 nm do
not detect eye pigment [32].
4.2. Protocol: coupled colorimetric assay for triglycerides
(1) Collect samples (25 mid-second instar larvae; 5 adult flies).
(2) Rinse several times with 1 ml cold PBS to remove all traces
of food that might be attached to the outside of the animal.
Larvae can be washed in a 1.5 ml microfuge tube, but adults
should be rinsed in a 9-well glass plate. Transfer adult flies
to a 1.5 ml microfuge tube. Carefully remove all liquid. For
larvae, centrifuge at 3000!g and remove all remnants of
PBS. Snap freeze animals in liquid nitrogen for later homog-
enization or add 100 ll of cold PBS + 0.05% Tween 20 (PBST).
(3) Rapidly homogenize animals in PBST with a pellet pestle
(Kontes; 749521-1500) on ice. A motor can be used to facil-
itate homogenization (Kontes; 749540-–0000). Frozen sam-
ples should be kept on dry ice until addition of PBST. If
samples are not kept cold, stored glycerolipids will be enzy-
matically degraded into free glycerol by endogenous
enzymes and skew the final analysis.
(4) Remove 10 ll of homogenized sample to measure protein
content with a Bradford assay. Keep samples on ice and do
not heat-treat. Protein samples can be frozen and stored at
"80 !C for later analysis.
(5) Heat supernatant for 10 min at 70 !C. Do not centrifuge the
heat-treated lysate because lipids are partially insoluble in
PBST. At this time, the heat-inactivated sample can be frozen
and stored at "80 !C, if desired.
(6) Prepare standards: Dilute 40 ll of the glycerol standard solu-
tion (Sigma 2.5 mg/ml triolein equivalent glycerol standard;
G7793) with 60 ll PBST (100 ll final volume) to generate a
1.0 mg/ml triolein equivalent standard. Do two 2-fold serial
dilutions into PBST (50 ll 1 mg/ml + 50 ll PBST for 0.5 mg/
ml standard, etc.) to generate 0.125, 0.25 and 0.5 mg/ml stan-
dards. Glycerol stock solutions can be stored at"20 !C or 4 !C.
(7) Add 20 ll of the glycerol standards, fly samples, and a PBST
blank to each of two 1.5 ml microfuge tubes. Add 20 ll of
PBST to one tube (this sample will be used to measure free
glycerol). Add 20 ll of triglyceride reagent (Sigma; T2449)
to the other tube (the TAG in this sample will be digested
by lipase to free the glycerol backbone). Incubate tubes at
37 !C for 30–60 min.
(8) Centrifuge for 3 min at full speed. Transfer 30 ll of each
sample to a clear-bottom 96-well plate.
Table 1
Caloric content of Drosophila diets.
Semi-defined (Bloomington) g/liter Carbs (g) Protein (g) Fat (g) Total kcal
Agar 10 8.9 0 0.1
Yeast 80 30.8 38.6 3.12
Yeast extract 20 7.7 8.6 1.72
Peptone 20 0.1 14.6 0
Sucrose 30 30 0 0
Glucose 60 60 0 0
Total grams 137.5 61.8 4.94
Total kcal 550 247.2 42.29 839.5
Percent total kcal 65.5 29.4 5.04
9% Sugar diet (normal)
Agar 10 8.9 0 0.1
Yeast 80 30.8 38.6 3.12
Sucrose 30 30 0 0
Glucose 60 60 0 0
Total grams 129.7 38.6 3.22
Total kcal 518.8 154.4 27.56 700.8
Percent total kcal 74.0 22.0 3.93
3% Sugar diet (low sugar)
Agar 10 8.9 0 0.1
Yeast 80 30.8 38.6 3.12
Sucrose 10 10 0 0
Glucose 20 20 0 0
Total grams 69.7 38.6 3.22
Total kcal 278.8 154.4 27.56 460.8
Percent total kcal 60.5 33.5 5.98
15% Sugar diet (high sugar)
Agar 10 8.9 0 0.1
Yeast 80 30.8 38.6 3.12
Sucrose 50 50 0 0
Glucose 100 100 0 0
Total grams 189.7 38.6 3.22
Total kcal 758.8 154.4 27.56 940.8
Percent total kcal 80.7 16.4 2.93
Diabetic diet
Agar 10 8.9 0 0.1
Yeast 80 30.8 38.6 3.12
Yeast extract 20 7.7 8.6 1.72
Peptone 20 0.1 14.6 0
Sucrose 342 342 0 0
Total grams 389.5 61.8 4.94
Total kcal 1558 247.2 42.29 1847.5
Percent total kcal 84.3 13.4 2.29
Diabetic diet from Musselman et al. [18].
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(9) Add 100 ll of free glycerol reagent (Sigma; F6428) to each
sample with a multichannel pipette and mix well. Seal the
wells with parafilm to prevent evaporation and incubate the
plate for 5 min at 37 !C. Centrifuge the plate in an appropriate
swing-bucket rotor to clear condensate from the sides of the
wells and to remove any air bubbles present in the samples.
Use a plate reader to measure absorbance at 540 nm.
(10) Determine the TAG concentration for each sample by sub-
tracting the absorbance for the free glycerol in the untreated
samples from the total glycerol concentration in samples
that have been incubated with triglyceride reagent. The
TAG content in each sample is calculated based on the
triolein-equivalent standard curve. This assay is linear from
0–1.0 mg/ml TAG.
As with any metabolic measurement, TAG levels must be con-
sidered in the larger context of animal growth and physiology.
Mutations that delay developmental progression and alter adult
body size could produce proportional changes in TAG in that do
not reflect metabolic defects. Similarly, wild-type adult flies do
not feed for a prolonged period after eclosion, and need to be aged
several days to achieve maturity [39]. Thus to prevent inaccurate
results, all samples should be developmentally staged and normal-
ized to an internal parameter such as soluble protein (although the
effects of a mutation on protein levels may require another
method, such as body weight, for normalization). A simple method
for measuring protein concentration is to remove 10 ll of homog-
enized sample prior to heat treatment, dilute between 1:10 and
1:20 in cold PBS, and use 10 ll of the dilution to conduct a Bradford
assay [40]. If protein concentration is not measured immediately,
samples should be stored at !80 !C.
4.3. Cholesterol quantification
Cholesterol is an essential component of cell membranes and
also the precursor for steroid hormone biosynthesis. In addition
to free cholesterol, cholesterol esterified to long chain fatty acids
is present in circulating lipoprotein particles as well as stored in li-
pid droplets. A fluorometric assay has been widely used to quantify
free cholesterol in Drosophila larvae and adults [14,41–44]. In addi-
tion, by sonicating the extracts to emulsify lipids and including
cholesterol esterase in the reaction, cholesterol esters can be di-
gested into free cholesterol, which can then be quantified by the
fluorometric assay and compared to the background level of free
cholesterol present in the sample. We use the Amplex Red Choles-
terol assay (Invitrogen; A12216) to detect either free cholesterol or
esterified cholesterol, as described below. This kit uses cholesterol
oxidase to convert free cholesterol into cholest-4-en-3-one and
hydrogen peroxide. The hydrogen peroxide then reacts with 10-
acetyl-3,7-dihydroxyphenoxazine in the presence of horseradish
peroxidase to generate resorufin, which can be detected by its fluo-
rescence at "590 nm. It should be noted that this assay will detect
all sterols, including the abundant sterols in Drosophila (ergosterol
and dehydrocholesterol), all of which are defined by a hydroxyl
group at the 3-position of the A-ring [33].
4.4. Protocol: fluorescent assay for free cholesterol
This assay does not involve sonicating the samples and thus
measures primarily free sterols. Sonication is needed to release
and emulsify the cholesterol esters stored in lipid droplets.
Although cholesterol esterase is included in this assay, it makes lit-
tle difference in the final result.
(1) Follow the Amplex Red Cholesterol Assay Kit (Invitrogen;
A12216) instructions to prepare aliquots of the 20 mM
Amplex Red reagent in DMSO, 200 U/ml HRP in 1# reaction
buffer, 200 U/ml cholesterol oxidase in 1# reaction buffer,
and 200 U/ml cholesterol esterase in 1# reaction buffer.
These can be stored at !20 !C for later use.
(2) Collect samples in 1.5 ml microfuge tubes (75 embryos, 30
first instar larvae, 5 adult male flies). Rinse several times
with cold PBS to remove all traces of food that might be
attached to the outside of the animal. Embryos should be
dechorionated following standard procedures and subse-
quently transferred to a 1.5 ml microfuge tube. Larvae can
be washed in a 1.5 ml microfuge tube, but adults should
be rinsed in a 9-well glass plate. Transfer adult flies to a
1.5 ml microfuge tube. Carefully remove all liquid. For
larvae, centrifuge at 3000#g and remove all remnants of PBS.
(3) Homogenize animals in 100 ll of 1# reaction buffer with a
pellet pestle (Kontes; 749521–1500) on ice. A motor can be
used to facilitate homogenization (Kontes; 749540–0000).
(4) Centrifuge homogenate for 5 min at 2300#g at room tem-
perature. Transfer the supernatant to a fresh 1.5 ml micro-
fuge tube, including the upper ‘‘fatty’’ layer and mix
gently. Remove 10 ll of homogenized sample to measure
protein content with a Bradford assay. Keep samples on ice
and do not heat-treat. Protein samples can be frozen and
stored at !80 !C for later analysis.
(5) Prepare cholesterol standards in 1# reaction buffer using the
2 mg/ml cholesterol reference standard provided in the kit.
We prepare a dilution series, ending up with at least 50 ll
each of 0, 2, 4, 6, 8 lg/ml cholesterol.
(6) Add 50 ll of the cholesterol standards and a 1# reaction buf-
fer blank to the first row of a black 96 well plate (Optiplate-
96 Perkin Elmer; 6005270). In the next row, add 50 ll of
each sample into individual wells.
(7) Prepare the reaction mix using stored aliquots:
15 ll 20 mM Amplex Red reagent in DMSO
10 ll 200 U/ml HRP in 1# reaction buffer
10 ll 200 U/ml cholesterol oxidase in 1# reaction buffer
1 ll 200 U/ml cholesterol esterase in 1# reaction buffer
+1494 ll 1# reaction buffer
(8) Add 90 ll of reaction mix to each well with a multichannel
pipette. Be sure to keep in the dark and incubate at least
30 min at 37 !C.
(9) Measure immediately using a fluorescence plate reader with
excitation at 530 nm and emission at 590 nm. Each data
point resulting from the assay should represent an average
of at least three collections of animals, and the assay should
be repeated at least three times.
4.5. Protocol: fluorescent assay for cholesterol esters
This assay uses sonication of the animal homogenates to release
and emulsify the cholesterol esters stored in lipid droplets. Each
sample is then divided into two tubes, one of which is treated with
cholesterol esterase. The amount of cholesterol esters is deter-
mined by subtracting the background level of free cholesterol in
the untreated sample from the total amount of esterified and free
cholesterol present in the sample treated with cholesterol esterase.
(1) Follow the Amplex Red Cholesterol Assay Kit (Invitrogen;
A12216) instructions to prepare aliquots of the 20 mM
Amplex Red reagent in DMSO, 200 U/ml HRP in 1# reaction
buffer, and 200 U/ml cholesterol oxidase in 1# reaction buf-
fer. These can be stored at !20 !C for later use.









(2) Collect samples in 1.5 ml microfuge tubes (30 adult male
flies). Rinse animals several times with cold PBS to remove
all traces of food. Carefully remove all liquid and homoge-
nize animals in 250 ll of cold PBS + 0.05% Tween 20 (PBST)
with a pellet pestle (Kontes; 749521-1500) on ice. A motor
can be used to facilitate homogenization (Kontes; 749540-
0000). Remove 10 ll of homogenized sample to measure
protein content with a Bradford assay. Protein samples can
be frozen and stored at !80 !C for later analysis.
(3) Add 650 ll of cold PBST to each sample and sonicate on ice
using a tip sonicator, three times for 30 sec each, at a
medium setting to prevent foaming.
(4) Split each sample into two 1.5 ml microfuge tubes and add
10 ll of 200 U/ml cholesterol esterase (either Sigma C1403
or C3766) to one set of tubes.
(5) Incubate both sets of tubes overnight (>16 h) at 37 !C with
occasional vortexing.
(6) Extract all tubes with 900 ll 2:1 chloroform:methanol by
shaking the tubes several times vigorously over a period of
about 3 min. Centrifuge to separate the phases, remove the
lower organic phase, and transfer to a fresh 1.5 ml microfuge
tube. Use a centrifugal vacuum concentrator to remove all of
the organic solvent, leaving an oily lipid residue (approx.
30 min).
(7) Solubilize lipids in 500 ll PBST by vortexing and sonicating
as above.
(8) Prepare free cholesterol standards in 1" reaction buffer
using the 2 mg/ml cholesterol reference standard provided
in the kit. We prepare a dilution series, ending up with at
least 50 ll each of 0, 2, 4, 6, 8 lg/ml cholesterol.
(9) Add 50 ll of the cholesterol standards and a 1" reaction
buffer blank to the first row of a black 96 well plate
(Optiplate-96 Perkin Elmer; 6005270). In the next rows,
add a 1:1 dilution of each sample with 1" reaction buffer
(25 ll of each sample + 25 ll 1" reaction buffer) to each
well.
(10) Prepare the reaction mix using stored aliquots:
15 ll 20 mM Amplex Red reagent in DMSO
10 ll 200 U/ml HRP in 1" reaction buffer
10 ll 200 U/ml cholesterol oxidase in 1" reaction buffer
+1495 ll 1" reaction buffer
(11) Add 90 ll of reaction mix to each well with a multichannel
pipette. Be sure to keep in the dark and incubate for at least
30 min at 37 !C.
(12) Measure immediately using a fluorescence plate reader with
excitation at 530 nm and emission at 590 nm.
(13) Determine the amount of cholesterol esters by subtracting
the measurements performed on samples that were not
treated with cholesterol esterase from those that were trea-
ted with the enzyme. Each data point resulting from the
assay should represent an average of at least three collec-
tions of animals, and the assay should be repeated at least
three times.
4.6. Stains
While quantitative assays provide a means of measuring total
stored TAG or cholesterol, staining of these neutral lipids in the
intestine, fat body, and oenocytes provide a valuable cell based
assay. This is especially powerful when combined with clonal anal-
ysis of mutant cells [45–47]. If relative quantification between
samples is the goal, however, all samples should be prepared
simultaneously and analyzed to ensure that the final results are
not influenced by variations in temperature, dye concentration,
incubation time, or microscope settings. Ideally, experimental
and control slides should be randomized and scored blindly to
eliminate confirmation bias. Many dyes are available for lipid
detection, with Oil Red O, Sudan Black, and Nile Red being the most
commonly used.
4. 6.1. Oil Red O
The dye Oil Red O provides a reliable means to visually assess
neutral lipids in fixed tissues [48–51]. Animals are dissected and
fixed using 4% formaldehyde in PBS for 30 min, washed twice in
PBS and twice in 100% propylene glycol. Fixed tissues are then
stained in a solution of 0.5% Oil Red O (Sigma; O0625) dissolved
in propylene glycol, which has been filtered through Whatman
#1 filter paper and preheated to 60 !C. Allow samples to incubate
for 1 h at 60 !C, then wash twice with 85% propylene glycol and
twice with PBS at room temperature. Stained samples are mounted
on microscope slides using glycerol. The use of this dye in Drosoph-
ila is well documented and provides a sensitive means to assay
neutral lipids in the oenocytes and intestine. The density of TAG
in the fat body, however, results in an Oil Red O stain that is too
intense for identifying modest defects in fat storage.
4.6.2. Sudan Black
Similar to Oil Red O, the dye Sudan Black allows for an accurate
assessment of neutral lipid stores in fixed tissues [49,52]. Tissues
that have been fixed with 4% formaldehyde are rinsed twice with
PBS, once with 50% ethanol, and then stained for 2 min at room
temperature with prefiltered 0.5% Sudan Black (Sigma; 199664)
dissolved in 75% ethanol. Once staining is completed, samples
are sequentially rinsed with 50% ethanol, 25% ethanol, and PBS be-
fore mounting on a microscope slide with glycerol. In general, Su-
dan Black results in less intense tissue stains than Oil Red O and
thus is better suited for visualizing the high levels of TAG in the
fat body.
4.6.3. Nile Red
Unlike Oil Red O and Sudan Black, Nile Red can be used to visu-
alize neutral lipids in unfixed tissues [53]. Animals should be
quickly dissected in a solution of 0.00002% Nile Red (Sigma;
19123) and 75% glycerol, and visualized using confocal micros-
copy. Although relatively straightforward, the use of Nile Red is
somewhat limited and can be employed improperly [54–56].
While this dye allows for the qualitative assessment of lipid drop-
let size and shape, it should not be used to quantitatively measure
fat reserves.
5. Methods to measure basic metabolites: carbohydrates
Proper regulation of carbohydrate homeostasis is critical for
maintaining normal physiology. The two primary forms of circulat-
ing carbohydrates in Drosophila are glucose and trehalose (a disac-
charide of glucose). While trehalose is abundant in larval
hemolymph, circulating glucose and trehalose can be readily de-
tected in the adult fly (Fig. 1). These sugars serve a variety of pur-
poses, including providing an essential energy source through
glycolysis, substrates for biosynthetic reactions in growing ani-
mals, and energy storage in the form of glycogen.
5.1. Enzymatic assays
A number of enzymatic assays are commercially available to
quantify levels of specific sugars and related metabolic intermedi-
ates. Although initially developed for use in mammalian systems,
many of these assays have been successfully co-opted for use in
Drosophila. Care should be taken, however, to properly validate
each enzymatic assay for a particular experimental system and/
or developmental stage.








Two enzymatic-based methods have been widely used to
measure free glucose levels in flies. The first of these utilizes the
enzyme Hexokinase (HK) to phosphorylate glucose, producing
glucose-6-phosphate [57]. Subsequent oxidation of glucose-
6-phosphate by glucose-6-phosphate dehydrogenase produces
6-phosphogluconate and NADH. Spectrophotometric readings at
340 nm can then be used to assess the amount of NADH produced,
as it naturally absorbs ultraviolet light at this wavelength. With
this method, NADH production is directly proportional to the start-
ing glucose concentration. Alternatively, free glucose levels can be
measured through a colorimetric-based enzymatic assay. This
method employs Glucose Oxidase (GO) activity to catalyze the oxi-
dation of glucose to hydrogen peroxide and gluconic acid [58]. Sub-
sequently, the hydrogen peroxide and an added compound, o-
dianisidine, react to produce an oxidized form of o-dianisidine (or-
ange color) in the presence of peroxidase. Sulfuric acid is then
added to stop the reaction and convert the color to a pink hue,
which can be quantified at an absorbance of 540 nm.
In our hands, the GO assay cannot be used to accurately quan-
tify carbohydrates in pupae; rather, the HK protocol should be fol-
lowed when studying this stage in development (W. Barry,
unpublished results). This finding emphasizes the need to carefully
validate the use of metabolite assays in new experimental contexts
prior to their use. In addition, when using either the GO or HK pro-
tocol, it is important to keep the samples of homogenized tissue
cold and to move rapidly prior to heat inactivation, which is essen-
tial to prevent the enzymatic breakdown of glycogen and trehalose
into glucose by endogenous enzymes in the extract. Similar to the
TAG assay described above, 10 ll of homogenate should be re-
moved prior to heat inactivation and reserved for Bradford quanti-
fication of protein levels, providing a means to internally normalize
glucose levels (although, as discussed above, effects of a mutation
on protein levels may require another method for normalization).
5.1.2. Protocol: glucose quantification
(1) Collect samples (25 mid-second instar larvae; 5 adult flies).
(2) Rinse several times with 1 ml cold PBS to remove all traces
of food that might be attached to the outside of the animal.
Larvae can be washed in a 1.5 ml microfuge tube, but adults
should be rinsed in a 9-well glass plate. Transfer adult flies
to a 1.5 ml microfuge tube. Carefully remove all liquid. For
larvae, centrifuge at 3000!g and remove all remnants of
PBS. Snap freeze animals in liquid nitrogen for later homog-
enization or add 100 ll cold PBS.
(3) Rapidly homogenize animals in PBS with a pellet pestle
(Kontes; 749521-1500) on ice. A motor can be used to facil-
itate homogenization (Kontes; 749540-0000). Frozen sam-
ples should be kept on dry ice until addition of PBS. If
samples are not kept cold, glycogen and trehalose will be
enzymatically degraded into free glucose by endogenous
enzymes and skew the final analysis.
(4) Remove 10 ll of homogenized sample to measure protein
content with a Bradford assay. Keep samples on ice and do
not heat-treat. Protein samples can be frozen and stored at
"80 !C for later analysis.
(5) Heat supernatant for 10 min at 70 !C, then centrifuge for
3 min at maximum speed in a refrigerated tabletop centri-
fuge that has been prechilled to 4 !C.
(6) Pipette the resulting supernatant into a new 1.5 ml micro-
fuge tube. At this time, the heat-inactivated sample can be
frozen and stored at "80 !C, if desired.
(7) Prepare glucose standards: Dilute 16 ll of 1 mg/ml glucose
with 84 ll PBS (100 ll final volume) for 0.16 mg/ml stan-
dard. Do four 2-fold serial dilutions into PBS (50 ll
0.16 mg/ml + 50 ll PBS for 0.08 mg/ml standard, etc.) to gen-
erate 0.01, 0.02, 0.04, 0.08, and 0.16 mg/ml glucose stan-
dards. These assays are linear from 0.01 to 0.16 mg/ml
glucose. Glucose stock solutions can be stored at "20 !C or
4 !C.
(8) Add 30 ll of glucose standards and a PBS blank to the first
row of a clear-bottom 96 well plate. In the next row, add
30 ll of each sample into an individual well (after diluting
them 1:4–1:8 with PBS).
(9a) For GO assay: Add 100 ll of GO reagent (Sigma; GAGO-20)
to each well with a multichannel pipette. Seal the wells with
parafilm to prevent evaporation and incubate the plate at
37 !C for 30–60 min. Stop the reaction by adding 100 ll of
12 N H2SO4 (the samples should visibly change color from yel-
low/orange to pink). Centrifuge the plate in an appropriate
swing-bucket rotor to clear condensate from the sides of the
wells and to remove any air bubbles present in the samples.
Use a plate reader to measure absorbance at 540 nm. Determine
the free glucose concentration by comparing the free glucose
measurements for each sample to the glucose standard curve.
(9b) For HK assay: Add 100 ll of HK reagent (Sigma; GAHK20)
to each well with a multichannel pipette. Seal the wells with
parafilm to prevent evaporation and incubate the plate at room
temperature for 15 min. Centrifuge the plate in an appropriate
swing-bucket rotor to clear condensate from the sides of the
wells and to remove any air bubbles present in the samples.
Use a plate reader to measure absorbance at 340 nm. Determine
the free glucose concentration by comparing the free glucose
measurements for each sample to the glucose standard curve.
Glucose transporters are bidirectional, and thus free glucose
will travel freely between intracellular and extracellular compart-
ments. As a result, most free glucose is found in the circulating
fluid rather than within cells. Measurements of free glucose from
whole animal homogenates therefore provide an approximate
assessment of circulating glucose levels. As always, however, accu-
rate measurements of circulating trehalose or glucose can only be
made by using hemolymph samples (see below).
5.1.3. Trehalose
Trehalose represents the major circulating sugar in Drosophila
and, together with glucose, provides essential information about
the metabolic state of an animal. Trehalose is quantified by an as-
say that is based on the protocol for measuring glucose levels, de-
scribed above [59,60]. The difference is that trehalase is added to

































Fig. 1. Circulating trehalose and glucose levels in larvae and adults (A) Circulating
trehalose is approximately equivalent and abundant during larval and adult stages.
(B) In contrast, circulating glucose is low in larvae and is elevated during adulthood.
Hemolymph was collected from w1118 mid-third instar larvae and 5 day old adults
maintained on a standard cornmeal-based lab medium by puncturing the cuticle
with a tungsten needle followed by centrifugation through glass wool into a
collection tube. Circulating trehalose and glucose concentrations were determined
using the HK assay kit.









be quantified by standard assays and compared to the background
level of glucose present in the original sample.
5.1.4. Protocol: trehalose quantification
(1) Collect samples (25 mid-second instar larvae; 5 adult flies).
(2) Rinse several times with 1 ml cold PBS to remove all traces
of food that might be attached to the outside of the animal.
Larvae can be washed in a 1.5 ml microfuge tube, but adults
should be rinsed in a 9-well glass plate. Transfer adult flies
to a 1.5 ml microfuge tube. Carefully remove all liquid. For
larvae, centrifuge at 3000!g and remove all remnants of
PBS. Snap freeze animals in liquid nitrogen for later homog-
enization or add 100 ll cold Trehalase Buffer (TB) (5 mM Tris
pH 6.6, 137 mM NaCl, 2.7 mM KCl).
(3) Rapidly homogenize animals in TB with a pellet pestle (Kon-
tes; 749521-1500) on ice. A motor can be used to facilitate
homogenization (Kontes; 749540-0000). Frozen samples
should be kept on dry ice until addition of TB. If samples
are not kept cold, glycogen and trehalose will be enzymati-
cally degraded into free glucose by endogenous enzymes
and skew the final analysis.
(4) Remove 10 ll of homogenized sample to measure protein
content with a Bradford assay. Keep samples on ice and do
not heat-treat. Protein samples can be frozen and stored at
"80 !C for later analysis.
(5) Heat supernatant for 10 min at 70 !C, then centrifuge for
3 min at maximum speed in a refrigerated tabletop centri-
fuge that has been prechilled to 4 !C.
(6) Pipette the resulting supernatant into a new 1.5 ml micro-
fuge tube. At this time, the heat-inactivated sample can be
frozen and stored at "80 !C, if desired.
(7) Prepare the trehalase stock (TS) by diluting 3 ll porcine tre-
halase (Sigma; T8778-1UN) in 1 ml TB.
(8) Generate glucose and trehalose standards for standard
curves:
For glucose standards, dilute 16 ll of 1 mg/ml glucose stock
solution with 84 ll TB (100 ll final volume) to generate a
0.16 mg/ml standard. Conduct a series of 2-fold serial dilu-
tions of the 0.16 mg/ml standard using TB (50 ll 0.16 mg/
ml + 50 ll TB for 0.08 mg/ml standard) to generate 0.01,
0.02, 0.04, 0.08, and 0.16 mg/ml glucose standards. Aliquots
of glucose stock solution can be stored at "20 !C or 4 !C.
For trehalose standards, dilute 16 ll of 1 mg/ml trehalose
(Sigma; 90208) with 50 ll TS and 34 ll TB (100 ll final vol-
ume) for 0.16 mg/ml standard. Conduct a series of 2-fold
serial dilutions of the 0.16 mg/ml standard using a 1:1 mix
of TB and TS (e.g., 50 ll 0.16 mg/ml + 50 ll TB + TS for
0.08 mg/ml standard) to generate 0.01, 0.02, 0.04, 0.08, and
0.16 mg/ml trehalose standards. Aliquots of trehalose stock
solution can be stored at "20 !C or 4 !C.
(9) Add 30 ll of TB blank or glucose standards to 30 ll TB in
1.5 ml microfuge tubes.
(10) Add 30 ll of TB blank or trehalose standards to two sets of
1.5 ml microfuge tubes. In one set, add 30 ll of TB to deter-
mine free glucose. In other set, add 30 ll TS to digest treha-
lose to glucose.
(11) If necessary, dilute fly samples between 1:2 and 1:4 in TB.
Larval samples do not need diluting at this step unless ana-
lyzing a mutant that possesses particularly high trehalose
levels.
(12) Add 30 ll of each fly sample to two 1.5 ml microfuge tubes.
In the first tube, add 30 ll of TB to determine the back-
ground level of free glucose. In the second tube, add 30 ll
of TS to digest trehalose into free glucose.
(13) Incubate all standards and samples at 37 !C for 18–24 h.
(14) Centrifuge at maximum speed in a tabletop centrifuge for
3 min. Transfer 30 ll of each sample into an individual well
of a 96-well plate for analysis and use either the GO or HK
assay to measure free glucose.
(15) Free glucose concentration in each sample is calculated
based on the glucose standard curve. For trehalose measure-
ments, first subtract the absorbance measured for free glu-
cose in the untreated samples from the absorbance of the
samples that have been digested with trehalase. The treha-
lose content in each sample is then calculated based on
the trehalose standard curve. This method is linear from
0.01 to 0.16 mg/ml trehalose.
5.1.5. Hemolymph
While analysis of whole animal homogenates provides a rela-
tively easy and high throughput approach for quantifying glucose
and trehalose, this method does not distinguish between circulat-
ing and stored sugars, and can be complicated by the presence of
food within the gut. Therefore, hemolymph samples are used to di-
rectly assay circulating sugars. Several alternate methods for
hemolymph collection have been described for both larvae and
adults [61–64]. Protocols based on filtration by centrifugation
and capillary-based collection of hemolymph are most widely
used. The centrifugation approach requires approximately 30–50
adult females (adult males contain less hemolymph per fly and
thus require larger numbers) carefully punctured in the thorax
using a tungsten needle. Punctured flies are placed in a 0.5 ml
microfuge tube that contains a hole at the bottom of the tube,
which is packed with glass wool. This tube is then placed within
a 1.5 ml collection tube and centrifuged at 9000!g for 5 min at
4 !C, yielding approximately 1.5 ll of hemolymph. Longer centrifu-
gation times, higher speeds, and more flies can increase yield, but
may also increase cellular or intestinal contamination. One way to
detect possible contamination from intestinal contents is to add
food coloring to the medium and check the collected hemolymph
for the absence of the dye. Additionally, hemolymph can be ana-
lyzed under a dissection scope for the absence of cellular debris.
Hemolymph can also be collected by immobilizing an adult fly
wing-side down on a piece of double-sided tape and carefully
puncturing the head cuticle with a tungsten needle [64]. Gentle
pressure is applied to the thorax with a blunt object, and a capillary
tube or pipette tip is used to collect the small drop of hemolymph
that is forced out of the puncture site. While this method is labor
intensive and not well suited for the collection of large numbers
of samples, it minimizes potential hemolymph contamination.
Regardless of which method is used, a 1 ll aliquot of the col-
lected hemolymph is diluted in 99 ll of trehalase buffer (1:100),
followed by heat treatment for 5 min at 70 !C to inactivate endog-
enous trehalase. After heat treatment, the sample is split into two
50 ll aliquots, one of which is diluted further with an equal vol-
ume of trehalase buffer alone, and the other with trehalase buffer
plus trehalase [3 ll of porcine trehalase (Sigma; T8778-1UN) per
1 ml of buffer]. The resulting sample will have a final dilution of
1:200. These diluted samples are then placed at 37 !C for 18–
24 h to allow for breakdown of trehalose into free glucose. A
30 ll aliquot of each sample (+/"trehalase) is then loaded onto a
96 well plate to measure the concentration of hemolymph treha-
lose and glucose using the enzymatic assays described above. As
previously mentioned, the ideal dilution will depend on dietary
conditions, genetic background and developmental stage.
5.1.6. Glycogen
Most carbohydrate in the fly is stored in the form of glycogen,
which provides a large and accessible energy source during times
of fasting and intense activity. Most glycogen in the adult fly is
stored in the fat body, flight muscle, halteres, and gut, while larval









glycogen is primarily located in the body wall muscle [3,65].
Although periodic acid/Schiff staining can be used to visually as-
sess glycogen deposits, the easiest and most quantitative method
uses an enzymatic assay that breaks down glycogen into molecules
of free glucose, which is then quantified using the GO or HK assays
described above [66]. As with the other assays above, homogenized
tissue samples must be kept cold and moved rapidly to the heat
treatment step to prevent the breakdown of glycogen into free glu-
cose by endogenous enzymes present in the extract. Due to the
high level of glycogen in the samples, the resulting supernatant
should be appropriately diluted to ensure that the concentrations
of all samples are within the linear range of the assay. If the con-
centration of any sample exceeds that of the 0.16 mg/ml glycogen
standard, then the assay should be repeated using more dilute
samples. Although either the GO or HK assays can be used to mea-
sure glycogen, the HK assay is preferred for glycogen measure-
ments in pupae, when the GO kit can be unreliable.
5.1.7. Protocol: glycogen quantification using the GO kit
(1) Collect samples (25 mid-second instar larvae; 5 adult flies).
(2) Rinse several times with 1 ml cold PBS to remove all traces
of food that might be attached to the outside of the animal.
Larvae can be washed in a 1.5 ml microfuge tube, but adults
should be rinsed in a 9-well glass plate. Transfer adult flies
to a 1.5 ml microfuge tube. Carefully remove all liquid. For
larvae, centrifuge at 3000!g and remove all remnants of
PBS. Snap freeze animals in liquid nitrogen for later homog-
enization or add 100 ll cold PBS.
(3) Rapidly homogenize animals in PBS with a pellet pestle
(Kontes; 749521-1500) on ice. A motor can be used to facil-
itate homogenization (Kontes; 749540-0000). Frozen sam-
ples should be kept on dry ice until addition of PBS. If
samples are not kept cold, glycogen and trehalose will be
enzymatically degraded into free glucose by endogenous
enzymes and skew the final analysis.
(4) Remove 10 ll of homogenized sample to measure protein
content with a Bradford assay. Keep samples on ice and do
not heat-treat. Protein samples can be frozen and stored at
"80 !C for later analysis.
(5) Heat supernatant for 10 min at 70 !C, then centrifuge for
3 min at maximum speed in a refrigerated tabletop centri-
fuge that has been prechilled to 4 !C.
(6) Pipette the resulting supernatant into a new 1.5 ml micro-
fuge tube. At this time, the heat-inactivated sample can be
frozen and stored at "80 !C, if desired.
(7) Set up glucose and glycogen standards. Using 1 mg/ml glu-
cose or glycogen stock solutions, make a dilution series of
glucose or glycogen standards in PBS, both in the range of
0–0.16 mg/ml, as outlined in glucose assay protocol. Glyco-
gen stock solutions can be stored at "20 !C or 4 !C.
(8) Add 30 ll of each glycogen standard (including PBS blank) to
the top row of a clear-bottom 96 well plate. Similarly, add
30 ll of each glucose standard in the next row down.
(9) Dilute heat-treated fly samples for glycogen measurements
1:5 in PBS (the required dilution may range from 1:5 to
1:20 depending on experimental conditions) and load
30 ll into each well. Samples should be loaded in duplicate
rows such that one row will be used to measure glyco-
gen + glucose (treated with amyloglucosidase) and the adja-
cent row will be used to measure glucose alone (no
amyloglucosidase).
(10) Prepare the GO reagent (see glucose assay protocol) for your
glycogen measurements by adding 1 ll amyloglucosidase
(Sigma A1602; 25 mg) per 1 ml of GO reagent.
(11) Using a multichannel pipette, add 100 ll of GO reagent +
amyloglucosidase to the glycogen standards and the first
row of each set of duplicate samples. Then add 100 ll of
GO reagent alone (without amyloglucosidase) to the glucose
standards and the remaining samples.
(12) Seal the wells with parafilm to prevent evaporation and
incubate the plate at 37 !C for 30–60 min. Briefly centrifuge
the plate in an appropriate swing-bucket rotor to clear con-
densate from the sides of the wells and remove any air bub-
bles present in the samples. Then add 100 ll of 12 N sulfuric
acid andmeasure absorbance at 540 nm using a plate reader.
(13) Free glucose concentration in each sample is calculated
based on the glucose standard curve. For glycogen measure-
ments, first subtract the absorbance measured for free glu-
cose in the untreated samples from the absorbance of the
samples that have been digested with amyloglucosidase.
The glycogen content in each sample is then calculated
based on the glycogen standard curve. This method is linear
from 0.01 to 0.16 mg/ml glycogen.
5.1.8. Protocol: glycogen quantification using the HK kit
(1) Collect samples (25 mid-second instar larvae; 5 adult flies).
(2) Rinse several times with 1 ml cold PBS to remove all traces
of food that might be attached to the outside of the animal.
Larvae can be washed in a 1.5 ml microfuge tube, but adults
should be rinsed in a 9-well glass plate. Transfer adult flies
to a 1.5 ml microfuge tube. Carefully remove all liquid. For
larvae, centrifuge at 3000!g and remove all remnants of
PBS. Snap freeze animals in liquid nitrogen for later homog-
enization or add 100 ll cold PBS.
(3) Rapidly homogenize animals in PBS with a pellet pestle
(Kontes; 749521-1500) on ice. A motor can be used to facil-
itate homogenization (Kontes; 749540-0000). Frozen sam-
ples should be kept on dry ice until addition of PBS. If
samples are not kept cold, glycogen and trehalose will be
enzymatically degraded into free glucose by endogenous
enzymes and skew the final analysis.
(4) Remove 10 ll of homogenized sample to measure protein
content with a Bradford assay. Keep samples on ice and do
not heat-treat. Protein samples can be frozen and stored at
"80 !C for later analysis.
(5) Heat supernatant for 10 min at 70 !C, then centrifuge for
3 min at maximum speed in a refrigerated tabletop centri-
fuge that has been prechilled to 4 !C.
(6) Pipette the resulting supernatant into a new 1.5 ml micro-
fuge tube. At this time, the heat-inactivated sample can be
frozen and stored at "80 !C, if desired.
(7) Prepare amyloglucosidase stock (AS) solutionbyadding1.5 ll
amyloglucosidase (Sigma A1602; 25 mg) to 1 ml of PBS.
(8) Set up glycogen standards by diluting 16 ll of glycogen
stock (1 mg/ml) with 50 ll of AS solution and 34 ll of PBS
(100 ll final volume) for 0.16 mg/ml standard. Do four 2-
fold serial dilutions into 1:1 mix of AS and 1!PBS (50 ll
0.16 mg/ml + 50 ll AS + PBS for 0.08 mg/ml standard, etc.)
to generate 0.01, 0.02, 0.04, 0.08, and 0.16 mg/ml glycogen
standards. Glucose standards should be diluted as outlined
in the glucose assay protocol (no amyloglucosidase added).
(9) In 1.5 ml microfuge tubes, dilute the heat-treated fly sam-
ples 1:3 in PBS (this dilution can range from 1:2 to 1:5
depending on experimental conditions) by combining 20 ll
of sample with 40 ll PBS. Aliquot 20 ll of these diluted sam-
ples into two separate tubes, one containing 20 ll of AS solu-
tion, and the other containing 20 ll of PBS (final sample
dilution will equal 1:6).








(10) Add 30 ll of each glycogen standard (including PBS blank) to
one row at the top of the plate. Add 30 ll of the glucose stan-
dards (and PBS blank) to the next row.
(11) Load 30 ll of each diluted sample to the plate. Samples
should be loaded in duplicate rows such that one row will
be used to measure glycogen + glucose (amyloglucosidase
treated) and the adjacent row will be used to measure glu-
cose alone (no amyloglucosidase).
(12) Seal the wells with parafilm and incubate the plate at 37 !C
for 60 min to digest the glycogen. Spin briefly to clear the
condensate from the sides of the wells.
(13) Add 100 ll of HK reagent to each well with a multichannel
pipette and incubate at room temperature for 15 min. Mea-
sure absorbance at 340 nm using a plate reader.
(14) Free glucose concentration in each sample is calculated
based on the glucose standard curve.
For glycogen measurements, first subtract the absorbance
measured for free glucose in the untreated samples from the absor-
bance of the samples that have been digested with amyloglucosi-
dase. The glycogen content in each sample is then calculated
based on the glycogen standard curve. This method is linear from
0.01 to 0.16 mg/ml glycogen.
6. ATP
ATP measurements represent a direct readout of cellular energy
levels and thus can provide important insights into metabolic phe-
notypes. This analysis can be conducted with a luciferase-based as-
say kit that uses endogenous ATP to generate light [67]. Because
ATP is so unstable, a chaotropic buffer is used to preserve as much
of the intact metabolite as possible.
6.1. Protocol: fluorescence assay for ATP quantification
(1) Collect samples (25 mid-second instar larvae; 5 adult flies).
(2) Rinse several times with 1 ml cold PBS to remove all traces
of food that might be attached to the outside of the animal.
Larvae can be washed in a 1.5 ml microfuge tube, but adults
should be rinsed in a 9-well glass plate. Transfer adult flies
to a 1.5 ml microfuge tube. Carefully remove all liquid. For
larvae, centrifuge at 3000!g and remove all remnants of PBS.
(3) Prior to homogenizing the samples, prepare the ATP reaction
mix (Molecular Probes ATP kit; A22066) by mixing 3.56 ml
ddH20, 200 ll 20! reaction buffer, 40 ll 0.1 M DTT, 200 ll
10 mM D-luciferin, and 1 ll firefly luciferase. The resulting
mix is sufficient for 40 reactions, and should be kept on ice
and protected from light.
(4) Animals are rapidly homogenized in 100 ll of homogeniza-
tion buffer [6 M guanidine HCl, 100 mM Tris (pH 7.8),
4 mM EDTA] with a pellet pestle (Kontes; 749521-1500)
on ice. A motor can be used to facilitate homogenization
(Kontes; 749540-0000).
(5) Remove 10 ll of homogenized sample to measure protein
content with a Bradford assay. Keep samples on ice and do
not heat-treat. Protein samples can be frozen and stored at
"80 !C for later analysis.
(6) The remaining samples are boiled for 5 min and centrifuged
for 3 min at maximum speed in a refrigerated tabletop cen-
trifuge that has been prechilled to 4 !C.
(7) Transfer 10 ll of the supernatant into a 1.5 ml microfuge
tube and dilute 1:10 with 90 ll dilution buffer [25 mM Tris
(pH 7.8), 100 lM EDTA], then transfer 10 ll of the diluted
supernatant to a second 1.5 ml tube and dilute 1:75 by add-
ing 740 ll of dilution buffer (final dilution of 1:750). The
diluted homogenate is centrifuged at 20,000!g, and 10 ll
of the supernatant is transferred to individual wells of a
white, opaque 96 well plate (Corning; 3362).
(8) Prepare a series of ATP standards by diluting the 5 mM ATP
stock solution provided with the assay kit with ddH2O (0,
0.01, 0.05, 0.1, 0.5, 1 lM).Add10 ll of eachATPstandard solu-
tion to the first row of the plate to provide a standard curve.
ATP standards can be stored at "20 !C for several weeks.
(9) Start the assay by adding 100 ll of the luciferase reaction
mix with a multichannel pipette and immediately begin
measuring luminescence with a plate reader. A minimum
of three sequential measurements should be made for the
entire plate, and the results should be averaged.
(10) Determine the ATP concentration by comparing the lumi-
nescence measurements for each sample to the ATP stan-
dard curve.
7. Metabolomics
The emerging field of metabolomics provides an unprecedented
opportunity to simultaneously measure hundreds of metabolic
compounds in animal extracts. This technique has proven to be a
powerful tool for conducting studies in the fly [17,68–71]. In addi-
tion, when combined with classical genetic analysis, metabolomics
can be used to precisely identify metabolic reactions that are af-
fected by a mutation, providing key insights into gene function.
The field of metabolomics is too large to summarize in a single re-
view because a variety of methods have been developed to assay
several classes of metabolites, ranging from small, charged mole-
cules to lipids. Rather, we provide here a relatively simple protocol
that allows users to quantify#100 small, polarmolecules, which in-
cludes the basic amino acids, sugars, and intermediates in glycolysis
and the TCA cycle. This range of compounds is sufficient to provide
insights into the metabolic state of the corresponding animal.
7.1. Genetic background
Metabolomic analysis is particularly sensitive to genetic back-
ground effects. An example of this is the use of rosy mutant strains
as a control for transgenic lines that were established by scoring
for rescue of the eye phenotype. ry mutations render animals un-
able to synthesize uric acid, which not only results in elevated lev-
els of purine-related intermediates [72], but also induces
significant changes in a diverse group of metabolites, including
tryptophan, kynurenine, and related compounds [73]. Studies of
transgenic lines in which the ry background is not controlled
would therefore inaccurately identify widespread metabolic de-
fects. Similarly, yellow mutants exhibit defects in lysine metabo-
lism [74], and other widely-used mutant lines, such as white or
vermillion, may produce similar metabolomic artifacts. Therefore,
the same genetic background should be used for all samples, ide-
ally using multiple control genotypes for internal confirmation.
7.2. Sample collection
The amount of material required for a successful metabolomics
experiment varies depending on the developmental stage and type
of analysis. For a basic survey of small, polar metabolites using GC-MS,
samples should contain at least 300 embryos, 25 second-instar
larvae, and 20 mature adult males. All samples, except for larvae,
are collected in screw-cap tubes that contain 1.4 mm ceramic
beads (MoBio; 13113-50) and flash frozen in liquid nitrogen. These
tubes are designed for the Omni Bead Ruptor, described below.
Embryos do not need to be dechorionated prior to collection, but









should be washed gently with a paintbrush on a piece of Whatman
filter paper soaked in PBS. Larvae are collected in a 1.5 ml tube,
repeatedly washed with ice-cold PBS, and flash frozen in liquid
nitrogen. The frozen pellet is then dislodged by gently flicking
the tube and transferred into a pre-chilled screw cap tube with
ceramic beads.
7.3. Sample processing for GC–MS
All samples should be stored at !80 !C until processing, at
which point they are transferred to an enzyme-type carrier caddy
(Nunc Lab-Top cooler) that has been chilled to !20 !C. Add 800 ll
of prechilled 90% methanol containing 1.25 lg/ml succinic-d4 acid
(Sigma–Aldrich; 293075) and 6.25 lg/ml U-13C, U-15N amino acid
mix (Cambridge Isotope; CDNLM-6784) to each tube with a posi-
tive displacement pipette. These stable-isotope labeled internal
standards provide a means to normalize samples, provide quality
control, and allow for the monitoring of instrument efficiency
across batches. Additionally, negative controls that contain no fly
tissue should be prepared to detect chemical contamination and
false-positive peaks during the subsequent GC-MS analysis.
The hard cuticle of the fly is difficult to homogenize and
requires a strong physical disruption to efficiently release metabo-
lites. We have found that the Omni Bead Ruptor 24 homogenizer
(Omni International) is ideally suited to rapidly and efficiently dis-
rupt fly tissue, with samples homogenized for 30 sec at 6.45 m/sec.
While a variety of bead-filled tubes can be used for this purpose,
screw-cap tubes containing 1.4 mm ceramic beads are optimal
for removing extraction solvent after processing. Homogenized
samples are incubated at !20 !C for 1 h to enhance protein precip-
itation and centrifuged at 20,000"g for 5 min at 4 !C to remove the
resulting precipitate. The supernatant is transferred to a 1.5 ml
microfuge tube and the solvent removed with a Speed-Vac
(Genevac).
7.4. GC–MS analysis
We perform GC–MS analysis with a Waters GCT Premier mass
spectrometer fitted with an Agilent 6890 gas chromatograph and
a Gerstel MPS2 autosampler. Dried samples are suspended in
40 ll of 40 mg/ml O-methoxylamine hydrochloride (MOX) (MP
Biomedicals; 155405) in pyridine solution (EMD Millipore;
PX2012-7) and incubated for 1 h at 30 !C. Samples are then centri-
fuged for 5 min at 20,000"g to remove particulate matter, and
25 ll of the supernatant is placed in an autosampler vial (Agilent;
8010-0172 and 5181-1215) with a 250 ll deactivated glass mic-
rovolume liner (Agilent; 5183–2086). Forty microliters of N-
methyl-N-trimethylsilyltrifluoracetamide containing 1% TMCS
(MSTFA) (Thermo Scientific; TS-48915) is added automatically
via a Gerstal autosampler and the samples are incubated for
60 min at 37 !C with shaking. Following incubation, 3 ll of a fatty
acid methyl ester standard solution (FAMES; Table 2) is added via
the autosampler and 1 ll of the prepared sample is injected to the
gas chromatograph inlet at a 10:1 split ratio with the inlet temper-
ature held at 250 !C. Fatty acid methyl esters do not occur natu-
rally, but will elute in a highly reproducible manner across the
entire chromatogram. The retention time curve of FAMES solution,
therefore, allows for the building of reliable retention time libraries
of metabolites. Furthermore, this solution is used to assess column
quality because a degraded column will exhibit peak tailings of the
FAMES standards.
The gas chromatograph is set to an initial temperature of 95 !C
for one minute followed by a 40 !C/min ramp to 110 !C and a hold
time of 2 min. This is followed by a 5 !C/min ramp to 250 !C and a
third ramp to 330 !C with a final hold time of 3 min. A 30 meter
Phenomex ZB5-5 MSi column with a 5 meter long guard column
is employed for chromatographic separation. For each analysis,
instrument performance is assessed by analyzing the negative con-
trol samples, which only contain the internal standard. Experimen-
tal samples are only processed if the instrument passes a preset
sensitivity and peak shape criteria. Finally, samples are run in a
randomized order, except for quality control samples, which are
analyzed every nine samples.
7.5. Data analysis
An initial dataset is prepared using a targeted approach to iden-
tify known metabolites. Chromatograms are analyzed using the
MassLynx utility QuanLynx, and metabolites are identified based
on known retention times and mass fragmentation patterns. The
peak area for each metabolite is recorded, and the data is exported
to Excel. For our analyses, metabolite identity in QuanLynx is
experimentally established using pure, purchased standards, and
in limited cases by the commercially available NIST library (Na-
tional Institute of Standards and Technology; version 11). Marker-
Lynx is used for peak identification during a second, non-targeted
analysis of the chromatograms, and the formatted data is trans-
ferred to SIMCA-P+ for principle component analysis (PCA) and
partial least squares-discriminate (PLS-DA) analysis. If the PCA
analysis identifies significant separation between the experimental
groups, PLS-DA analysis is employed to detect significantly altered
metabolites. The peaks of unknown metabolites are quantified and
the resulting data is exported to Excel. Statistical analysis can be
performed with any number of software packages that are
available for uni- and multivariate analysis, including JMP and
Statistica.
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The Drosophila HNF4 nuclear receptor
promotes glucose-stimulated insulin
secretion and mitochondrial function in
adults
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Abstract Although mutations in HNF4A were identified as the cause of Maturity Onset Diabetes
of the Young 1 (MODY1) two decades ago, the mechanisms by which this nuclear receptor
regulates glucose homeostasis remain unclear. Here we report that loss of Drosophila HNF4
recapitulates hallmark symptoms of MODY1, including adult-onset hyperglycemia, glucose
intolerance and impaired glucose-stimulated insulin secretion (GSIS). These defects are linked to a
role for dHNF4 in promoting mitochondrial function as well as the expression of Hex-C, a homolog
of the MODY2 gene Glucokinase. dHNF4 is required in the fat body and insulin-producing cells to
maintain glucose homeostasis by supporting a developmental switch toward oxidative
phosphorylation and GSIS at the transition to adulthood. These findings establish an animal model
for MODY1 and define a developmental reprogramming of metabolism to support the energetic
needs of the mature animal.
DOI: 10.7554/eLife.11183.001
Introduction
The global rise in the prevalence of diabetes has prompted increased efforts to advance our under-
standing of metabolic systems and how they become disrupted in the diseased state. Although
genetics and environment have a significant impact on diabetes susceptibility, severity, and care, the
causal factors are often complex and unclear. Several cases of familial diabetes have been identified,
however, that show clear patterns of heritability due to monogenic disease alleles, highlighting these
genes as critical factors for glycemic control. To date, mutations in 13 genes have been shown to
cause autosomal dominant inheritance of Maturity Onset Diabetes of the Young (MODY1-13), repre-
senting the most common forms of monogenic diabetes. MODY patients typically present with
hyperglycemia and impaired glucose-stimulated insulin secretion (GSIS) by young adulthood, while
having normal body weight and lacking b-cell autoimmunity (Fajans and Bell, 2011). Consistent with
this, several genes associated with MODY have well-characterized functions in glucose homeostasis,
including the glycolytic enzyme Glucokinase (GCK/MODY2), and Insulin (INS/MODY10). Mechanistic
insight into the anti-diabetic roles of other MODY genes, however, remains limited.
The genetic basis for the first MODY subtype was reported two decades ago, identifying loss-of-
function mutations in Hepatocyte Nuclear Factor 4A (HNF4A) as responsible for MODY1
(Yamagata et al., 1996). HNF4A is a member of the nuclear receptor superfamily of ligand-regu-
lated transcription factors, which play important roles in the regulation of growth, development, and
metabolic homeostasis. Studies in mice demonstrated a critical requirement for Hnf4A in early devel-
opment, with null mutants dying during embryogenesis due to defects in gastrulation (Chen et al.,
1994). Heterozygotes, however, show no apparent phenotypes. As a result, tissue-specific genetic










studies were used to investigate the functions of Hnf4A in key tissues where it is expressed, includ-
ing the liver, kidney, intestine, and pancreatic b-cells. Two groups generated adult mice deficient for
Hnf4A in b-cells with the goal of modeling MODY1 (Gupta et al., 2005; Miura et al., 2006).
Although both studies reported impaired glucose tolerance in Hnf4A deficient mice, along with
defects in GSIS, neither study observed sustained hypoinsulinemic hyperglycemia – the defining
symptom that brings MODY1 patients to the clinic. As a result, we still have a limited understanding
of the mechanisms by which Hnf4A maintains carbohydrate homeostasis and the molecular basis for
MODY1.
Studies in Drosophila have revealed a high degree of conservation with major pathways that reg-
ulate cellular metabolism and systemic physiology in humans (Diop and Bodmer, 2015; Owusu-
Ansah and Perrimon, 2014; Padmanabha and Baker, 2014; Teleman et al., 2012). This includes a
central role for the insulin-signaling pathway in maintaining proper levels of circulating sugars
through nutrient-responsive secretion of Drosophila insulin-like peptides (DILPs) from neuroendo-
crine cells in the fly brain (Nassel et al., 2015). Destruction of these insulin-producing cells (IPCs)
results in elevated levels of circulating sugars, analogous to type 1 diabetes (Rulifson et al., 2002).
In addition, nutrient-sensing mechanisms for insulin release are conserved in adult Drosophila,
including roles for the Glut1 glucose transporter, mitochondrial metabolism, and ATP-sensitive
potassium channels in the IPCs, which respond to the anti-diabetic sulfonylurea drug glibenclamide
(Fridell et al., 2009; Kreneisz et al., 2010; Park et al., 2014). Consistent with these similarities, an
increasing number of studies in Drosophila have proven relevant to mammalian insulin signaling and
metabolic homeostasis, highlighting the potential to provide insight into human metabolic disorders
such as diabetes (Alfa et al., 2015; Owusu-Ansah and Perrimon, 2014; Park et al., 2014;
Ugrankar et al., 2015; Xu et al., 2012).
eLife digest Diabetes is a complex disease that is caused by a combination of factors, including
the person’s habits and environment, as well as their genetic make-up. However, there are some
rare forms of diabetes that are caused simply by mutations in single genes and are directly inherited.
For example, it has been known for twenty years that a type of diabetes called “Maturity Onset
Diabetes of the Young type 1” (or MODY1 for short) occurs when a gene called HNF4 is mutated or
deleted. The symptoms of MODY1 usually appear during early adulthood and include abnormally
high levels of sugar in the blood, as well as the pancreas not being able to release the hormone
insulin properly in response to these sugars.
Previous studies in mice have tried to understand how losing the HNF4 gene leads to MODY1.
However, these mouse models did not fully recreate the symptoms of this disorder and the precise
role of HNF4 in preventing diabetes remains unclear. Barry and Thummel have now used the fruit
fly, because it is a model organism with simple genetics, to help shed light on this question.
Furthermore, flies and mammals use many of the same pathways to control metabolism, making the
fly a good model for the disease in humans.
Barry and Thummel deleted the HNF4 gene in fruit flies and observed that the flies had all the
symptoms that are typical in people with MODY1. These symptoms included high sugar levels and
decreased production of insulin-like hormones. The experiments also showed that HNF4 normally
supports the proper expression of another gene called Hex-C; this gene encodes a protein that
senses how much sugar is available and helps to keep the amount of sugar circulating the body
within normal levels. Barry and Thummel went on to discover that the HNF4 gene is required for the
expression of some genes in structures called mitochondria, which provide most of the energy used
by animal cells. Lastly, the HNF4 gene became more active as the flies matured, and appeared to
help the metabolism of a developing fruit fly transition towards that of an adult.
Together these findings show that HNF4 protects against MODY1 by influencing several
components of sugar metabolism in fruit flies. In the future, more studies are needed to understand
how exactly HNF4 acts in mitochondria and to explore if similar results are seen in mammals.
DOI: 10.7554/eLife.11183.002
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Here we describe our functional studies of Drosophila HNF4 (dHNF4) with the goal of defining its
roles in maintaining carbohydrate homeostasis. dHNF4 is a close ortholog of human HNF4A, with
89% amino acid identity in the DNA-binding domain and 61% identity in the ligand-binding domain.
The spatial expression patterns of the fly and mammalian receptors are also conserved through evo-
lution, raising the possibility that they share regulatory activities (Palanker et al., 2009). In support
of this, our previous studies of dHNF4 mutant larvae demonstrated a critical role in fatty acid catabo-
lism, leading to defects in lipid homeostasis that are similar to those caused by liver-specific HNF4A
deficiency in mammals (Palanker et al., 2009). Here we report the first functional study of dHNF4
mutants at the adult stage of development. Our studies show that adult dHNF4 mutants display the
hallmark symptoms of MODY1, including hyperglycemia, glucose intolerance and impaired GSIS.
Metabolomic analysis of dHNF4 mutants revealed coordinated changes in metabolites that are indic-
ative of diabetes, along with an unexpected effect on mitochondrial activity. This was further evident
in our RNA-seq and ChIP-seq studies, which indicate that dHNF4 is required for the proper tran-
scription of both nuclear and mitochondrial genes involved in oxidative phosphorylation (OXPHOS).
A homolog of mammalian GCK, Hex-C, is also under-expressed in mutants. dHNF4 appears to act
through these pathways to promote GSIS in the IPCs and glucose clearance by the fat body. In addi-
tion, we show that dHNF4 expression increases dramatically at the onset of adulthood, along with
its downstream transcriptional programs. These studies suggest that dHNF4 triggers a developmen-
tal transition that establishes the metabolic state of the adult fly, promoting GSIS and OXPHOS to
support the energetic needs of the mature animal.
Results
dHNF4 mutants are sugar intolerant and display hallmarks of diabetes
All genetic studies used a transheterozygous combination of dHNF4 null alleles (dHNF4D17/
dHNF4D33) and genetically-matched controls that were transheterozygous for precise excisions of
the EP2449 and KG08976 P-elements, as described previously (Palanker et al., 2009). Consistent
with this earlier study, dHNF4 null mutants die as young adults, with most mutants failing to emerge
properly from the pupal case when raised under standard lab conditions (Figure 1A)
(Palanker et al., 2009). While testing for potential dietary effects on dHNF4 mutant viability, we dis-
covered that sugar levels have a dramatic influence on their survival. When reared on either standard
cornmeal food or a medium containing 15% sugar (2:1 glucose to sucrose, 8% yeast), less than 30%
of mutant animals survive though eclosion, and the rest die primarily during the first day of adult-
hood (Figure 1A,B). In contrast, a five-fold reduction in dietary sugar content is sufficient to rescue
most dHNF4 mutants through eclosion and allow them to survive as adults for several weeks
(Figure 1B,C). Sugar intolerance persists through adulthood, indicating that dHNF4 plays a critical
role in carbohydrate metabolism at this stage (Figure 1C). Notably, this dietary response is specific
to alterations in carbohydrate levels, as calorically matched changes in dietary protein did not affect
mutant viability (Figure 1—figure supplement 1).
To examine the effects of sugar consumption on the metabolic state of dHNF4 mutants, major
metabolites were measured in adult males raised on the low 3% sugar diet and transferred to the
3%, 9% or 15% sugar diet for three days. Although dHNF4 mutants display elevated levels of trigly-
cerides, similar to our observations in mutant larvae, these levels are not affected by the different
sugar diets (Figure 1—figure supplement 2A). Similarly, while dHNF4 mutants have reduced glyco-
gen stores and a modest decrease in total protein, the severity of these phenotypes does not corre-
late with the improved viability due to decreasing dietary sugar (Figure 1—figure supplement 2B,
C). In contrast, the abundance of free glucose is greatly elevated in dHNF4 mutants on the 15%
sugar diet, but is progressively reduced in mutants exposed to decreasing amounts of dietary sugar,
similar to the response of diabetics to a low carbohydrate diet (Figure 1D). As expected, the accu-
mulation of free glucose in dHNF4 mutants represents increased levels in circulation and is accompa-
nied by elevated levels of the glucose disaccharide trehalose (Figure 1E,F). Taken together, these
results demonstrate that Drosophila HNF4 is required for proper glycemic control.
To assess whether the hyperglycemia in dHNF4 mutants arises due to impaired glucose clear-
ance, adult flies were subjected to an oral glucose tolerance test. Control and mutant animals were
reared on the low sugar diet, fasted overnight, transferred to a glucose diet for one hour, and then
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Figure 1. dHNF4 mutants are sugar intolerant and display hallmarks of diabetes. (A) Percent survival of genetically-matched controls and dHNF4
mutants at each stage of development when raised on standard media. Adult viability represents survival past the first day of adulthood. (B) Percent of
control and dHNF4 mutants that successfully eclose when reared on the 15%, 9%, or 3% sugar diet. (C) Controls and dHNF4 mutants were reared on
the 3% sugar diet until 5 days of adulthood, transferred to the indicated diet, and scored for survival. (D) Free glucose levels measured from whole
animal lysates of controls and dHNF4 mutants raised on the 3% sugar diet and transferred to the indicated diet for three days. (E) Circulating free
glucose levels were measured from hemolymph extracted from control and dHNF4 mutant adults raised on the 3% sugar diet and transferred to the
15% sugar diet for 1 day prior to analysis. (F) Trehalose levels measured from whole animal lysates of controls and dHNF4 mutants raised on the 3%
sugar diet and transferred to the 15% sugar diet for three days. (G) Oral-glucose tolerance test performed on adults raised on the 3% sugar diet, fasted
overnight, fed on 15% glucose media for 1 hr, and then re-fasted for either 2 or 4 hr. Data represents relative free glucose levels from whole animal
homogenates. (H) Relative ATP levels in control and dHNF4 mutant adults raised on the 3% sugar diet and transferred to sugar-only medium (10%
sucrose) for 1 day prior to analysis. Data is plotted as the mean ± SEM. ***p!0.001, **p!0.01, *p!0.05.
DOI: 10.7554/eLife.11183.003
The following figure supplements are available for figure 1:
Figure 1 continued on next page
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re-fasted for 2 or 4 hr. Although dHNF4 mutants display a normal postprandial spike in free glucose
levels after feeding, glucose clearance is significantly impaired in mutant animals at both 2 and 4 hr,
indicating glucose intolerance (Figure 1G). Taken together, these data demonstrate that dHNF4
mutant adults display hallmarks of diabetes and may provide an animal model of MODY1.
dHNF4 mutants display defects in glycolysis and mitochondrial
metabolism
Small-molecule gas chromatography/mass spectrometry (GC/MS) metabolomic analysis was used to
further characterize the metabolic state of dHNF4 mutants fed a 3% or 15% sugar diet (Figure 2).
This study confirmed and extended our observations of their diabetic phenotype and revealed
underlying defects in glucose homeostasis that are independent of dietary sugar content. Consistent
with hyperglycemia, dHNF4 mutants accumulate glycolytic metabolites on both diets. These include
elevated glucose-6-phosphate, dihydroxyacetone phosphate (DHAP), and serine, which is produced
from 3-phosphoglycerate, although the increased DHAP was only observed on the 15% sugar diet
(Figure 2). Several other glucose-derived metabolites are aberrantly increased in dHNF4 mutants,
including sorbitol and fructose, which are intermediates in the polyol pathway (Figure 2 and Fig-
ure 2—figure supplement 1). This pathway provides an alternate route for cellular glucose uptake
under conditions of sustained hyperglycemia. As a result, these metabolites can accumulate to high
levels in diabetics and correlate with neuropathy and nephropathy (Gabbay, 1975). dHNF4 mutants
also display increased levels of inosine, adenine, xanthine, hypoxanthine, and uric acid, which are
purine metabolites that are associated with increased diabetes risk and diabetic nephropathy (Fig-
ure 2) (Johnson et al., 2013). Taken together, these findings reveal additional similarities between
the dHNF4 mutant phenotype and the metabolic complications of diabetes in humans. Finally, in
addition to elevated carbohydrates, we observed increased levels of pyruvate and lactate accompa-
nied by decreased levels of ATP, suggesting a potential defect in mitochondrial respiration
(Figure 1H, 2).
To further assess mitochondrial metabolism, dHNF4 mutant adults were maintained on 10%
sucrose medium for three days and analyzed for TCA cycle intermediates using GC/MS metabolo-
mics. This approach was aimed at restricting the ability of dietary amino acids to replenish TCA cycle
intermediates by anapleurosis to provide more robust detection of underlying defects in this path-
way. Interestingly, dHNF4 mutants display specific alterations in these metabolites, with increased
abundance of citrate, aconitate, isocitrate, fumarate and malate, along with decreased levels of
alpha-ketoglutarate and succinate, suggesting a specific block in TCA cycle progression (Figure 3—
figure supplement 1). Taken together, these metabolite changes suggest that mitochondrial func-
tion is impaired in dHNF4 mutants, providing a possible primary cause for their glucose intolerance.
dHNF4 regulates nuclear and mitochondrial gene expression
As a first step toward identifying transcriptional targets of dHNF4 that mediate its effects on glucose
homeostasis, we performed RNA-seq profiling in control and mutant adults. A total of 1370 genes
are differentially expressed in dHNF4 mutants (!1.5-fold change, 1% FDR), with just over half of
these genes showing reduced abundance (726 down, 644 up) (Supplementary file 1). Gene ontol-
ogy analysis revealed that the majority of the down-regulated genes correspond to metabolic func-
tions, with the most significant category corresponding to oxidoreductases (Supplementary file 2).
In contrast, the up-regulated genes largely correspond to the innate immune response, reflecting a
possible inflammatory response in dHNF4 mutants (Supplementary file 2). Interestingly, most of the
transcripts encoded by the mitochondrial genome (mtDNA) are expressed at greatly reduced levels
in mutant animals (Supplementary file 1). In Drosophila, as in humans, the mitochondrial genome
contains 13 protein-coding genes, all of which encode critical components of the electron transport
chain (ETC) that contribute to oxidative phosphorylation (OXPHOS). Further analysis of these
Figure 1 continued
Figure supplement 1. Dietary sugar, but not protein, correlates with reduced dHNF4 mutant survival.
DOI: 10.7554/eLife.11183.004
Figure supplement 2. Profiling of major metabolites in dHNF4 mutant adults fed different levels of dietary sugar.
DOI: 10.7554/eLife.11183.005
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transcripts by northern blot hybridization confirmed their reduced expression in dHNF4 mutants,
corresponding to mtDNA genes involved in Complex I (mt:ND1, mt:ND2, mt:ND4, mt:ND5), Com-
plex IV (mt:Cox1, mt:Cox2, mt:Cox3) and Complex V/ATP synthase (mt:ATPase6, mt:ATPase8),
along with reduced levels of the mitochondrial large ribosomal RNA (mt:lrRNA) (Figure 3A,
Supplementary file 1). Importantly, not all mtDNA genes are misregulated, as the expression of mt:
Cyt-b is consistently unaltered in mutants (Figure 3A). In addition, the copy number of mtDNA is
Figure 2. dHNF4 mutants display defects in glycolysis and mitochondrial metabolism. GC/MS metabolomic profiling of controls and dHNF4 mutants
raised to adulthood on the 3% sugar diet, transferred to the indicated diet for 3 days, and subjected to analysis. Data were obtained from three
independent experiments consisting of 5–6 biological replicates per condition and values were normalized to control levels on the 15% sugar diet. Box
plots are presented on a log scale, with the box representing the lower and upper quartiles, the horizontal line representing the median, and the error
bars representing the minimum and maximum data points. ***p!0.001, **p!0.01, *p!0.05.
DOI: 10.7554/eLife.11183.006
The following figure supplement is available for figure 2:
Figure supplement 1. dHNF4 mutants show broad defects in carbohydrate homeostasis.
DOI: 10.7554/eLife.11183.007
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Figure 3. dHNF4 regulates nuclear and mitochondrial gene expression. (A) Validation of RNA-seq data by northern blot using total RNA extracted from
control and dHNF4 mutant adults. Affected transcripts include those involved in glucose homeostasis (Hex-C, pdgy), the electron transport chain
(Sdhaf4, mt:ND1, mt:ND2, mt:ND4, mt:ND5, mt:CoxI, mt:Cox2, mt:Cox3, mt:ATPase6/8, mt:Cyt-b and mt:lrRNA), the TCA cycle (Scsalpha, dSdhaf4),
and insulin signaling (4EBP, InR). rp49 is included as a control for loading and transfer. Mitochondrial-encoded transcripts are indicated by the prefix
’mt’. Depicted results were consistent across multiple experiments. (B–C) ChIP-seq analysis performed on adult flies for endogenous dHNF4 genomic
binding shows direct association with both nuclear (B) and mitochondrial-encoded (C) genes involved in OXPHOS. Data tracks display q value FDR
(QValFDR) significance values (y-axis) compared to input control, where QValFDR 50 corresponds to P=10–5 and 100 corresponds to P=10–10. Gene
names in bold represent those expressed at reduced levels in dHNF4 mutants by RNA-seq and/or northern blot analysis. Gene names in red (ND6, Cyt-
B) denote the mtDNA-encoded transcriptional unit confirmed to show no change in dHNF4 mutants. (D) Whole-mount immunostaining of adult fat
body tissue for ATP5A (green) to detect mitochondria and DAPI (blue) to mark nuclei, showing fragmented mitochondrial morphology in dHNF4
mutants. (E) Analysis of dHNF4 mutant MARCM clones (GFP+) shows reduced mitochondrial membrane potential by TMRE staining of live fat body
tissue from adult flies maintained on the 15% sugar diet.
DOI: 10.7554/eLife.11183.008
The following figure supplements are available for figure 3:
Figure supplement 1. dHNF4 mutants display changes in TCA cycle intermediates that correlate with changes in gene expression.
DOI: 10.7554/eLife.11183.009
Figure supplement 2. dHNF4 mutants display mitochondrial defects.
DOI: 10.7554/eLife.11183.010
Figure supplement 3. Predicted functions of dHNF4 target genes.
DOI: 10.7554/eLife.11183.011
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unaffected in dHNF4 mutants, suggesting that mitochondrial abundance is normal in these animals
(Figure 3—figure supplement 2A).
Several nuclear-encoded OXPHOS genes also require dHNF4 for their maximal expression,
including genes that encode the alpha and beta subunits of the electron transfer flavoprotein (ETFA
and ETFB), ETF-ubiquinone oxidoreductase (ETF-QO), and the Complex II (succinate dehydroge-
nase, SDH) assembly factor dSdhaf4 (Figure 3A, Supplementary file 1). Similar to flies lacking
dSdhaf4, dHNF4 mutants display reduced steady-state levels of SDH complex as assayed by western
blot (Figure 3—figure supplement 1) (Van Vranken et al., 2014). These observations are thus con-
sistent with impaired mitochondrial SDH function, and suggest that dSdhaf4 is a critical functional
target of dHNF4. Additional genes involved in the TCA cycle are misexpressed in dHNF4 mutants,
including Succinyl-CoA synthetase alpha (Scsalpha), CG5599 (which encodes a protein with homol-
ogy to the E2 subunit of the a-ketoglutarate dehydrogenase complex (a-KGDHC) as well as the E2
subunit of the branched-chain alpha-ketoacid dehydrogenase complex), CG1544 (which encodes a
homolog of a-KGDHC E1), as well as Isocitrate dehydrogenase (IDH, NADP+-dependent)
(Figure 3A, Supplementary file 1). These changes in gene expression are consistent with the
observed changes in the levels of TCA cycle intermediates in dHNF4 mutants, suggesting that they
are functionally relevant to the mutant metabolic phenotype (Figure 3—figure supplement 1).
Notably, dHNF4 mutants also have decreased expression of the GCK homolog Hexokinase-C
(Hex-C) (Figure 3A). GCK is a tissue-specific glycolytic enzyme that is required for glucose sensing
by pancreatic b-cells and glucose clearance by the liver. These activities, combined with the associa-
tion of GCK mutations with MODY2, make Hex-C a candidate for mediating the effects of dHNF4
on carbohydrate metabolism. The glucose transporter CG1213 is also down-regulated in dHNF4
mutants, along with phosphoglucomutase (pgm), which is involved in glycogen metabolism, and
transaldolase and CG17333, which are involved in the pentose phosphate shunt. Additionally, the
gluconeogenesis genes Pyruvate carboxylase (CG1514) and Phosphoenolpyruvate carboxykinase
(Pepck, CG17725) show reduced expression in mutant animals, similar to their dependence on
Hnf4A for expression in the mammalian liver (Supplementary file 1) (Chavalit et al., 2013;
Yoon et al., 2001). Finally, dHNF4 mutants display transcriptional signatures of reduced insulin sig-
naling, including up-regulation of the dFOXO-target genes 4EBP and InR (Figure 3A,
Supplementary file 1). Taken together, these findings indicate an important role for dHNF4 in mito-
chondrial OXPHOS and glucose metabolism, and suggest that it acts through multiple pathways to
maintain glycemic control.
Chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) was per-
formed to identify direct transcriptional targets of the receptor. Through this analysis, forty-seven
genes were identified as high confidence targets by fitting the criteria of showing proximal dHNF4
binding along with reduced transcript abundance in mutant animals (!1.5 fold change, 1% FDR)
(Figure 3—figure supplement 3, Supplementary file 3). These include nuclear-encoded OXPHOS
genes such as ETFB, ETF-QO, dSdhaf4, and genes that encode TCA cycle factors Scsalpha and
CG5599 (Figure 3B). We also observed abundant and specific binding of dHNF4 within the control
region of the mitochondrial genome (Figure 3C and Supplementary file 3). Taken together with
our other results, these data suggest that dHNF4 is required to maintain normal mitochondrial func-
tion. Consistent with this, mitochondrial morphology is severely fragmented in mutant animals, and
MARCM clonal analysis in the adult fat body shows reduced mitochondrial membrane potential in
dHNF4 mutant cells (Figure 3D,E and Figure 3—figure supplement 2B,C). In contrast, we were
unable to detect changes in reactive oxygen species (ROS) in dHNF4 mutant clones by DHE staining
(Figure 3—figure supplement 2D). This might be due to the decreased levels of ROS-generating
ETC complexes in dHNF4 mutants, along with no detectable effect on the transcripts that encode
ROS-scavenging enzymes, such as catalase and SOD (Supplementary file 1). Taken together, these
data support the model that dHNF4 regulates both nuclear and mitochondrial gene expression to
promote OXPHOS and maintain mitochondrial integrity.
dHNF4 acts through multiple tissues and pathways to control glucose
homeostasis
Tissue-specific RNAi was used to disrupt dHNF4 expression in the IPCs, fat body, and intestine to
examine the contributions of dHNF4 in these tissues to systemic glucose homeostasis. This revealed
a requirement in both the IPCs and fat body for glucose homeostasis, consistent with the well-
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established roles of these tissues in insulin signaling and the regulation of circulating sugar levels
(Figure 4A, Figure 4—figure supplement 1B). Our initial functional analysis of dHNF4 target genes
supports these tissue-specific activities and provides insights into the molecular mechanisms of
dHNF4 action. Tissue-specific inactivation of Hex-C by RNAi demonstrates that it is required in the
fat body, but not the IPCs, to maintain normal levels of circulating glucose (Figure 4B,C). This is con-
sistent with the important role of mammalian GCK for glucose clearance by the liver as well as its
association with MODY2 (Postic et al., 1999). In contrast, both fat body and IPC-specific RNAi for
the direct target of dHNF4, CG5599, significantly impaired glucose homeostasis (Figure 4B,C). This
indicates that CG5599 is required in each of these tissues for glycemic control, similar to dHNF4,
suggesting that it is a key downstream target of the receptor. Although technical limitations prevent
us from performing tissue-specific RNAi studies of mitochondrial-encoded transcripts, disruption of
ETC Complex I by targeting a critical assembly factor, CIA30 (Complex I intermediate-associated
protein 30 kDa) (Cho et al., 2012) in either the IPCs or fat body produced elevated levels of free
Figure 4. dHNF4 acts through multiple tissues and pathways to control glucose homeostasis. (A) Circulating glucose levels in adult males expressing
tissue-specific RNAi against mCherry (TRiP 35785, grey bars) or dHNF4 (TRiP 29375, dark red bars) in the fat body (r4-GAL4), IPCs (dilp2-GAL4), or
midgut (mex-GAL4). (B–C) Relative free glucose levels in adult males on the 15% sugar diet expressing fat body (r4-GAL4, B) or IPC (dilp2-GAL4, C)-
specific RNAi compared to mCherry RNAi controls (light grey bars). RNAi lines directed against Hex-C, CG5599, Scsa, CIA30, Cox5a, and ATPsynb
were obtained from the TRiP RNAi collection. Blue and orange bars depict significant changes in glucose levels. Dark grey bars are not significant. Data
represents the mean ± SEM. ***p!0.001, **p!0.01, *p!0.05. (D) Confocal imaging of mitochondrial morphology (marked by ATP5A immunostaining,
red) in the adult fat body from animals expressing fat-body specific RNAi (r4-GAL4). The extended network of mitochondria seen in controls is
disrupted and appears more punctate upon RNAi for dHNF4, CIA30, or CG5599, indicative of mitochondrial fragmentation. No effect is seen upon
RNAi for Hex-C.
DOI: 10.7554/eLife.11183.012
The following figure supplements are available for figure 4:
Figure supplement 1. dHNF4 is required in the insulin-producing cells and fat body to maintain glucose homeostasis.
DOI: 10.7554/eLife.11183.013
Figure supplement 2. Fat body-specific disruption of the electron transport chain causes sugar intolerance.
DOI: 10.7554/eLife.11183.014
Figure supplement 3. Additional RNAi lines confirming the importance of Hex-C in the fat body for glycemic control.
DOI: 10.7554/eLife.11183.015
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glucose (Figure 4B,C). Fat body-specific RNAi for dHNF4, CIA30, or CG5599 resulted in fragmented
mitochondrial morphology, consistent with previous reports of CIA30 loss of function and the onset
of mitochondrial dysfunction (Figure 4D) (Cho et al., 2012). In contrast, RNAi for Hex-C had no
detectable effect on mitochondrial morphology (Figure 4D).
While RNAi for Complex V (ATPsynb RNAi) in the fat body caused lethality prior to eclosion, IPC-
specific RNAi produced viable adults that appeared normal but displayed significant hyperglycemia
(Figure 4C). In contrast, disruption of ETC Complex IV in the IPCs (Cox5a RNAi) failed to produce
hyperglycemia, while RNAi in the fat body caused lethality prior to adulthood, similar to ATPsynb.
This premature lethality was accompanied by severe developmental delay and more than 50% of the
animals dying prior to puparium formation when raised on the 15% sugar diet. Interestingly, we dis-
covered that these animals are sugar intolerant, similar to dHNF4 mutants, such that rearing them
on the 3% sugar diet allowed for 100% survival to puparium formation while also alleviating the
developmental delay (Figure 4—figure supplement 2). Although adult viability was not achievable
through dietary intervention, these findings demonstrate that ETC function in the fat body is impor-
tant for sugar tolerance during development, similar to the requirement for dHNF4. Taken together,
these data reveal important roles for dHNF4 in both the IPCs and fat body to maintain glucose
homeostasis, likely in part by promoting Hex-C expression in the fat body for glucose clearance and
supporting mitochondrial function and OXPHOS in both the IPCs and fat body.
dHNF4 is required for glucose-stimulated DILP2 secretion
The requirement for dHNF4 function in the IPCs for systemic glucose homeostasis fits with the
important roles for Hnf4A in mouse pancreatic b-cells as well as the contribution of b-cell physiology
to the onset of MODY1. Accordingly, we examined if dHNF4 mutants display defects in GSIS. We
used an experimental approach developed for this purpose in Drosophila larvae, assaying for the
steady-state levels of DILP2 peptide in the IPCs using a fasting/refeeding paradigm
(Geminard et al., 2009). As expected, DILP2 accumulates in the IPCs of fasted control animals and
is effectively released into circulation in response to glucose feeding (Figure 5A,B). In contrast, while
DILP2 accumulates normally in fasted dHNF4 mutants, it fails to respond to dietary glucose stimula-
tion, despite these animals having normal IPC number and morphology (Figure 5A,B). Peripheral
insulin signaling is also reduced in dHNF4 mutants relative to controls, consistent with their reduced
GSIS (Figure 5C). This defect in GSIS is due to a tissue-specific requirement for dHNF4 in the IPCs
since IPC-specific RNAi for dHNF4 resulted in impaired DILP2 secretion into the hemolymph, along
with reduced peripheral insulin signaling (Figure 5D,E and Figure 5—figure supplement 1)
(Park et al., 2014). Taken together, these data demonstrate that impaired GSIS plays a central role
in the diabetic phenotype of dHNF4 mutants.
dHNF4 is required to establish the metabolic state of adult Drosophila
As we reported in our prior study of dHNF4, the receptor is not expressed in the larval IPCs
(Figure 6A) (Palanker et al., 2009). It is, however, expressed in the IPCs of the adult fly, consistent
with its central roles at this stage in GSIS, insulin signaling, and glucose homeostasis (Figure 6B).
Interestingly, this cell-type specific switch in dHNF4 expression correlates with a developmental
change in IPC physiology. Unlike mammalian b-cells, larval IPCs fail to secrete DILPs in response to
dietary glucose (Geminard et al., 2009). Adult IPCs, however, display calcium influx, membrane
depolarization, and DILP2 secretion in response to glucose, analogous to b-cells (Alfa et al., 2015;
Fridell et al., 2009; Kreneisz et al., 2010; Park et al., 2014). Along with the temporal induction of
dHNF4 expression in adult IPCs, these results suggest that there is a developmental switch in the
response to glucose at the onset of adulthood. Consistent with this, glucose feeding activates insulin
signaling in adult flies, but not in larvae (Figure 6C). This correlates with a ~ ten-fold increase in the
basal circulating levels of glucose in adults compared to larvae, which first becomes apparent during
the final stages of pupal development (Figure 6D) (Tennessen et al., 2014a). Moreover, dHNF4
mutants maintain euglycemia on a normal diet during larval and early pupal stages, but display
hyperglycemia just prior to eclosion (Figure 6D). Taken together, these observations point to a
switch in IPC physiology and glucose homeostasis as Drosophila transition into maturity.
The induction of dHNF4 in the adult IPCs and the adult onset of hyperglycemia in dHNF4 mutants
raise the interesting possibility that this receptor may play a role in coordinating the metabolic
Barry and Thummel. eLife 2016;5:e11183. DOI: 10.7554/eLife.11183 10 of 26










switch toward GSIS and OXPHOS at this stage. Indeed, northern blot analysis of RNA samples iso-
lated from staged wild-type larvae, pupae, and young adults, demonstrate that dHNF4 expression
increases dramatically at the onset of adulthood (Figure 6E). Moreover, this temporal pattern of
expression is accompanied by increased expression of both nuclear and mitochondrial-encoded
dHNF4 target genes that contribute to OXPHOS as well as Hex-C. The expression of these target
genes is also reduced in staged dHNF4 mutants, consistent with our earlier findings that their maxi-
mal expression depends on receptor function (Figure 6E). Taken together, our results support the
Figure 5. dHNF4 is required for glucose-stimulated DILP2 secretion by the insulin-producing cells. (A) Whole-
mount staining for DILP2 peptide in brains dissected from adult control and dHNF4 mutants that were either
fasted overnight or re-fed glucose for two hours. (B) Quantification of relative DILP2 fluorescent intensity in the
IPCs of fasted and glucose-fed controls and dHNF4 mutants. Data is plotted as a Tukey boxplot with outliers
denoted as individual data points (n= 11 ± 3 brains per-condition). Results were consistent between three
independent experiments. (C) Western blot analysis to detect phosphorylated AKT (pAKT), total AKT, and Tubulin
in extracts from controls and dHNF4 mutants that were either fasted overnight or re-fed glucose for two hours. (D)
Levels of circulating HA-FLAG-tagged DILP2 (DILP2HF) were assayed in animals with IPC-specific RNAi (TRiP)
against either mCherry as a control (blue) or dHNF4 (red) using the dilp2-GAL4 driver (dilp2>RNAi). Data is
combined from five independent experiments, each containing 5–6 biological replicates per genotype. The
horizontal lines depict the mean value. (E) Western blot analysis to detect phosphorylated AKT (pAKT), total AKT,
and Tubulin in extracts from ad libitum fed adult males with IPC-specific RNAi against either mCherry as a control
or dHNF4 using the dilp2-GAL4 driver (dilp2>RNAi). ***p!0.001, **p!0.01, *p!0.05.
DOI: 10.7554/eLife.11183.016
The following figure supplement is available for figure 5:
Figure supplement 1. dHNF4 RNAi in the IPCs causes reduced levels of circulating DILP2-HF.
DOI: 10.7554/eLife.11183.017
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Figure 6. dHNF4 supports a developmental transition toward GSIS and OXPHOS in adult Drosophila. (A–B)
Whole-mount immunostaining of larval (A) or adult (B) brains to detect dHNF4 protein (magenta) or GFP, which
marks the IPCs (dilp2>GFP, green). (C) Western blot analysis to detect phosphorylated AKT (pAKT) and total AKT
in extracts from w1118 third-instar larvae or mature adults that were fasted overnight and re-fed 10% glucose for
two hours. (D) Relative levels of free glucose in controls and dHNF4 mutants staged as either feeding third-instar
larvae (larva), white prepupae (wpp), pharate adults ( ~ 4 day-old pupae), or mature adults. Data is plotted as the
mean ± SEM. ***p!0.001, **p!0.01, *p!0.05. (E) Northern blot analysis of RNA extracted from feeding third-instar
larvae (larva), white prepupae (wpp), pupae at one-day intervals, mid-eclosion (eclo), and mature adults. rp49 is
included as a control for loading and transfer.
DOI: 10.7554/eLife.11183.018
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model that dHNF4 contributes to a metabolic switch in glucose homeostasis at the onset of adult-
hood that promotes GSIS and OXPHOS to meet the energy demands of the adult fly.
Discussion
The association of MODY subtypes with mutations in specific genes provides a framework for under-
standing the monogenic heritability of this disorder as well as the roles of the corresponding path-
ways in systemic glucose homeostasis. In this paper, we investigate the long-known association
between HNF4A mutations and MODY1 by characterizing a whole-animal mutant that recapitulates
the key symptoms associated with this disorder. We show that Drosophila HNF4 is required for both
GSIS and glucose clearance in adults, acting in distinct tissues and multiple pathways to maintain
glucose homeostasis. We also provide evidence that dHNF4 promotes mitochondrial OXPHOS by
regulating nuclear and mitochondrial gene expression. Finally, we show that the expression of
dHNF4 and its target genes is dramatically induced at the onset of adulthood, contributing to a
developmental switch toward GSIS and oxidative metabolism at this stage in development. These
results provide insights into the molecular basis of MODY1, expand our understanding of the close
coupling between development and metabolism, and establish the adult stage of Drosophila as an
accurate context for genetic studies of GSIS, glucose clearance, and diabetes.
dHNF4 acts through multiple pathways to regulate glucose
homeostasis
Drosophila HNF4 mutants display late-onset hyperglycemia accompanied by sensitivity to dietary
carbohydrates, glucose intolerance, and defects in GSIS – hallmarks of MODY1. These defects arise
from roles for dHNF4 in multiple tissues, including a requirement in the IPCs for GSIS and a role in
the fat body for glucose clearance. The regulation of GSIS by dHNF4 is consistent with the long-
known central contribution of pancreatic b-cells to the pathophysiology of MODY1 (Fajans and Bell,
2011). Similarly, several MODY-associated genes, including GCK, HNF1A and HNF1B, are important
for maintaining normal hepatic function. These distinct tissue-specific contributions to glycemic con-
trol may explain why single-tissue Hnf4A mutants in mice do not fully recapitulate MODY1 pheno-
types and predict that a combined deficiency for the receptor in both the liver and pancreatic b-cells
of adults would produce a more accurate model of this disorder.
We used metabolomics, RNA-seq, and ChIP-seq to provide initial insights into the molecular
mechanisms by which dHNF4 exerts its effects on systemic metabolism. These studies revealed sev-
eral downstream pathways, each of which is associated with maintaining homeostasis and, when dis-
rupted, can contribute to diabetes. These include genes identified in our previous study of dHNF4 in
larvae that act in lipid metabolism and fatty acid b-oxidation, analogous to the role of Hnf4A in the
mouse liver to maintain normal levels of stored and circulating lipids (Hayhurst et al., 2001;
Palanker et al., 2009). Extensive studies have linked defects in lipid metabolism with impaired b-cell
function and peripheral glucose uptake and clearance, suggesting that these pathways contribute to
the diabetic phenotypes of dHNF4 mutants (Prentki et al., 2013; Qatanani and Lazar, 2007). An
example of this is pudgy, which is expressed at reduced levels in dHNF4 mutants and encodes an
acyl-CoA synthetase that is required for fatty acid oxidation (Figure 3A) (Xu et al., 2012). Interest-
ingly, pudgy mutants have elevated triglycerides, reduced glycogen, and increased circulating sug-
ars, similar to dHNF4 mutants, suggesting that this gene is a critical downstream target of the
receptor. It is important to note, however, that our metabolomic, RNA-seq, and ChIP-seq studies
were conducted on extracts from whole animals rather than individual tissues. As a result, some of
our findings may reflect compensatory responses between tissues, and some tissue-specific changes
in gene expression or metabolite levels may not be detected by our approach. Further studies using
samples from dissected tissues would likely provide a more complete understanding of the mecha-
nisms by which dHNF4 maintains systemic physiology.
Notably, the Drosophila GCK homolog encoded by Hex-C is expressed at reduced levels in
dHNF4 mutants (Figure 3A). The central role of GCK in glucose sensing by pancreatic b-cells as well
as glucose clearance by the liver places it as an important regulator of systemic glycemic control.
Our functional data supports these associations by showing that Hex-C is required in the fat body
for proper circulating glucose levels, analogous to the role of GCK in mammalian liver (Figure 4B)
(Postic et al., 1999). Unlike mice lacking GCK in the b-cells, however, we do not see an effect on
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glucose homeostasis when Hex-C is targeted by RNAi in the IPCs. This is possibly due to the pres-
ence of a second GCK homolog in Drosophila, Hex-A, which could act alone or redundantly with
Hex-C to mediate glucose sensing by the IPCs. In mammals, GCK expression is differentially regu-
lated between hepatocytes and b-cells through the use of two distinct promoters, and studies in rats
have demonstrated a direct role for HNF4A in promoting GCK expression in the liver (Roth et al.,
2002). Our findings suggest that this relationship has been conserved through evolution. In addition,
the association between GCK mutations and MODY2 raise the interesting possibility that defects in
liver GCK activity may contribute to the pathophysiology of both MODY1 and MODY2.
Interestingly, gene ontology analysis indicates that the up-regulated genes in dHNF4 mutants
correspond to the innate immune response pathways in Drosophila (Supplementary file 2). This
response parallels that seen in mice lacking Hnf4A function in enterocytes, which display intestinal
inflammation accompanied by increased sensitivity to DSS-induced colitis and increased permeability
of the intestinal epithelium, similar to humans with inflammatory bowel disease (Ahn et al., 2008;
Babeu and Boudreau, 2014; Cattin et al., 2009). Disruption of Hnf4A expression in Caco-2 cells
using shRNA resulted in changes in the expression of genes that act in oxidative stress responses,
detoxification pathways, and inflammatory responses, similar to the effect we see in dHNF4 mutants
(Marcil et al., 2010). Moreover, mutations in human HNF4A are associated with chronic intestinal
inflammation, irritable bowel disease, ulcerative colitis, and Crohn’s disease, suggesting that these
functions are conserved through evolution (UK IBD Genetics Consortium et al., 2009; Marcil et al.,
2012; van Sommeren et al., 2011). Taken together, these results support the hypothesis that
dHNF4 plays an important role in suppressing an inflammatory response in the intestine. Future
studies are required to test this hypothesis in Drosophila. In addition, further work is required to bet-
ter define the regulatory functions of HNF4 that are shared between Drosophila and mammals.
Although our work described here suggests that key activities for this receptor have been conserved
in flies and mammals, corresponding to the roles of HNF4 in the IPCs (b-cells) for GSIS, fat body
(liver) for lipid metabolism and glucose clearance, and intestine to suppress inflammation, there are
likely to be divergent roles as well. One example of this is the embryonic lethality of Hnf4A mutant
mice, which is clearly distinct from the early adult lethality reported here for dHNF4 mutants. Further
studies are required to dissect the degree to which the regulatory functions of this receptor have
been conserved through evolution.
It is also important to note that mammalian Hnf4A plays a role in hepatocyte differentiation and
proliferation in addition to its roles in metabolism (Bonzo et al., 2012; Li et al., 2000). This raises
the possibility that early developmental roles for dHNF4 could impact the phenotypes we report
here in adults. Indeed, all of our studies involve zygotic dHNF4 null mutants that lack function
throughout development. In an effort to address this possibility and distinguish developmental from
adult-specific functions, we are constructing a conditional dHNF4 mutant allele using CRISPR/Cas9
technology. Future studies using this mutation should allow us to conduct a detailed phenotypic
analysis of this receptor at different stages of Drosophila development.
It is also interesting to speculate that our functional studies of dHNF4 uncover more widespread
roles for MODY-associated genes in glycemic control, in addition to the link with MODY2 described
above. HNF1A and HNF1B, which are associated with MODY3 and MODY5, respectively, act
together with HNF4A in an autoregulatory circuit in an overlapping set of tissues, with HNF4A pro-
posed to be the most upstream regulator of this circuit (Boj et al., 2001; Nagaki and Moriwaki,
2008). The observation that Drosophila do not have identifiable homologs for HNF1A and HNF1B
raises the interesting possibility that dHNF4 alone replaces this autoregulatory circuit in more primi-
tive organisms. The related phenotype of these disorders is further emphasized by cases of MODY3
that are caused by mutation of an HNF4A binding site within the HNF1A promoter (Gragnoli et al.,
1997). Consistent with this link, MODY1, MODY3 and MODY5 display similar features of disease
complication and progression, and studies of HNF1A and HNF4A in INS-1 cells have implicated roles
for these transcription factors in promoting mitochondrial metabolism in b-cells (Wang et al., 2002).
In line with this, mitochondrial diabetes is clearly age progressive, as are MODY1, 3, and 5, but not
MODY2, which represents a more mild form of this disorder. Furthermore, the severity and progres-
sion of MODY3 is significantly enhanced when patients carry an additional mutation in either HNF4A
or mtDNA (Forlani et al., 2010). Overall, these observations are consistent with the well-established
multifactorial nature of diabetes, with multiple distinct metabolic insults contributing to disease
onset.
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dHNF4 regulates nuclear and mitochondrial gene expression
Our RNA-seq analysis supports a role for dHNF4 in coordinating mitochondrial and nuclear gene
expression (Supplementary file 1 and Figure 3A). This is represented by the reduced expression of
transcripts encoded by the mitochondrial genome, along with effects on nuclear-encoded genes
that act in mitochondria. In addition, ChIP-seq revealed that several of the nuclear-encoded genes
are direct targets of the receptor. Mitochondrial defects have well-established links to diabetes-
onset, with mutations in mtDNA causing maternally-inherited diabetes and mitochondrial OXPHOS
playing a central role in both GSIS and peripheral glucose clearance (Sivitz and Yorek, 2010). Con-
sistent with this, our functional studies indicate that dHNF4 is required to maintain normal mitochon-
drial function and that defects in this process contribute to the diabetic phenotypes in dHNF4
mutants.
It is important to note that the number of direct targets for dHNF4 in the nucleus is difficult to
predict with our current dataset. A relatively low signal-to-noise ratio in our ChIP-seq experiment
allowed us to identify only 37 nuclear-encoded genes as high confidence targets by fitting the crite-
ria of proximal dHNF4 binding along with reduced expression in dHNF4 mutants (Figure 3B and
Supplementary file 3). Future ChIP-seq studies will allow us to expand this dataset to gain a more
comprehensive understanding of the scope of the dHNF4 regulatory circuit and may also reveal tis-
sue-restricted targets that are more difficult to detect. Nonetheless, almost all of the genes identi-
fied as direct targets for dHNF4 regulation correspond to genes involved in mitochondrial
metabolism, including the TCA cycle, OXPHOS, and lipid catabolism, demonstrating that this recep-
tor has a direct impact on these critical downstream pathways that influence glucose homeostasis
(Figure 3—figure supplement 3, Supplementary file 3).
dHNF4 is required for mitochondrial function
An unexpected and significant discovery in our studies is that dHNF4 is required for mitochondrial
gene expression and function. Several lines of evidence support the model that dHNF4 exerts this
effect through direct regulation of mitochondrial transcription, although a number of additional
experiments are required to draw firm conclusions on this regulatory connection. First, most of the
13 protein-coding genes in mtDNA are underexpressed in dHNF4 mutants (Figure 3A,
Supplementary file 1). Our lab and others have conducted RNA-seq studies of Drosophila nuclear
transcription factor mutants and, to our knowledge, similar effects on mitochondrial gene expression
have not been reported previously. Second, dHNF4 protein is abundantly bound to the control
region of the mitochondrial genome, representing the fifth strongest enrichment peak in our ChIP-
seq dataset (Figure 3C). Although the promoters in Drosophila mtDNA have not yet been identified,
the site bound by dHNF4 corresponds to a predicted promoter region for Drosophila mitochondrial
transcription and coincides with the location of the major divergent promoters in human mtDNA
(Garesse and Kaguni, 2005; Roberti et al., 2006). It is unlikely that the abundance of mtDNA rela-
tive to nuclear DNA had an effect on our ChIP-seq peak calling because the MACS2 platform used
for our analysis accounts for local differences in read depth across the genome (including the abun-
dance of mtDNA). In addition, although the D-loop in mtDNA has been proposed to contribute to
possible false-positive ChIP-seq peaks in mammalian studies (Marinov et al., 2014), the D-loop
structure is not present in Drosophila mtDNA (Rubenstein et al., 1977). Nonetheless, additional
experiments are required before we can conclude that this apparent binding is of regulatory signifi-
cance for mitochondrial function. Third, the effects on mitochondrial gene expression do not appear
to be due to reduced mitochondrial number in dHNF4 mutants (Figure 3—figure supplement 2A).
This is consistent with the normal expression of mt:Cyt-b in dHNF4 mutants (Figure 3A), which has a
predicted upstream promoter that drives expression of the mt:Cyt-b and mt:ND6 operon (although
we could not detect mt:ND6 RNA in our northern blot studies) (Berthier et al., 1986; Roberti et al.,
2006). Fourth, immunostaining for dHNF4 shows cytoplasmic protein that overlaps with the mito-
chondrial marker ATP5A, in addition to its expected nuclear localization (Figure 3—figure supple-
ment 2B). Some of the cytoplasmic staining, however, clearly fails to overlap with the mitochondrial
marker, making it difficult to draw firm conclusions from this experiment. Multiple efforts to expand
on this question biochemically with subcellular fractionation studies have been complicated by abun-
dant background proteins that co-migrate with the receptor in mitochondrial extracts. We are cur-
rently developing new reagents to detect the relatively low levels of endogenous dHNF4 protein in
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mitochondria, including use of the CRISPR/Cas9 system for the addition of specific epitope tags to
the endogenous dHNF4 locus. Finally, we observe multiple hallmarks of mitochondrial dysfunction,
including elevated pyruvate and lactate, specific alterations in TCA cycle metabolites, reduced mito-
chondrial membrane potential, reduced levels of ATP, and fragmented mitochondrial morphology.
These phenotypes are consistent with the reduced expression of key genes involved in mitochondrial
OXPHOS (Figure 3A and Supplementary file 1), and studies showing that decreased mitochondrial
membrane potential and ATP production are commonly associated with mitochondrial fragmenta-
tion (Mishra and Chan, 2014; Toyama et al., 2016).
Although unexpected, our proposal that dHNF4 may directly regulate mitochondrial gene
expression is not unprecedented. A number of nuclear transcription factors have been localized to
mitochondria, including ATFS-1, MEF2D, CREB, p53, STAT3, along with several nuclear receptors,
including the estrogen receptor, glucocorticoid receptor, and the p43 isoform of the thyroid hor-
mone receptor (Leigh-Brown et al., 2010; Nargund et al., 2015; Szczepanek et al., 2012). The sig-
nificance of these observations, however, remains largely unclear, with few studies demonstrating
regulatory functions within mitochondria. In addition, these factors lack a canonical mitochondrial
localization signal at their amino-terminus, leaving it unclear how they achieve their subcellular distri-
bution (Marinov et al., 2014). In contrast, one of the five mRNA isoforms encoded by dHNF4,
dHNF4-B, encodes a predicted mitochondrial localization signal in its 5’-specific exon, providing a
molecular mechanism to explain the targeting of this nuclear receptor to this organelle. Efforts are
currently underway to conduct a detailed functional analysis of dHNF4-B by using the CRISPR/Cas9
system to delete its unique 5’ exon, as well as establishing transgenic lines that express a tagged
version of dHNF4-B under UAS control. Future studies using these reagents, along with our dHNF4
mutants, should allow us to dissect the nuclear and mitochondrial functions of this nuclear receptor
and their respective contributions to systemic physiology.
Finally, it is interesting to speculate whether the role for dHNF4 in mitochondria is conserved in
mammals. A few papers have described the regulation of nuclear-encoded mitochondrial genes by
HNF4A (Rodriguez et al., 1998; Wang et al., 2000). In addition, several studies have detected cyto-
plasmic Hnf4A by immunohistochemistry in tissue sections, including in postnatal pancreatic islets
(Miura et al., 2006; Nammo et al., 2008) and hepatocytes (Bell and Michalopoulos, 2006;
Soutoglou et al., 2000; Sun et al., 2007; Yanger et al., 2013). Moreover, the regulation of nuclear/
cytoplasmic shuttling of HNF4A has been studied in cultured cells (Soutoglou et al., 2000). The evo-
lutionary conservation of the physiological functions of HNF4A, from flies to mammals, combined
with these prior studies, argue that more effort should be directed at defining the subcellular distri-
bution of HNF4A protein and its potential roles within mitochondria. Taken together with our studies
in Drosophila, this work could provide new directions for understanding HNF4 function and MODY1.
dHNF4 contributes to an adult switch in metabolic state
Physiological studies by George Newport in 1836 noted that holometabolous insects reduce their
respiration during metamorphosis leading to a characteristic “U-shaped curve” in oxygen consump-
tion (Needham, 1929; Newport, 1836). Subsequent classical experiments in Lepidoptera, Bombyx,
Rhodnius and Calliphora showed that this reduction in mitochondrial respiration during metamor-
phosis and dramatic rise in early adults is seen in multiple insect species, including Drosophila (Bod-
ine, 1925; Merkey et al., 2011). Consistent with this, the activity of oxidative enzyme systems and
the levels of ATP also follow a “U-shaped curve” during development as the animal transitions from
a non-feeding pupa to a motile and reproductively active adult fly (Agrell, 1953). Although first
described over 150 years ago, the regulation of this developmental increase in mitochondrial activity
has remained undefined. Here we show that this temporal switch is dependent, at least in part, on
the dHNF4 nuclear receptor. The levels of dHNF4 expression increase dramatically at the onset of
adulthood, accompanied by the expression of downstream genes that act in glucose homeostasis
and mitochondrial OXPHOS (Figure 6E). This coordinate transcriptional switch is reduced in dHNF4
mutants, indicating that the receptor plays a key role in this transition. Importantly, the timing of this
program correlates with the onset of dHNF4 mutant phenotypes in young adults, including sugar-
dependent lethality, hyperglycemia, and defects in GSIS, indicating that the upregulation of dHNF4
expression in adults is of functional significance. It should also be noted, however, that dHNF4 target
genes are still induced at the onset of adulthood in dHNF4 mutants, albeit at lower levels, indicating
that other regulators contribute to this switch in metabolic state (Figure 6E). Nonetheless, the
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timing of the induction of dHNF4 and its target genes in early adults, and its role in promoting
OXPHOS, suggest that this receptor contributes to the end of the “U-shaped curve” and directs a
systemic transcriptional switch that establishes an optimized metabolic state to support the ener-
getic demands of adult life.
Interestingly, a similar metabolic transition towards OXPHOS was recently described in Drosoph-
ila neuroblast differentiation, mediated by another nuclear receptor, EcR (Homem et al., 2014).
Although this occurs during early stages of pupal development, prior to the dHNF4-mediated transi-
tion at the onset of adulthood, the genes involved in this switch show a high degree of overlap with
dHNF4 target genes that act in mitochondria, including ETFB, components of Complex IV, pyruvate
carboxylase, and members of the a-ketoglutarate dehydrogenase complex. This raises the possibility
that dHNF4 may contribute to this change in neuroblast metabolic state and play a more general
role in supporting tissue differentiation by promoting OXPHOS.
To our knowledge, only one other developmentally coordinated switch in systemic metabolic
state has been reported in Drosophila and, intriguingly, it is also regulated by a nuclear receptor.
Drosophila Estrogen-Related Receptor (dERR) acts in mid-embryogenesis to directly induce genes
that function in biosynthetic pathways related to the Warburg effect, by which cancer cells use glu-
cose to support rapid proliferation (Tennessen et al., 2011; Tennessen et al., 2014b). This switch
toward aerobic glycolysis favors lactate production and flux through biosynthetic pathways over
mitochondrial OXPHOS, supporting the ~ 200-fold increase in mass that occurs during larval devel-
opment. Taken together with our work on dHNF4, these studies define a role for nuclear receptors
in directing temporal switches in metabolic state that meet the changing physiological needs of dif-
ferent stages in development. Further studies should allow us to better define these regulatory path-
ways as well as determine how broadly nuclear receptors exert this role in coupling developmental
progression with systemic metabolism.
Although little is known about the links between development and metabolism, it is likely that
coordinated switches in metabolic state are not unique to Drosophila, but rather occur in all higher
organisms in order to meet the distinct metabolic needs of an animal as it progresses through its life
cycle. Indeed, a developmental switch towards OXPHOS in coordination with the cessation of
growth and differentiation appears to be a conserved feature of animal development. Moreover, as
has been shown for cardiac hypertrophy, a failure to coordinate metabolic state with developmental
context can have an important influence on human disease (Lehman and Kelly, 2002).
Adult Drosophila as a context for genetic studies of GSIS and diabete
In addition to promoting a transition toward systemic oxidative metabolism in adult flies, dHNF4
also contributes to a switch in IPC physiology that supports GSIS. dHNF4 is not expressed in larval
IPCs, but is specifically induced in these cells at adulthood (Figure 6A,B). Similarly, the fly homologs
of the mammalian ATP-sensitive potassium channel subunits, Sur1 and Kir6, which link OXPHOS and
ATP production to GSIS, are not expressed in the larval IPCs but are expressed during the adult
stage (Fridell et al., 2009; Kim and Rulifson, 2004). They also appear to be active at this stage as
cultured IPCs from adult flies undergo calcium influx and membrane depolarization upon exposure
to glucose or the anti-diabetic sulfonylurea drug glibenclamide (Kreneisz et al., 2010). In addition,
reduction of the mitochondrial membrane potential in adult IPCs by ectopic expression of an uncou-
pling protein is sufficient to reduce IPC calcium influx, elevate whole-animal glucose levels, and
reduce peripheral insulin signaling (Fridell et al., 2009). This switch in IPC physiology is paralleled
by a change in the nutritional signals that trigger DILP release. Amino acids, and not glucose, stimu-
late DILP2 secretion by larval IPCs (Geminard et al., 2009). Rather, glucose is sensed by the corpora
cardiaca in larvae, a distinct organ that secretes adipokinetic hormone, which acts like glucagon to
maintain carbohydrate homeostasis during larval stages (Kim and Rulifson, 2004; Lee and Park,
2004). Interestingly, this can have an indirect effect on the larval IPCs, triggering DILP3 secretion in
response to dietary carbohydrates (Kim and Neufeld, 2015). Adult IPCs, however, are responsive to
glucose for DILP2 release (Park et al., 2014) (Figure 5A,D). In addition, dHNF4 mutants on a normal
diet maintain euglycemia during larval and early pupal stages, but display hyperglycemia at the
onset of adulthood, paralleling their lethal phase on a normal diet (Figure 6D). Taken together,
these observations support the model that the IPCs change their physiological state during the lar-
val-to-adult transition and that dHNF4 contributes to this transition toward GSIS. The observation
that glucose is a major circulating sugar in adults, but not larvae, combined with its ability to
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stimulate DILP2 secretion from adult IPCs, establishes this stage as an experimental context for
genetic studies of glucose homeostasis, GSIS, and diabetes. Functional characterization of these
pathways in adult Drosophila will allow us to harness the power of model organism genetics to bet-
ter understand the regulation of glucose homeostasis and the factors that contribute to diabetes.
Materials and methods
Drosophila strains and media
All genetic studies used a transheterozygous combination of dHNF4 null alleles (dHNF4D17/
dHNF4D33) and genetically-matched controls that were transheterozygous for precise excisions of
the EP2449 and KG08976 P-elements, as described previously (Palanker et al., 2009). Sugar diets
were made using 8% yeast, 1% agar, 0.05% MgSO4, 0.05% CaCl2, and either 3%, 9% or 15% dietary
sugar (2:1 ratio of glucose to sucrose, percentages represent weight/final food volume. 10 ml/
L tegosept and 6 ml/L propionic acid were added just prior to pouring). Fasting was achieved by
using 1% agar as a medium. For adult studies, 8–10 day old males were selected for all studies
unless otherwise indicated.
GAL4/UAS lines for tissue-specific RNAi studies
The following GAL4 driver lines were used for tissue-specific expression experiments: Fat body: r4-
GAL4 (Lee and Park, 2004), midgut: mex-GAL4 (Phillips and Thomas, 2006), IPCs: yw; UAS-Dicer2;
dilp21 dilp2HF dilp2-GAL4 (Park et al., 2014). RNAi lines used in this study include: UAS-dHNF4RNAi
(TRiP 29375 used in Figure 4A, Figure 4—figure supplement 1A, Figure 5D,E; VDRC 12692 used
in Figure 4—figure supplement 1A–B, Figure 5—figure supplement 1), UAS-mCherryRNAi (TRiP
35785), UAS-Cox5aRNAi (TRiP 27548), UAS-CIA30RNAi (TRiP 55660), UAS-ATPsynbRNAi (TRiP 28056),
UAS-Scs-aRNAi (TRiP 51807), UAS-CG5599RNAi (TRiP 32876), and UAS-HexCRNAi (TRiP 57404 used in
Figure 4B–D, and VDRC 35337 and VDRC 35338 used in Figure 4—figure supplement 3).
Lifespan studies
The dHNF4 mutant lethal phase was assessed by raising 50–60 newly hatched first instar larvae in
vials of standard laboratory media at 25˚C and scoring for survival through embryonic hatching, wan-
dering third instar, puparium formation, eclosion, and survival through the first day of adulthood
(Figure 1A). Eclosion rates were scored in a similar manner for dHNF4 mutants and genetically
matched controls raised on the 3%, 9% or 15% sugar diets. For adult survival studies on different
diets (Figure 1C), 50–60 newly hatched first instar larvae were placed in vials with the 3% sugar diet
and raised until five days of adulthood. These mature adults were then transferred to fresh vials of
3%, 9%, or 15% dietary sugar with approximately 25 males and 25 females per vial at 25˚C and
scored daily for lethality. Flies were transferred to fresh vials every 2–3 days. At least three replicate
vials were analyzed per condition and each experiment was repeated at least three times with similar
results.
Developmental staging
For the developmental time course northern blot, we collected 0–12 hr feeding third instar larvae,
pupae at 24, 48 or 72 hr after puparium formation, stage P12 males (newly formed pharate adult
with visible sex combs) for 4 day pupae, and males at mid-eclosion from the pupal case (to ensure
that all dHNF4 mutants were alive) (n=15 animals per sample). Animals collected for developmental
RNA and glycemia measurements (Figure 6D–E) were raised on the 15% sugar diet, except for the
adults, which were reared on the 3% sugar diet and transferred to the 15% sugar diet after eclosion.
Metabolic assays
Glycogen, trehalose, and free glucose levels were determined using the Hexokinase (HK) and/or Glu-
cose Oxidase (GO) assay kits (Sigma GAHK20, GAGO20) as previously described, with approxi-
mately six biological replicates (n=5 animals per sample) assayed per condition (Tennessen et al.,
2014a). Total protein levels were determined in parallel by Bradford assay to control for potential
variations in sample homogenization and/or animal size. Hemolymph glucose measurements were
determined by centrifuging 60–100 adult males in a prepared zymogen barrier column (Zymo
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Research Corporation C1006) at 9000 g for 5 min at 4˚C, as described (Park et al., 2014). The
hemolymph flow-though was diluted 1:100 in 1xPBS prior to heat treatment, followed by analysis
using the HK assay kit.
ATP assay
Mature adult males were placed on 10% sucrose + 1% agar overnight prior to analysis. Six biological
replicates per genotype (n=5 males per sample) were analyzed for ATP levels by using a lumines-
cence assay kit (Molecular Probes ATP kit; A22066, ) as described (Tennessen et al., 2014a).
GC/MS Metabolomic analysis
Animals were raised on the 3% sugar diet until five days of adulthood and transferred to a fresh vial
with either the 3% or 15% sugar diet for three days prior to collection. Twenty adult males per sam-
ple were snap-frozen in liquid nitrogen and prepared for analysis by gas chromatography-mass spec-
trometry (GC/MS) as described (Tennessen et al., 2014a). Data is presented from three
independent experiments, each consisting of 5–6 biological replicates per condition. Sample prepa-
ration and GC/MS analysis were performed by the Metabolomics Core Research Facility at the Uni-
versity of Utah School of Medicine.
Immunostaining
Tissues were dissected in cold 1xPBS, fixed in 4% paraformaldehyde for 20-30 min at room tempera-
ture, and washed once quickly followed by three washes for 20 min each in PBS, 0.2% Triton-X100.
Samples were blocked using 5% normal goat serum for 1–2 hr at room temperature and incubated
with primary antibodies for a minimum of 24 hr at 4˚C, washed, and incubated with secondary anti-
body at 4˚C for 24 hr. Images were acquired using an Olympus FV1000 confocal microscope and
analyzed by Volocity software to generate Z-stack projections and overlay images. The following
antibodies were used for immunofluorescence studies: rat anti-dHNF4 (Palanker et al., 2009), rat
anti-DILP2 (a gift from P. Leopold), rabbit anti-GFP (Molecular Probes A-6455), chicken anti-GFP
(Abcam 13970), and mouse anti-ATP5A (Abcam 14748).
Quantification of DILP2 fluorescence
Dissected brains stained for DILP2 peptide were mounted in SlowFade! Gold (Life Technologies)
and imaged using an Olympus FV1000 confocal microscope and 60X water-immersion objective.
Scan settings were fixed to be identical for all captured images, with Z-stack limits set to encompass
the entire depth of DILP2 fluorescence for each brain. Maximum projection Z-stacks were analyzed
using Volocity software to calculate mean pixel intensity of DILP2 fluorescence within the IPCs
(selected by ROI tool) for each set of IPCs analyzed.
Northern blot analysis
Total RNA was extracted from groups of 10–20 animals using TriPure isolation reagent (Roche). RNA
was fractionated by 1% formaldehyde gel electrophoresis at a constant voltage (70V) for ~ 3.5 hr
prior to transfer to a nylon membrane overnight. After transfer, RNA was UV cross-linked to the
membrane and placed in hybridization buffer (5 mls formamide, 2 mls 10x PIPES buffer, pH 6.5, 2
mls ddH20, 1 ml 10% SDS, 100 ml sheared herring sperm ssDNA) for two hours at 42˚C prior to the
addition of radiolabeled probe. Probes were generated by Klenow-mediated random primer amplifi-
cation of purified template DNA corresponding to approximately 100–500 bp of the transcript of
interest, allowing incorporation of 32P radiolabeled-nucleotide (dCTP, PerkinElmer). Probes were
incubated with membranes overnight, and the hybridized membranes were washed and exposed to
X-ray film at -80˚C using two intensifying screens.
RNA-seq
dHNF4 mutants and genetically-matched controls were reared on the 3% sugar diet for five days of
adulthood and transferred to the 15% sugar diet for 3 days prior to extracting total RNA. Eight bio-
logical replicates per genotype (n=20 males per sample) were collected using TriPure isolation
reagent (Roche). Pairs of biological replicates were pooled to obtain four biological replicates for
further purification using an RNeasy kit (QIAGEN). RNA quality was subsequently analyzed using an
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Agilent Bioanalyzer RNA 6000. PolyA-selected RNAs from each biological replicate were then
assembled into barcoded libraries and pooled into a single-flow cell lane for Illumina HighSeq2000
50-cycle single-read sequencing, which produced !21.9 million reads per sample. Standard replicate
RNA-seq analysis was performed using USeq and DESeq analysis packages with alignment to the
Drosophila melanogaster dm3 genome assembly. Transcripts meeting a cutoff of !1.5 fold differ-
ence in mRNA abundance and FDR "1% were considered as differentially expressed genes. RNA
quality control, library preparation, sequencing, and data analysis were performed at the University
of Utah High Throughput Genomics and Bioinformatics Core Facilities. Although mt:Cyt-b and mt:
ND6 are included among the down-regulated genes in our RNA-Seq dataset (Supplementary file
1), these represent false positives as demonstrated by subsequent repeated northern blot hybridiza-
tion studies for mt:Cyt-b (Figure 3A). We are also unable to detect mt:ND6 mRNA in either mutant
or control flies, consistent with a previous report (Berthier et al., 1986).
ChIP-seq
Chromatin isolation and immunoprecipitation were performed as described (Schwartz et al., 2003).
w1118 flies were reared on standard cornmeal-based lab medium and 1–1.5 g of mature adults were
homogenized in ice-cold buffer A (0.3 M sucrose, 2 mM MgOAc, 3 mM CaCl2, 10 mM Tris-Cl [pH 8],
0.3% Triton X-100, 0.5 mM dithiothreitol, 1 Roche protease inhibitor tablet per 10 ml) for 1.5 min
using a Brinkmann Homogenizer Polytron PT 10/35. The homogenate was filtered through a layer of
100 mm-pore nylon mesh into a pre-chilled glass-Teflon homogenizer, stroked on ice 35 times using
a B pestle, and filtered through two layers of 40-mm-pore nylon mesh prior to adding one volume of
warm cross-linking buffer (0.1 M NaCl, 1 mM EDTA, 0.5 mM EGTA, 50 mM Tris [pH 8], pre-warmed
to 40˚C) to bring the sample to room temperature for crosslinking (0.3% formaldehyde for 3 min).
2.5 M glycine was added to a final concentration of 125 mM to stop the crosslinking after 3 min.
The mixture was pelleted for resuspension into 10 ml of RIPA buffer (140 mM NaCl, 10 mM Tris-Cl
[pH 8.0], 1 mM EDTA, 1% Triton, 0.3% SDS, 0.1% sodium deoxycholate, and Roche protease inhibi-
tor cocktail) for sonication. The sonicated material was centrifuged at 20,000 g, and the supernatant
was distributed into 500 ml aliquots that were snap frozen in liquid nitrogen. To each aliquot, 1 ml of
cold RIPA buffer (without SDS) was added prior to removing 150 ml for an input control, and then 5
ml of polyclonal affinity-purified anti-dHNF4 antibody was added to each sample for immunoprecipi-
tation overnight at 4˚C (Palanker et al., 2009). 50 ml of prepared Protein G Dynabeads (Life Technol-
ogies) were added to each sample and incubated for 4 hr at 4˚C prior to wash and elution using a
magnetic stand. Washes were performed for 3 min each at 4˚C with 1 ml of the following ice-cold
solutions: three times in low salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-
Cl [pH 8.0], 150 mM NaCl), one time in high salt wash buffer (0.1% SDS, 1% Triton X-100, 2 mM
EDTA, 20 mM Tris-Cl [pH 8.0], 500 mM NaCl), once in LiCl wash buffer (0.25 M LiCl, 1% NP-40, 1%
deoxycholate, 1 mM EDTA, 10 mM Tris-Cl [pH 8.0]), and twice with Tris-EDTA. Protein-DNA com-
plexes were eluted in 1.5 ml DNA-low bind tubes (Eppendorf) using two 15-minute washes with
250 ml elution buffer (1% SDS, 0.1 M NaHCO3). NaCl was added to a final concentration of 0.2 M to
reverse the crosslinks of IP and input control samples, followed by an overnight incubation at 65˚C.
dHNF4-bound DNA was purified by using PCR-purification columns (Qiagen), and pooled to acquire
four replicates of dHNF4-IP chromatin and input controls. Barcoded libraries for dHNF4-IP and input
control samples were generated by the University of Utah High Throughput Genomics core facility
and sequenced in a single lane Illumina HiSeq 50-cycle single-read sequencing. Data analysis was
performed by the Bioinformatics Core at the University of Utah School of Medicine using USeq Scan-
Seqs (FDR80) as well as Model-based Analysis for ChIP-seq 2.0 (MACS2) (Zhang et al., 2008) with
an FDR cutoff of 1% (FDR20), identifying 68 enrichment regions. Nearest neighboring genes were
compiled using USeq FindNeighboringGenes and UCSC dm3 EnsGenes gene tables and were com-
pared to our RNA-seq dataset to identify proximal genes that are also misexpressed in dHNF4
mutants, highlighting these as direct targets of dHNF4.
Immunoblotting
Samples were homogenized in Laemmli sample buffer with protease and phosphatase inhibitor cock-
tails, resolved by SDS-PAGE (10% acrylamide), transferred to PVDF membrane overnight at 4˚C, and
blocked with 5% BSA prior to immunoblotting. Antibodies used for western blots include rabbit
Barry and Thummel. eLife 2016;5:e11183. DOI: 10.7554/eLife.11183 20 of 26










anti-pAKT (Cell Signaling #4054), rabbit anti-AKT (Cell Signaling #4691), mouse anti-SDHA (Abcam
137756), rabbit anti-SDHB (a generous gift from D. Winge, generated against yeast SDH2/SDHB),
mouse anti-ATP5A (Abcam 14748), and mouse anti-bTubulin (Chemicon MAB380).
DILP2HF ELISA for measuring circulating DILP2
Transgenic lines expressing HA-FLAG tagged DILP2 (DILP2-HF) peptide were used for ELISA assays,
essentially as described (Park et al., 2014). The indicated UAS-RNAi line or w1118 controls
(Figure 5D and Figure 5—figure supplement 1) were crossed to yw; UAS-Dcr2; dilp21 DILP2HF
dilp2-GAL4 flies. Adult male progeny were either fed ad libitum (Figure 5—figure supplement 1) or
fasted overnight and then re-fed the 15% sugar diet for 45 min prior to analysis (Figure 5D). The
posterior end of the abdomen was removed using micro-dissection scissors and placed in 60 ml of
PBS, using 10 males per biological replicate. Tubes were vortexed for 20 min, after which 50 ml of
supernatant was collected in a fresh tube. Samples were homogenized in 600 ml of PBS, 1% Triton X-
100. HA-FLAG peptide standards from 0, 20, 40 80, 160, 320 and 640 pg/ml were generated for a
linear standard curve. 50 ml of circulating DILP2HF, total DILP2HF, or peptide standards were added
to 50 ml of anti-HA-peroxidase (5 ng/ml, Roche 3F10) in PBS (with or without 1% Triton X-100) and
then pipetted into a 96-well ELISA plate (Thermo Scientific MaxiSorp Immulon 4 HBX, Cat# 3855)
coated with mouse anti-FLAG antibody (Sigma F1804, M2 monoclonal). Samples were incubated at
4˚C overnight and washed 6 times with PBS, 0.2% Tween-20. 100 ml of 1-Step Ultra TMB ELISA Sub-
strate (Thermo Scientific 34029) was added to the plate and incubated at room temperature for 30
min. 100 ml of 2M sulfuric acid was added to stop the reaction and the absorbance was measured
immediately at 450 nm. Circulating DILP2HF (pg/fly) versus total remaining peptide was calculated
to determine the percent secretion relative to controls (n!4 biological replicates per condition).
Clonal analysis
Virgin female flies (yw,hsFLP,UAS-GFP; tub-GAL80,FRT40A;tub-GAL4) were crossed to w;HNF4D33/
CyO twi>GFP males for MARCM analysis. Flies were reared on the 3% sugar diet and heat treated
at 37˚C for one hour as pharate adults, and again as newly-eclosed adults. Adults were maintained
on the 15% sugar diet for 8–10 days prior to analysis.
Tetramethylrhodamine ethyl ester (TMRE) staining
Adult flies were dissected in room temperature Schneider’s medium (ThermoFisher 21720024) with
microdissection scissors to separate the abdomen from the thorax. The intestine was removed and
the abdominal cavity was cut open to allow maximal contact of fat body with the TMRE solution
(ThermoFisher T669). Dissected abdomens were placed in freshly-prepared solution of 20 nM TMRE
in Schneider’s medium and incubated in the dark for 5–7 min. Samples were then washed briefly
twice in Schneider’s medium, mounted on glass slides in fresh Schneider’s medium, and immediately
imaged on an Olympus FV1000 confocal microscope with a 60x water objective.
Dihydroethidium (DHE) staining
DHE staining was performed as previously described (Owusu-Ansah and Banerjee, 2009). Briefly,
adult abdomens were dissected as described for TMRE staining, but instead placed in freshly pre-
pared 30 mM DHE (ThermoFisher D11347) in Schneider’s medium and incubated in the dark for 5–7
min. Samples were washed rapidly three times with Schneider’s medium, followed by fixation in 4%
formaldehyde in 1xPBS for seven minutes. Samples were then washed twice in 1xPBS, mounted in
SlowFade Gold (ThermoFisher S36936), and imaged on an Olympus FV1000 confocal microscope
with a 20X objective.
Statistics
GraphPad PRISM 6 software was used to plot data and perform statistical analysis. Pairwise compari-
son P values were calculated using a two-tailed Student’s t-test, multiple comparison P values were
calculated using one-way ANOVA with Sˇı´da´k multiple test correction (except Figure 4B,C which
included Dunnett’s correction). Error bars are ± 1xSEM unless otherwise noted. Box plots display the
full range of data (error bars), the 25–75th quartiles (box), and the median (midline).
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Figure 1—figure supplement 1. Dietary sugar, but not protein, correlates with reduced dHNF4 mutant survival.
Newly hatched first instar larvae were placed in vials (~ 60 larvae per vial) containing either the 3% sugar diet, the
3% sugar diet + 240 kcal/L extra sugar (2:1 glucose to sucrose, 9% final concentration), or the 3% sugar diet + 240
kcal/L of additional protein (peptone). All diets contained 8% yeast, 1% agar, 0.05% MgSO4, and 0.05% CaCl2,, as
described in Materials and methods. Animals were reared at 25˚C and successful eclosion was scored as complete
emergence from the pupal case. Data is plotted as the mean ± SEM. ***p!0.001.
DOI: 10.7554/eLife.11183.004
Barry and Thummel. eLife 2016;5:e11183. DOI: 10.7554/eLife.11183 3 of 19










Figure 1—figure supplement 2. Profiling of major metabolites in dHNF4 mutant adults fed different levels of
dietary sugar. Controls and dHNF4 mutants were raised to adulthood on the 3% sugar diet under density-
controlled conditions. Five days after eclosion, mature adult males were transferred to the 3%, 9%, or 15% sugar
diets for three days prior to analysis. Whole-animal lysates were analyzed for concentrations of total triacylglycerol
(TAG) (A), glycogen (B), or protein (C). All data was normalized to the level in controls on the 9% sugar diet. Data
represents six biological replicates each with five animals, and results were consistent between at least three
independent experiments. Data is plotted as the mean ± SEM. ***p!0.001, **p!0.01, *p!0.05 Student’s t-test.
DOI: 10.7554/eLife.11183.005
Barry and Thummel. eLife 2016;5:e11183. DOI: 10.7554/eLife.11183 4 of 19









Figure 2—figure supplement 1. dHNF4 mutants show broad defects in carbohydrate homeostasis. GC/MS
metabolomic profiling reveals that a range of sugars and sugar alcohols are increased in dHNF4 mutants
compared to genetically matched controls, indicating that dHNF4 is required for proper carbohydrate
metabolism. Animals were raised to adulthood on the 3% sugar diet prior to being transferred to the indicated
diet for 3 days. Data was obtained from three independent experiments consisting of five to six biological
replicates per condition and values were normalized to control levels on the 15% sugar diet. Data are graphically
represented as a box plot, with the box representing the lower and upper quartiles, the horizontal line
representing the median, and the error bars denoting the minimum and maximum data points. ***p!0.001, **p!
0.01, *p!0.05.
DOI: 10.7554/eLife.11183.007
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Figure 3—figure supplement 1. dHNF4 mutants display changes in TCA cycle intermediates that correlate with changes in gene expression. GC/MS
metabolomic profiling of adult flies fed a sugar only diet (10% sucrose + 1% agar) reveals defective TCA cycle metabolism in dHNF4 mutants.
Intermediates of the TCA cycle are presented along with genes that are underexpressed in dHNF4 mutants (in italics). The mRNA abundance for each
gene in dHNF4 mutants is indicated (red text) relative to matched controls from RNA-seq data. These genes are predicted to affect enzymatic
complexes for isocitrate dehydrogenase (IDH1/2), alpha-ketoglutarate dehydrogenase (a-KGDH), succinyl-CoA synthetase (SCS), or succinate
dehydrogenase (SDH). Consistent with impaired IDH and SCS activity, levels of alpha-ketoglutarate and succinate are reduced, while upstream citrate,
aconitate, and isocitrate accumulate. The modest effect on succinate abundance is possibly due to a combined effect of impaired succinate production
balanced by decreased succinate oxidation resulting from impaired SDH activity. In addition, intermediates of the urea cycle are broadly accumulated
in dHNF4 mutants including fumarate, which lies at the interface of these two pathways. This may contribute to the elevated levels of fumarate and
downstream malate independent of impaired SDH activity. Metabolites lacking graphical data were not detected or could not be measured by GC/MS.
Animals were reared on the 3% sugar diet until 5 days of adulthood and then transferred to medium containing 10% sucrose with 1% agar (sugar only)
for 3 days prior to analysis. Data represents six biological replicates consisting of 20 males per replicate. ***p!0.001, **p!0.01, *p!0.05. Inset - western
blot analysis of whole animal lysates revealed reduced levels of SDHB protein, but no effect on SDHA, in dHNF4 mutants. ATP5A was detected as a
control for loading and transfer.
DOI: 10.7554/eLife.11183.009
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Figure 3—figure supplement 2. dHNF4 mutants display mitochondrial defects. (A) mtDNA abundance relative to nuclear DNA quantified by qPCR in
control and dHNF4 mutant adult males on the 15% sugar diet. (B) Adult fat body tissue from control or dHNF4 mutants immunostained for ATP5A
(green) to detect mitochondria, dHNF4 protein (red), and DAPI (blue) to mark nuclei. (C) Analysis of dHNF4 mutant MARCM clones (GFP+) shows
reduced mitochondrial membrane potential by TMRE staining of live fat body tissue from adult flies maintained on the 15% sugar diet. (D) MARCM
clonal analysis of adult dHNF4 mutant fat body cells (GFP+) for reactive oxygen species (ROS) by DHE staining shows no detectable difference in ROS
levels in mutant cells.
DOI: 10.7554/eLife.11183.010
Barry and Thummel. eLife 2016;5:e11183. DOI: 10.7554/eLife.11183 9 of 19
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Figure 3—figure supplement 3. Predicted functions of dHNF4 target genes. Forty-seven genes identified as high confidence targets for direct
regulation by dHNF4 are depicted. These genes fit the criteria of showing proximal dHNF4 binding along with reduced transcript abundance in mutant
animals as determined by RNA-seq (!1.5 fold change, 1% FDR) (Supplementary Tables 1,3).
DOI: 10.7554/eLife.11183.011
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Figure 4—figure supplement 1. dHNF4 is required in the insulin-producing cells and fat body to maintain
glucose homeostasis. (A) Tissue-specific RNAi directed against dHNF4 effectively reduces steady-state levels of
dHNF4 protein. Immunostaining was used to detect dHNF4 in organs dissected from third instar larvae that
express either the r4-GAL4 driver alone as a control or fat body-specific RNAi for dHNF4 (r4>dHNF4RNAi) using
UAS-RNAi constructs from either the TRiP or VDRC stock collections (fb = fat body, mt = Malpighian tubules). (B)
dHNF4 function is required in both the IPCs and fat body for glucose homeostasis. This data reproduces that
shown in Figure 4A using a distinct dHNF4 UAS-RNAi construct. Circulating glucose levels were measured in
animals with tissue-specific RNAi against dHNF4 (VDRC) in the IPCs (dilp2-GAL4) or fat body (r4-GAL4) compared
to GAL4 and UAS lines alone as controls. Controls are represented by grey bars while dHNF4 RNAi is represented
by blue bars. Data represents the mean ± SEM, ***p!0.001.
DOI: 10.7554/eLife.11183.013
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Figure 4—figure supplement 2. Fat body-specific disruption of the electron transport chain causes sugar
intolerance. Newly hatched first instar larvae were placed in vials ( ~ 60 per vial) containing the 3% or 15% sugar
diet and scored for puparium formation when raised at either 25˚C (A) or 18˚C (B). Disruption of ETC complex IV
(Cox5a RNAi) or complex V (ATPsynb RNAi) in the fat body (r4-GAL4) results in sugar intolerance as seen by a
pronounced developmental delay and reduced survival to puparium formation on the 15% sugar diet. These
defects are partially suppressed when reared on the low sugar diet at either temperature; however, the 18˚C
condition allows for more robust suppression of the sugar-dependent developmental delay (B).
DOI: 10.7554/eLife.11183.014
Barry and Thummel. eLife 2016;5:e11183. DOI: 10.7554/eLife.11183 14 of 19










Figure 4—figure supplement 3. Additional RNAi lines confirming the importance of Hex-C in the fat body for
glycemic control. Tissue-specific RNAi directed against Hex-C in the fat body, but not midgut, results in elevated
levels of free glucose. RNAi lines against Hex-C were obtained from the VDRC RNAi collection (UAS-Hex-C
RNAi#1: VDRC 35337, and UAS-Hex-C RNAi#2: VDRC 35338). Grey bars represent the indicated GAL4 driver line
crossed to w1118 as a negative control. These results are consistent with those in Figure 4B showing
hyperglycemia upon fat body-specific RNAi for Hex-C using a line from the TRiP collection (Bloomington stock
#57404).
DOI: 10.7554/eLife.11183.015
Barry and Thummel. eLife 2016;5:e11183. DOI: 10.7554/eLife.11183 15 of 19










Figure 5—figure supplement 1. dHNF4 RNAi in the
IPCs causes reduced levels of circulating DILP2-HF.
This data reproduces that shown in Figure 5D using a
distinct dHNF4 UAS-RNAi construct (VDRC collection).
Levels of circulating HA-FLAG-tagged DILP2 (DILP2HF)
were assayed in ad libitum fed animals with IPC-
specific RNAi against dHNF4 (VDRC 12692) using the
dilp2-GAL4 driver compared to animals carrying the
dilp2-GAL4 driver alone as a control. Dot plot depicts
individual sample values from two independent
experiments and the midline represents the mean (n=6
biological replicates per genotype per experiment).
***p!0.001.
DOI: 10.7554/eLife.11183.017
Barry and Thummel. eLife 2016;5:e11183. DOI: 10.7554/eLife.11183 17 of 19
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 The nuclear receptor HNF4A is an essential regulator of development and 
metabolic homeostasis. In humans, haploinsufficiency for HNF4A results in diabetes-
onset during young adulthood, yet the molecular basis for this remains unclear. My 
previous studies in Drosophila revealed an important role for dHNF4 in promoting 
mitochondrial function at the transition to adulthood to support insulin secretion and 
glucose homeostasis in the mature animal. Here I present a collaborative effort to assess 
the potential evolutionarily conserved role of HNF4 in supporting mitochondrial 
function. This includes an extended analysis of dHNF4-dependent mitochondrial activity 
during Drosophila development, showing an adult-specific requirement for dHNF4 to 
maintain mitochondrial integrity and the activity of the electron transport chain (ETC). 
dHNF4 maintains ETC complex I activity through the regulation of mtDNA-encoded 
genes and through CG7461, a nuclear-encoded acyl-CoA dehydrogenase that is 
homologous to mammalian ACAD9. Mutations in ACAD9 cause complex I deficiency in 
humans and HNF4A binds to the ACAD9 promoter region in the adult mouse liver. 
HNF4A also associates with Polrmt, and Pink1, encoding the mitochondrial RNA 
polymerase gene and a factor necessary for both mitochondrial quality control and ETC 
activity, respectively. Although HNF4A is dispensable for proper expression of Polrmt 
and Acad9 under normal conditions, their expression is significantly reduced in HNF4A 
mutant livers under the metabolic stress condition of cold exposure. In contrast, Pink1 
and mtDNA-encoded transcripts require HNF4A for maximal expression at both room 
temperature and under cold stress. Although mitochondrial localization was not observed 
for HNF4A in mouse hepatocytes, staining of human pancreas specimens revealed 
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distinct mitochondrial localization in islets. Taken together, these findings suggest that 
the role for HNF4A in regulating mitochondrial activity has been conserved through 
evolution and may represent a critical function of this nuclear receptor to maintain 
metabolic homeostasis and prevent diabetes.  
 
Introduction 
 The rising prevalence of metabolic disorders has generated an urgent need to 
better understand how metabolic systems are regulated to help advance clinical progress. 
A major focus of these studies is on nuclear receptors, which comprise a family of ligand-
regulated transcription factors that play important roles in development and metabolic 
homeostasis. One of the first nuclear receptors to be associated with a human metabolic 
disorder is HNF4A, which was linked to a heritable form of diabetes termed Maturity 
Onset Diabetes of the Young 1 (MODY1) two decades ago (Yamagata et al., 1996). 
Autosomal dominant inheritance of HNF4A mutations results in impaired insulin 
secretion and hyperglycemia, which typically manifest during young adulthood (Fajans 
and Bell, 2011). Attempts to model MODY1 have been limited, however, as 
heterozygous loss of HNF4A in mice shows no apparent phenotypes, and null mutants die 
during early embryogenesis (Chen et al., 1994). Two separate groups have reported 
studies of adult mice with β-cell specific deletion of HNF4A; however, overt diabetes was 
not observed in either case (Gupta et al., 2005; Miura et al., 2006). Although insulin 
secretion was found to be impaired in one these studies, there was no impact on sustained 
glycemic control (Miura et al., 2006). In contrast, hyperinsulinemic hypoglycemia was 
reported in a separate study of adult mice lacking β-cell HNF4A (Gupta et al., 2005). As 
a result, the molecular function of HNF4A to support insulin secretion and maintain 
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systemic glucose homeostasis remains unclear.  
 Although β-cell dysfunction is thought to be the major cause of MODY1, HNF4A 
is expressed in several other important metabolic tissues, including the liver, intestine, 
and kidney. In the liver, HNF4A acts as a master regulator of hepatocyte differentiation 
and metabolic gene expression. As a result, liver-specific deletion leads to hepatic 
dedifferentiation, over proliferation, steatosis, reduced glycogen stores, and early lethality 
(Bonzo et al., 2012; Hayhurst et al., 2001; Walesky et al., 2013a; Walesky et al., 2013b). 
In the fed state, the liver helps to clear excess circulating glucose by storing it in the form 
of glycogen. As circulating glucose levels drop during fasting, free glucose is released 
from the liver through gluconeogenesis and glycogen breakdown to prevent 
hypoglycemia. Although HNF4A is known to regulate several genes involved in 
gluconeogenesis, liver-specific disruption of HNF4A in an otherwise wild-type 
background has little effect on circulating glucose levels (Bonzo et al., 2012; Yin et al., 
2011; Yoon et al., 2001). RNAi for HNF4A in the adult liver, however, exacerbates 
glucose intolerance in a mouse model of type-2 diabetes, suggesting an important role in 
this tissue to maintain euglycemia under metabolically stressed conditions (Yin et al., 
2011). 
 In Drosophila, null mutants for the single ortholog of HNF4A, dHNF4, 
recapitulate the hallmark features of MODY1, including impaired insulin secretion and 
hyperglycemia (Barry and Thummel, 2016). dHNF4 mutants display an adult onset form 
of diabetes due, in part, to a role for dHNF4 in promoting increased mitochondrial 
function in the mature animal. dHNF4 mutants also recapitulate several phenotypes of 
mice carrying liver-specific deletion of HNF4A, including triglyceride accumulation and 
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low glycogen stores (Barry and Thummel, 2016; Palanker et al., 2009). Interestingly, 
Drosophila HNF4 functions in both the fat body and insulin-producing cells to maintain 
glucose homeostasis. These tissues represent the functional equivalents of mammalian β-
cells and the liver, respectively, raising the possibility that HNF4A may act in a similar 
manner in flies and mammals to support glycemic control.  
 The developmental-onset of diabetes in dHNF4 mutant adults relates to the well-
established link between mitochondrial activity and cellular development. In contrast to 
growing and proliferative cells, differentiated tissues are more reliant on mitochondrial 
oxidative phosphorylation (OXPHOS) for ATP production (Shyh-Chang et al., 2013; 
Vander Heiden et al., 2009). This likely explains the developmental upregulation of 
mitochondrial gene expression at the transition to adulthood in Drosophila, which 
requires dHNF4 (Barry and Thummel, 2016). OXPHOS is also central to the process of 
insulin secretion from β-cells, where increased ATP production resulting from elevated 
blood glucose triggers a signaling cascade for insulin release (Aleyassine, 1970; 
Erecinska et al., 1992; Gerbitz et al., 1996; Sivitz and Yorek, 2010; Soejima et al., 1996; 
Wiederkehr and Wollheim, 2006). Consistent with this, mutations in the mitochondrial 
genome (mtDNA), which encodes 13 respiratory chain proteins, result in maternally-
inherited diabetes linked to progressive defects in glucose-stimulated insulin secretion 
(GSIS) (Sivitz and Yorek, 2010). Furthermore, haploinsufficiency for the nuclear-
encoded mtDNA transcription factor, TFB1M, causes impaired GSIS and diabetes 
susceptibility in both humans and mice (Koeck et al., 2011) and β-cell-specific deletion 
of the nuclear-encoded mitochondrial transcription factor Tfam, or Opa1, a regulator of 
mitochondrial fusion, results in impaired GSIS and diabetes in mice (Koeck et al., 2011; 
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Silva et al., 2000; Zhang et al., 2011). In addition, mitochondrial dysfunction in the liver 
and skeletal muscle has been implicated in the development of insulin resistance, 
suggesting an important role for mitochondrial function in multiple tissues to protect 
against diabetes onset (Sivitz and Yorek, 2010).  
 Here I report evidence for a conserved role for HNF4A to support mitochondrial 
function in adults. Consistent with the role for Drosophila HNF4 to promote increased 
expression of OXPHOS genes at the transition to maturity, dHNF4 is required in adults, 
but not larvae, to maintain mitochondrial integrity and activity of the ETC complexes I 
and IV. dHNF4 supports complex I activity through both mtDNA gene expression and 
nuclear regulation of CG7461, a homolog of the mammalian acyl-CoA dehydrogenase 
and complex I assembly factor, ACAD9. ChIP-seq analysis of HNF4A in the adult mouse 
liver shows association with the ACAD9 promoter region, along with several other 
important regulators of mitochondrial gene expression and function. Consistent with this, 
HNF4A is required for maximal expression of mtDNA-encoded genes involved in the 
ETC and PINK1, an important factor for mitochondrial quality control and complex I 
activity. Although HNF4A does not appear to be localized to mitochondria in 
hepatocytes, HNF4A colocalizes with mitochondria in human islets. Taken together, 
these data suggest that regulation of mitochondrial function is an evolutionarily 
conserved function of HNF4A, with defects in this process potentially contributing to the 





Materials and Methods 
Fly stocks and maintenance 
 A transheteroallelic combination of dHNF4∆17 and dHNF4∆33 alleles were used for 
all studies of dHNF4 loss-of-function and were compared to genetically-matched controls 
consisting of a transheteroallelic combination of precise excisions of P-elements EP2449 
and KG08976, as previously described (Barry and Thummel, 2016; Palanker et al., 2009). 
RNAi lines were acquired from the Bloomington stock center TRiP RNAi collection. 
UAS-RNAi lines used include: TRiP 55347 (CG7461RNAi), TRiP 55660 (CIA30RNAi), and 
TRiP 35785 (mCherryRNAi). Fat body-specific RNAi was achieved by crossing to r4-
GAL4 transgenics (Lee and Park, 2004). Stocks were maintained at room temperature and 
experimental crosses were set up in vials in a humidified incubator at 25˚C. Animals 
were reared on the 3% sugar diet as previously described (Barry and Thummel, 2016). 
For conditioning on the 15% sugar diet, mature adults were transferred to the 15% sugar 
diet for three days prior to analysis. Diets consist of 0.8-1% agar, 8% yeast, 3% or 15% 
sugar (2:1 ratio of glucose to sucrose), and 0.5% MgSO4 and 0.5% CaCl2, where 
percentages represent weight by volume. The media was cooked by microwaving on high 
power to achieve at least 5 min of rapid boiling and slowly cooled while stirring. After 
allowing the media to cool to ~50˚C, 10 ml/L tegosept and 6 ml/L propionic acid were 
added prior to pouring into vials for solidification.   
 
Whole-mount immunostaining of Drosophila tissues 
 Fat body was dissected from either feeding L3 larvae or mature adult males in ice-
cold PBS. The dissected tissues were then transferred to 4% paraformaldehyde for 
fixation at room temperature for either 20 (larval fat body) or 30 (adult) min while 
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rocking. Samples were quickly washed in PBS+0.2% Triton X-100 and then washed for 
three additional times for 10-15 min each at room temperature. Samples were blocked for 
2 hr at room temperature with 5% normal donkey serum in PBS+0.2% Triton. Primary 
antibody (mouse anti-ATP5A, Abcam 14748) was added at a dilution of 1:200 in block 
solution and incubated overnight at 4˚C while rocking. Samples were then washed once 
quickly with PBS+0.2% Triton and for three additional times for 10-15 min each at room 
temperature. Secondary antibody was added at a final dilution of 1:1000 (donkey 
antimouse Cy2, Jackson Immuno) and incubated overnight at 4˚C in the dark. Samples 
were then washed and mounted in Slowfade Gold (Thermo Fisher Scientific). Imaging 
was performed with an Olympus FlowView 1000 with a 60x water or oil immersion 
objective and processed using ImageJ software.  
 
Mitochondrial isolation 
 Approximately sixty adult male flies were placed in a 15 ml ice-cold dounce 
homogenizer and stroked approximately 20 times with glass pestle A. Animals were 
homogenized in 1 ml of cold isolation buffer plus protease inhibitor. The homogenizer 
and pestle were rinsed with 1 ml of isolation buffer, and the final 2 mls of homogenate 
was passed through100-micron nylon filter basket. The membrane was washed with 1 ml 
of buffer, which was subsequently centrifuged through a 10 micron filter at 1000 g for 30 
sec. After rinsing the membrane with an additional 1 ml of isolation buffer, the flow 
through was centrifuged at 1,000 g for 5 min at 4˚C to pellet cell debris. The supernatant 
was then transferred to a fresh tube and centrifuged for an additional 15 min at 13,000 g. 
The supernatant was then discarded and the pellet was resuspended in 50-100 µl of 
hypotonic buffer (0.5 mM NaCl, 25 mM potassium phosphate, pH 7.5) and split into 
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three separate aliquots before storing at -80˚C.  
 
Electron transport chain complex activity assays 
 ETC complex activity assays were performed as previously described with minor 
alterations (Spinazzi et al., 2012). Mitochondrial isolates were subjected to at least four 
freeze-thaw cycles followed by Bradford assay to quantify mitochondrial protein. 
Samples were adjusted, if necessary, to achieve comparable protein concentrations and to 
be sufficiently dilute for accurate pipetting volumes to be used in the assays. For complex 
I activity, 15-20 ug of mitochondrial extracts were used per assay with three biological 
replicates analyzed per genotype. Parallel wells were analyzed +/- addition of rotenone to 
a final concentration of 10 µM. The reaction was initiated by addition of ubiquinone (10 
µM final concentration) and the decrease in absorbance at 340 nm was monitored for up 
to 5 min as a read-out of NADH oxidation. Rotenone-independent activity was quantified 
and subtracted to determine specific complex I activity. 
 For complex II activity, approximately 10 µg of mitochondrial protein was 
assayed. Complex II activity was measured by reading the decrease in absorbance at 600 
nm for 5 min to assess oxidation of succinate upon addition of decylubiquinone (50 µM 
final concentration). Malonate was used at a final concentration of 10 mM to determine 
SDH-specific activity.  
 Two µg of mitochondrial protein was used to assay complex IV activity. Baseline 
activity was determined by assaying the change in absorbance prior to addition of 
mitochondria. Upon addition of mitochondrial protein, the decrease in absorbance was 
monitored at 550 nm for 5 min to determine the oxidation of cytochrome C. Specific 
activity of complex IV was determined by adding KCN  (300 µM final concentration) to 
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parallel replicates.  
 To examine citrate synthase activity, approximately 4 µg of mitochondrial protein 
was assayed for oxidation of oxaloacetic acid by monitoring the increase in absorbance at 
412 nM for 3 min.  
 
Blue-native polyacrylamide gel electrophoresis 
 Blue-native PAGE was performed as described previously (Van Vranken et al., 
2014). Briefly, isolated mitochondria were resuspended in lysis buffer (50 mM NaCl, 5 
mM 6-aminocaproic acid, 50 mM imidazole, 1 mM AEBSF, and protease inhibitor 
cocktail). Mitochondria were permeabilized with 1% digitonin. Samples were resolved on 
a 3-13% gradient native gel prior to membrane transfer and subsequent immune blotting.   
 
Antibodies 
 Antibodies used for immunostaining and blotting were mouse anti-ATP5A 
(Abcam 14748), rabbit anti-SDHB (generated against yeast SDH2, a generous gift from 
Dennis Winge), Goat anti-TIM17 (Santa Cruz, sc-13293), mouse anti-NDUFS3 (Abcam, 
ab14711), and goat anti-HNF4A (Santa Cruz, sc-6556).   
 
Immunostaining of mammalian tissues 
 Tissue fixation, processing, and immunostaining were performed as previously 
described (Krah et al., 2015). For staining of mouse liver, the liver was dissected from six 
week-old adult female mice (CD1 background), washed in cold PBS, then fixed for one 
hr in 4% paraformaldehyde followed by processing in Paraplast Plus (McCormick 
Scientific). Human pancreas specimens were de-identified prior to use and therefore do 
not fall under human subject research according to the US Department of Human and 
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Health Services regulations guide (45 CDR Part 46). Six µM paraffin sections were cut 
and stained with primary antibodies against HNF4A and ATP5A. Fluorescently 
conjugated donkey secondary antibodies were acquired from JacksonImmuno Labs along 
with DAPI to mark nuclei. Slides were mounted in Fluoromount-G (Southern Biotech) 
and imaged on an Olympus FV1000 confocal microscope. ImageJ was used for image 
processing.  
 
Gene expression analysis 
 Three month-old HNF4Aflox/flox (Hayhurst et al., 2001)were injected with viral 
AAV8-TBG-Cre or AAV8-TBG-eGFP (University of Pennsylvania Vector Core, 
Philadelphia, PA) through the tail-vein.  Liver was harvested one week after viral 
delivery for RNA isolation. Liver samples were homogenized with a TissueLyzer II 
(Qiagen) and RNA was isolated using Trizol reagent (Invitrogen). Reverse transcription 
was performed with SuperScript VILO Master Mix (Thermofisher). Quantification of 
gene expression was performed with KAPA SYBR FAST qPCR 2x Master Mix Rox 
Low (Kapabiosystems) on an Applied Biosystems QuantStuio 6 Flex Real-Time PCR 
System, 384-well. Relative expression was calculated by extrapolation from a standard 
curve for each primer pair that was then normalized to expression of the housekeeping 
gene RPL13. Primer pairs were designed with Universal Probe Library (Roche) or 







Drosophila HNF4 is required for mitochondrial  
function in adulthood 
My previous studies of Drosophila HNF4 identified a critical role for this nuclear 
receptor to support mitochondrial function in adulthood (Barry and Thummel, 2016). The 
question remains, however, whether dHNF4 is also required during larval development 
for mitochondrial activity. Examination of mitochondrial morphology in dHNF4 mutant 
larvae fed a 15% sugar diet revealed normal mitochondrial structure, in contrast to the 
severely fragmented morphology of mutant adults (Figure 4.1). Even though dHNF4 is 
required for the expression of genes involved in mitochondrial β-oxidation during this 
stage (Palanker et al., 2009), this finding indicates that mitochondrial integrity is not 
reliant on dHNF4 during larval development. Defects in mitochondrial morphology thus 
correlate with the susceptibility of dHNF4 mutants to diabetes-onset in the adult, but not 
larval stage.  
Although mitochondrial morphology is disrupted in dHNF4 mutant adults fed a 
15% sugar diet, this could either represent a secondary effect of diabetes or a 
predisposing factor for impaired glycemic control (Barry and Thummel, 2016). As an 
initial approach to address this question, I examined the effect of dietary sugar on 
mitochondrial integrity. Although dHNF4 mutants do not display hyperglycemia on a low 
sugar diet (Barry and Thummel, 2016), mitochondrial morphology is nonetheless 
severely fragmented, demonstrating a critical role for dHNF4 to maintain mitochondrial 
integrity independent of dietary sugar content (Figure 4.1). Furthermore, this finding 
indicates that mitochondrial fragmentation is not a secondary effect of hyperglycemia in 
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dHNF4 mutants. Rather, mitochondrial dysfunction likely provides a metabolic 
predisposition to hyperglycemia when dietary sugar is in abundance.  
To more directly assess the requirement of dHNF4 for mitochondrial activity 
during development, ETC complex activities were analyzed from larval and adult 
mitochondrial extracts. This further confirmed a specific requirement for dHNF4 in 
adults, but not larvae, for normal ETC function. In contrast to larvae, adult mutants show 
a severe reduction in complex I activity (Figure 4.2 A). Consistent with this, dHNF4 
mutants also display reduced complex I assembly/stability by blue native-PAGE analysis 
(Figure 4.3). Interestingly, complex I activity is also elevated in mitochondria from wild-
type adults compared to larvae (Figure 4.2 A). This result is not explained by differences 
in mitochondrial abundance, as the same amount of mitochondrial protein was assayed. 
Rather, this finding suggests that either the abundance of complex I per mitochondrion is 
increased in adulthood, or that there is an increase in the inherent activity of the complex. 
In contrast, complex IV shows no significant difference in enzymatic activity between 
larval and adult mitochondria, yet dHNF4 is also required for its maximal activity in the 
adult stage (Figure 4.2 C). The effects on complex I and IV are specific, and not due to 
general mitochondrial damage during isolation, as the activities of citrate synthase and 
complex II are unaffected (Figure 4.2 B,D). The normal activity of complex II is 
unexpected, however, since dHNF4 mutant adults show reduced steady state levels of 
SDHB and reduced expression of the complex II assembly factor dSdhaf4 (Barry and 
Thummel, 2016) (Figure 4.3). However, these effects were observed under conditions 
high dietary sugar, while ETC activity was analyzed from animals fed a low sugar diet. 
Any defects in complex II activity in dHNF4 mutants might therefore only manifest when 
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fed a high sugar diet. Nonetheless, these data demonstrate that dHNF4 is required for 
maximal activity of ETC complexes I and IV in the mature fly. The specific effect on 
these complexes could relate to impaired mtDNA gene expression in dHNF4 mutants, as 
ten of the thirteen protein-coding genes of the mitochondrial genome function in these 
two complexes of the respiratory chain. Furthermore, these data reveal a developmental 
increase in complex I activity in adult Drosophila, although the basis of this remains 
unclear. 
 
CG7461 is a direct target of dHNF4 and  
supports complex I function 
 Although dHNF4 regulates the expression of several nuclear and mitochondrial- 
encoded genes involved in OXPHOS, the majority of dHNF4 nuclear targets function in 
the mitochondrial β-oxidation pathway (Barry and Thummel, 2016; Palanker et al., 
2009). One of these, CG7461, has two closely related mammalian homologs, ACAD9 and 
ACADVL. These paraologous genes represent mitochondrial-localized acyl-CoA 
dehydrogenases with preferential activity toward very long chain fatty acids. 
Interestingly, recent studies have uncovered an additional role for ACAD9 in supporting 
complex I activity, where mutations in this gene cause complex I deficiency in humans 
(Nouws et al., 2014). This raised the possibility that CG7461 might also be required for 
maximal complex I activity in Drosophila. 
  dHNF4 directly associates with the CG7461 promoter region and is required for 
its expression (Figure 4.4 A) (Barry and Thummel, 2016), and thus could represent an 
import target for dHNF4 to maintain complex I function. Similar to dHNF4, CG7461 
expression is enriched in the adult fat body (Figure 4.4 B). Tissue-specific RNAi against 
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CG7461 in the fat body significantly impairs complex I activity in adult flies to a similar 
level as disruption of a known complex I assembly factor, CIA30 (Figure 4.4 C). These 
findings suggest that CG7461 is an important transcriptional target of dHNF4 to support 
ETC complex I activity in Drosophila.  
 
Conserved functions for HNF4 in regulating  
mitochondrial gene expression 
 To determine whether HNF4 has an evolutionarily conserved role in supporting 
mitochondrial function, we sought to examine the consequences of HNF4A loss-of-
function in the adult mouse liver. To this end, adenovirus-mediated delivery of Cre 
recombinase was used for excision of a floxed HNF4A locus in adult mice. Three month-
old HNF4Aflox/flox mice received tail-vein injection of AAV8-TBG-iCre or AAV8-TBG-
eGFP virus to provide hepatocyte-specific Cre expression compared to eGFP controls. 
One week after viral injection, HNF4A transcript was undetectable in the liver along with 
expected changes in known target genes, confirming a high efficiency of Cre-mediated 
recombination (Figure 4.5 A). Transcriptional profiling of mtDNA-encoded transcripts in 
HNF4A mutant livers revealed significant reduction in the expression of all mitochondrial 
genes examined, suggesting that HNF4A is important for mitochondrial activity in the 
adult liver (Figure 4.5 B). Furthermore, these findings provide evidence of a conserved 
function for HNF4 to maintain mitochondrial gene expression in both flies and mice.  
 My previous studies of Drosophila HNF4 uncovered evidence for a direct role in 
both nuclear and mtDNA-encoded gene expression (Barry and Thummel, 2016). To 
investigate whether mammalian HNF4A functions in a similar manner, HNF4A 
subcellular localization was examined in adult hepatocytes. Immunostaining showed 
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abundant nuclear localization, as expected, in addition to a substantial cytoplasmic signal 
(Figure 4.5 C). In contrast to Drosophila, however, there is not an appreciable amount of 
overlap with the mitochondrial marker ATP5A. This suggests that the effect of HNF4A 
loss-of-function on mtDNA gene expression is likely due to an indirect role in regulating 
mitochondrial gene expression through nuclear encoded target genes, or impacts 
mitochondrial copy number.  
 To investigate possible direct regulation of nuclear-encoded mitochondrial genes, 
publically available ChIP-seq data was examined for HNF4A genomic localization in the 
adult mouse liver (Alpern et al., 2014). Analysis of several candidate regions revealed 
HNF4A enrichment at loci encoding important regulators of mitochondrial gene 
expression and function. Amongst these include genes for the mitochondrial transcription 
factor Tfam, the mitochondrial RNA polymerase, Polrmt, a critical factor for 
mitochondrial quality control and complex I activity, PINK1, and ACAD9, an acyl-CoA 
dehydrogenase involved in both β-oxidation and ETC complex I activity (Figure 4.6 A 
and data not shown). These findings raised the possibility that HNF4A may regulate 
mitochondrial gene expression and function through nuclear-encoded genes. 
Furthermore, targeting of ACAD9 in mammals, and CG7461 in flies, represents a 
possible conserved role for HNF4 to support complex I activity.   
 Recent studies have uncovered a critical role for HNF4A in the liver to support 
thermoregulation under the metabolic stress condition of cold exposure (Judith Simcox et 
al., manuscript in preparation). To examine the requirement of hepatic HNF4A for 
expression of nuclear encoded mitochondrial genes, transcript abundance was assessed in 
HNF4A mutant livers under both room temperature and cold stress (Figure 4.6 B). PINK1 
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expression was significantly reduced under both conditions in HNF4A mutant livers, 
while ACAD9 and Polrmt expression was significantly reduced only upon cold exposure. 
The paralog of ACAD9, ACADVL, which does not function in complex I activity, shows 
only minor ChIP-seq enrichment for HNF4A (Figure 4.6 A). ACADVL expression, 
however, was significantly reduced in HNF4A mutant liver under both conditions. 
Analysis of Tfam expression was unsuccessful due to poor detection. While these data 
further implicate HNF4A in regulating mitochondrial function, they do not fully explain 
the reduced mtDNA gene expression in HNF4A mutant livers at room temperature. 
Furthermore, these findings highlight the need to validate HNF4A ChIP-seq enrichment 
peaks for relevant changes in gene expression, as the putative targets ACAD9 and Polrmt 
were unaffected by HNF4A loss-of-function under normal conditions. Nonetheless, our 
findings are consistent with a conserved role for HNF4A in supporting mitochondrial 
activity and suggest an increased need for this function upon cold exposure in mammals. 
The reason for this, however, remains unclear and further experiments are necessary to 
determine the extent to which hepatic mitochondria rely on HNF4A. Moreover, 
additional putative mitochondrial-localized HNF4A target genes have been identified 
through more systematic searches (Figure 4.7). Further studies are therefore needed to 
examine the full extent to which HNF4A directly regulates these loci to impact 
mitochondrial function. 
 Mitochondrial metabolism is critical for maximal GSIS from pancreatic β-cells 
(Aleyassine, 1970; Silva et al., 2000; Sivitz and Yorek, 2010; Soejima et al., 1996). 
Mutations in HNF4A result in impaired GSIS in both mice and humans, yet the 
molecular basis for this remains unknown. Although HNF4A was not localized to 
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mitochondria in hepatocytes, we sought to investigate this possibility in β-cells. 
Consistent with the important role for HNF4 in insulin secretion, immunostaining in the 
human pancreas showed enriched expression of HNF4A in islets of Langerhans (Figure 
4.8 A). Similarly, the mitochondrial marker ATP5A is enriched in islets, consistent with 
previous reports (Figure 4.8 A). Unexpectedly, HNF4A showed no detectable nuclear 
signal, however substantial overlap with ATP5A was observed, suggesting mitochondrial 
localization (Figure 4.8 A-B). Although preliminary, these findings raise the possibility 
that HNF4A plays a direct role within mitochondria of the endocrine pancreas.  
 
Discussion  
 By investigating the function of HNF4 across multiple animal systems, we have 
uncovered a conserved role for this transcription factor to support mitochondrial function.  
In Drosophila, HNF4 promotes a developmental switch towards OXPHOS at the 
transition to adulthood to promote glucose tolerance and GSIS in the mature animal 
(Barry and Thummel, 2016). Here we have provided additional evidence of an adult-
specific role for dHNF4 to maintain mitochondrial integrity and increased activity of the 
ETC. Similar to Drosophila, mammalian HNF4A is also required for maximal expression 
of mtDNA-encoded transcripts in the mouse liver. Although HNF4A is not localized to 
mitochondria in hepatocytes, we uncovered evidence for direct regulation of several 
important nuclear-encoded mitochondrial genes by HNF4A. The specific mechanism 
affecting mtDNA gene expression remains unclear, but nonetheless, these findings 
demonstrate an important role for HNF4A to support mitochondrial activity. 
Furthermore, the observation that HNF4A colocalizes with mitochondria in the human 
endocrine pancreas raises the interesting possibility that HNF4A may directly promote 
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mtDNA gene expression in a tissue-specific manner. Although these findings are still 
preliminary, they set the framework for future studies of the potential role for mammalian 
HNF4A to maintain mitochondrial function in both the liver and β-cells to support 
glycemic control.  
 
dHNF4 promotes increased mitochondrial function in adulthood 
 In Drosophila, dHNF4 contributes to a transcriptional switch that promotes 
increased OXPHOS in the mature fly, and defects in this process are linked to the onset 
of diabetes in mutant adults (Barry and Thummel, 2016). Further analysis of this activity 
has illustrated a specific role for HNF4 to support mitochondrial integrity and the 
activities of complexes I and IV of the ETC in the mature animal. The differential 
expression of OXPHOS genes during development, along with increased complex I 
activity in wild-type adults, likely relates to the known role of mitochondrial metabolism 
in supporting cellular differentiation versus growth. During early development, rapidly 
dividing and growing cells have large biosynthetic demands and predominantly employ a 
metabolic program of aerobic glycolysis (Shyh-Chang et al., 2013; Vander Heiden et al., 
2009). Differentiated cells, in contrast, display a general increased reliance on 
mitochondrial respiration for ATP production. Thus, the role for dHNF4 to direct 
increased OXPHOS in fully differentiated adults can contribute to establishing the 
metabolic state that supports the energetic demands of this final stage in the life cycle 
(Barry and Thummel, 2016). 
 In mammals, HNF4A is a master regulator of hepatocyte differentiation. 
Therefore, a role for HNF4A to support hepatic mitochondrial function in the adult liver 
is consistent with the increased use of mitochondrial respiration in differentiated 
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hepatocytes (Wanet et al., 2014). The expression of mtDNA-encoded genes is broadly 
reduced in HNF4A-deficient livers, along with PINK1, a critical factor for mitochondrial 
quality control. PINK1 supports ETC activity and mtDNA abundance in addition to 
regulating micro-autophagy of damaged mitochondria (Gegg et al., 2009; Liu et al., 2011; 
Morais et al., 2014; Pogson et al., 2014). This raises the possibility that decreased PINK1 
expression may impact mitochondrial function in the HNF4A mutant liver. A previous 
study also demonstrated that liver-specific deletion of HNF4A exacerbates 
hyperglycemia in a mouse model of type-2 diabetes (db/db background) (Yin et al., 
2011). These findings, along with my previous studies in Drosophila, suggest that 
HNF4A dysfunction in the liver may contribute to poor glucose control in MODY1 
patients. Whether mitochondria dysfunction plays an important role in this process, 
however, warrants further investigation.  
 Defects in mitochondrial gene expression, polarization, or morphology are all 
known to impair insulin secretion and systemic glucose homeostasis in mammals 
(Gerbitz et al., 1996; Koeck et al., 2011; Silva et al., 2000; Sivitz and Yorek, 2010; 
Soejima et al., 1996; Wiederkehr and Wollheim, 2006; Zhang et al., 2011). Previous 
studies of HNF4 function in both Drosophila and rat insulinoma cells (INS-1) have 
implicated defects in mitochondrial metabolism as a potential cause of reduced insulin 
secretion due to HNF4 dysfunction (Barry and Thummel, 2016; Wang et al., 2000). It is 
therefore interesting to consider our observation of a potential direct role for HNF4 
within mitochondria of human β-cells. Although surprising, the localization of nuclear 
transcription factors to the mitochondrial compartment is not unprecedented. Similar 
roles have been proposed for other nuclear transcriptional regulators, including members 
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of the nuclear receptor family (Casas et al., 2003; Leigh-Brown et al., 2010; Nargund et 
al., 2015; Szczepanek et al., 2012). In at least some cases, accounts of this phenomenon 
have also been reported to be tissue specific (Leigh-Brown et al., 2010). Nonetheless, 
whether HNF4A truly localizes to β-cell mitochondria, and the potential physiological 
significance of this, requires further examination.  
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Figure 4.1. dHNF4 supports mitochondrial integrity in adulthood independent of 
dietary sugar    
Whole mount staining of fat body dissected from feeding third-instar larvae or 8 day-old 
adult males. Immunostaining for ATP5A was used to mark mitochondria. dHNF4 mutant 
larvae show normal mitochondrial morphology even on a high sugar diet. In contrast, 
mutant adults display fragmented and rounded mitochondrial morphology regardless of 






Figure 4.2. dHNF4 is required for activity of ETC complex I and IV in adults 
Mitochondria were isolated from feeding third-instar larvae or 8 day-old adult males to 
assess enzymatic activity of specific ETC complexes. (A) Complex I activity increases 
during development, from larvae to adults, and is significantly impaired in dHNF4 
mutant adults, but not larvae. (B) Complex II activity is unaffected by a loss of dHNF4 
function in either the adult or larval stage. (C) Similar to complex I, complex IV activity 
is reduced specifically in dHNF4 mutant adults. (D) Citrate synthase activity is 
unaffected in dHNF4 mutants regardless of the developmental stage. The same 
mitochondrial extracts were used for all assays shown above. This, combined with the 
normal activities of citrate synthase and complex II in dHNF4 mutants, indicates that the 
effect on I and IV are specific, and not a result of gross mitochondrial damage. P values 
represent one-way ANOVA with Šídák multiple test correction, * ≤ 0.05, ** ≤ 0.01. 
Mitochondrial isolates were obtained from 60-100 animals per sample, with each 
experiment including three separate biological samples per condition.  

















Figure 4.3. BN-PAGE analysis of ETC complex stability/assembly in dHNF4 mutant 
adults   
Mitochondria extracted from 8 day-old control or dHNF4 mutant adults fed a 15% sugar 
diet were subjected to blue-native PAGE followed by immunoblotting for ETC 
complexes I (NDUFS3), II (SDHB), V (ATP5A), and mitochondrial import inner 









Figure 4.4. CG7461 is a direct target of dHNF4 and is required for ETC complex I 
activity 
(A) CG7461 is a direct target of dHNF4. ChIP-seq enrichment for dHNF4 (blue) at the 
CG7461 locus in chromatin isolated from wild-type adult flies. Poly(A)-selected RNA 
extracted from control or dHNF4 mutant adult males was subjected to high throughput 
sequencing (green) and shows reduced expression in dHNF4 mutants. Raw data from 
(Barry and Thummel, 2016) was used to generate panel A by a screen shot of data tracks 
viewed with the IGV browser (Broad Institute, MIT). (B) FlyAtlas mRNA expression 
levels show enrichment of CG7461 in the adult fat body, similar to dHNF4. (C) 
Quantitation of complex I specific-activity in mitochondria isolated from adult flies 
expressing fat body-specific RNAi against a known complex I assembly factor, CIA30, 
CG7461, or mCherry as a negative control. P values were calculated by one-way 
ANOVA with Dunnett’s correction, * ≤ 0.05. Mitochondrial isolates were obtained from 
60 animals per sample, with each experiment including three separate biological samples 






Figure 4.5. HNF4A is required in the liver for maximal expression of mtDNA-
encoded transcripts 
(A) Quantitative RT-PCR analysis of transcript abundance in control and HNF4A 
deficient adult liver. Mice were injected with virus for hepatic expression of either Cre 
recombinase or EGFP under the control of the liver-specific TBG promoter element. 
HNF4A is undetectable one week after viral injection, indicating a high efficiency of 
recombination.  MTTP and CPT1a are known HNF4A target genes showing expected 
effects on gene expression upon HNF4A deletion. SCD1 and CrAT expression levels are 
provided as supporting evidence that the reduced gene expression levels in HNF4A 
mutant liver are not due to a global decrease in transcription or mRNA stability. 
Transcripts were normalized to Rpl13 mRNA. (B) Quantitative RT-PCR for mRNA 
levels of mtDNA-encoded transcripts show reduced expression of all genes analyzed in 
HNF4A-deficient livers. (C) Immunostaining of wild-type adult liver for HNF4A (green) 
and ATP5A (red) to mark mitochondria, and DAPI stain for nuclei (blue). A single 
hepatocyte is displayed at high magnification showing nuclear and cytoplasmic HNF4A 
staining with little appreciable overlap with mitochondria. (A-B) Data represents the 













Figure 4.6. Putative nuclear-encoded HNF4A targets involved in mitochondrial gene 
expression and ETC function 
(A) ChIP-seq enrichment peaks for hepatic HNF4A in the mouse liver (postnatal day 12). 
Data tracks were viewed in the IGV browser (Broad Institute, MIT) using publically 
available processed HNF4A ChIP-seq reads (Alpern et al., 2014). (B) Quantitative RT-
PCR analysis of transcript abundance of putative HNF4A target genes. RNA was 
extracted from control (HNF4Aflox/flox + AAV8-EGFP) or HNF4A deficient (HNF4Aflox/flox 
+ AAV8-Cre) adult liver one week after viral injection. Mice were either maintained at 
room temperature (RT) or placed at 4˚C for 5 hr prior to analysis. Data represents the 
















Figure 4.7. Candidate HNF4A target genes involved in mitochondrial function 
Publically available data of chromatin-immunoprecipitation for HNF4A protein followed 
by high-throughput sequencing (ChIP-seq) from adult mouse liver was manually scanned 
for association with important regulators of mitochondrial function (Alpern et al., 2014). 
Boxes represent individual enrichment peaks at the indicated locus. Genes homologous to 
those downregulated in Drosophila HNF4 mutants are marked with a single asterisk. 















Figure 4.8. HNF4A colocalizes with mitochondria in pancreatic islets of Langerhans 
in humans 
De-identified specimens of human pancreas were fixed in paraffin and immunostained 
for HNF4A (green), ATP5A (to mark mitochondria, red), INS (to mark β-cells, white), 
and DAPI stain to mark nuclei (blue). (A) HNF4A is enriched in the human endocrine 
pancreas and shows a high degree of overlap with ATP5A. (B) High magnification image 
of a separate human islet showing partial overlap of HNF4A signal with mitochondria 
and a lack of HNF4A nuclear stain. Arrowheads point to several regions of overlap 
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 Studies of nuclear receptors have provided important insights into the 
transcriptional regulation of animal physiology, development, and disease. The fruit fly, 
Drosophila melanogaster, has proved to be a valuable model system to expand our 
understanding of how nuclear receptors contribute to these processes (King-Jones and 
Thummel, 2005). My studies of Drosophila HNF4 (dHNF4) have contributed to this 
effort by identifying novel functions that are conserved through evolution. dHNF4 
mutants recapitulate the hallmark features of Maturity-Onset Diabetes of the Young 1 
(MODY1), a monogenic form of diabetes caused by HNF4A dysfunction in humans. 
Diabetic phenotypes first manifest in dHNF4 mutants during the transition to adulthood, 
revealing a coordination of metabolic dysfunction with developmental progression. These 
defects are linked to an important role for dHNF4 in supporting a developmental switch 
in glucose homeostasis, in part by promoting increased oxidative phosphorylation 
(OXPHOS) during adulthood. dHNF4 acts in both the fat body and adult insulin-
producing cells (IPCs) to support peripheral glucose uptake and glucose-stimulated 
insulin secretion (GSIS). My studies have uncovered valuable insights into the potential 
etiology of MODY1 and identified the mitochondrion as a central target of dHNF4 
activity to maintain cellular and organismal metabolic homeostasis.  
 By extending our analysis to mice, we identified a conserved role for HNF4A in 
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maintaining mtDNA gene expression in the adult liver. Several important nuclear-
encoded regulators of mitochondrial function were also identified as putative targets of 
HNF4A. Finally, we uncovered evidence for a potential direct role for HNF4A within the 
mitochondria of human β-cells. Although our studies in mammals are still preliminary, 
they strongly support the hypothesis that HNF4 is a critical regulator of mitochondrial 
function in flies, mice, and humans.  
 
Drosophila as a model system for studies  
of metabolism and physiology 
 The global rise in the prevalence of diabetes and obesity has sparked a resurgence 
of studies focused on understanding the mechanisms regulating metabolic homeostasis. 
The high conservation of pathways for intermediary metabolism makes simple genetic 
systems a useful context to gain insight into how these pathways are regulated. This is 
especially true for Drosophila, which employ conserved signaling pathways to regulate 
systemic metabolism, along with functionally analogous tissues to many important 
metabolic organs in mammals (Alfa and Kim, 2016; Owusu-Ansah and Perrimon, 2014; 
Padmanabha and Baker, 2014; Reyes-DelaTorre, 2012; Teleman et al., 2012). In Chapter 
2, I present methods that we developed to help advance studies of metabolism in the fruit 
fly. These include assays to examine carbohydrate, lipid, protein, and energy metabolism, 
along with a discussion of important considerations for determining appropriate 
methodologies and the effects of developmental progression on organismal metabolism. 
Our work, along with that of a growing number of investigators in the field, has helped to 
establish Drosophila as a powerful genetic system for understanding the mechanisms by 
which metabolic homeostasis is maintained.  
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Drosophila HNF4 mutants recapitulate the 
major symptoms of MODY1 
 Mutations in the HNF4A locus were identified as the underlying cause of 
MODY1 inheritance twenty years ago (Yamagata et al., 1996). Although the molecular 
link between HNF4A dysfunction and diabetes-onset has remained elusive, my studies in 
Drosophila have provided new insights into the mechanistic functions of HNF4 in 
supporting systemic glucose homeostasis. Through this work, I identified a dramatic 
effect of dietary sugar on the viability of dHNF4 null mutants. Although these animals 
normally die at the transition to adulthood, rearing them on a low sugar diet can almost 
completely suppress this lethality and supports adult survival for several weeks (Figure 
3.1 A-B). This demonstrated a severe intolerance of dHNF4 mutants to dietary sugar, 
suggesting a critical function for maintaining carbohydrate homeostasis in Drosophila. 
Consistent with this, dHNF4 mutant adults are hyperglycemic when fed a normal sugar 
diet and display adult-specific defects in insulin secretion. The developmental-onset of 
these phenotypes corresponds to a metabolic switch in systemic glucose homeostasis that 
occurs during the transition to adulthood.  
 In contrast to humans, glucose has long been considered as a minor circulating 
sugar in Drosophila. Rather, the predominant circulating carbohydrate is trehalose, a 
glucose disaccharide (Reyes-DelaTorre, 2012). Analysis of glycemia throughout 
development, however, revealed that free glucose is an abundant circulating sugar during 
the final stages of pupal development and that this is maintained throughout adulthood 
(Figure 3.6 E). Furthermore, previous studies had demonstrated that Drosophila larvae do 
not respond to glucose for secretion of insulin-like peptides, again in contrast to humans 
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(Geminard et al., 2009). Adult flies, however, display a robust response to glucose for 
insulin secretion, and dHNF4 is critical for this process (Figures 3.5 A-E, 3.6 A-D) (Park 
et al., 2014). Taken together, these studies uncovered a previously unrecognized 
developmental switch in systemic glucose homeostasis in Drosophila that requires 
dHNF4. Furthermore, my work has helped to establish the adult stage of Drosophila as 
an accurate context for studies relating to diabetes and GSIS in humans.  
 
Drosophila undergo a developmental switch  
in glucose homeostasis 
 In light of these findings, it is interesting to consider the physiological basis for 
the developmental switch in glucose homeostasis that occurs during Drosophila 
development. Unlike mammals, fruit flies employ a single insulin receptor through which 
insulin-like peptides signal to mediate functions in both metabolic homeostasis and 
growth promotion (Teleman et al., 2012). During larval development, the animal 
undergoes an extended phase of exponential growth, with amino acids acting as the 
primary stimulus for secretion of insulin-like peptides to support this growth (Geminard 
et al., 2009; Géminard, 2006). As glucose alone does not provide the nitrogen required 
for biosynthetic processes, a lack of response to glucose for insulin secretion is 
biologically rational. Rearing larvae on a sugar-only diet, for example, is not sufficient to 
support developmental progression and results in eventual lethality (data not shown). The 
adult stage, in contrast, does not have these same growth requirements, as the animal has 
reached final body size and mostly consists of differentiated tissues. The IPCs therefore 
have a less prominent role in promoting growth during this stage, while the need for 
insulin signaling to maintain metabolic homeostasis persists.  
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 Although the reason for the developmental difference in circulating glucose 
abundance is unknown, this may be at least be partially influenced by the general change 
in glycolytic and oxidative metabolism between larvae and adults. While larvae are 
programmed toward aerobic glycolysis, characterized by high glycolytic flux, the adult 
fly shifts toward a general increase in OXPHOS, likely accompanied by reduced 
glycolytic flux (Barry and Thummel, 2016; Tennessen et al., 2011). This could allow for 
greater glucose retention in the circulatory fluid resulting from slower glucose utilization 
by adult peripheral tissues. Although seemingly logical, these physiological 
considerations are only speculative. It will therefore be interesting to further examine the 
molecular basis of this physiological switch. While additional factors certainly contribute 
to this coordination between development and systemic metabolism, my studies indicate 
that HNF4 and mitochondrial function are central to this process.  
 
A direct role for Drosophila HNF4 in mtDNA gene expression 
 The mitochondrion is unique amongst cellular organelles in that it carriers its own 
genome (mtDNA), encoding rRNAs and tRNAs important for mitochondrial translation, 
along with 13 protein coding genes, all of which function in the ETC. dHNF4 supports 
expression of mtDNA-encoded transcripts in adulthood, likely through a direct role in 
this process (Figures 3.3 A, 3.6 E). Evidence for this includes ChIP-seq enrichment for 
dHNF4 at a predicted promoter region for mtDNA gene expression, along with 
immunostaining showing both nuclear and mitochondrial localization (Figures 3.3 C, 3.3 
S2B). Furthermore, although most mtDNA transcripts are reduced in dHNF4 mutants, 
mt:Cyt-b is unaffected, consistent with a specific regulatory defect in mitochondrial 
transcription, rather than a general reduction in mtDNA abundance. The expression of 
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mt:Cyt-b is also predicted to contain a separate promoter region, and dHNF4 does not 
associate with this locus (Berthier et al., 1986; Roberti et al., 2006). Moreover, mtDNA 
copy number is unchanged in mutant animals as assayed by determining the ratio of 
mtDNA to nuclear DNA (Figure 3.3 S2A). Due to technical limitations, however, I was 
unable to confirm the mitochondrial localization for dHNF4 through additional 
biochemical approaches. Taken together, these data nonetheless support the possibility 
that dHNF4 directly functions within mitochondria.   
 
CG7461 is an important nuclear-encoded target of  
dHNF4 to support complex I activity  
 In addition to regulating mtDNA genes, dHNF4 is required for the expression of 
several nuclear-encoded transcripts involved in mitochondrial metabolism. Although 
some of these have predicted functions in OXPHOS, the majority represent genes 
involved in mitochondrial β-oxidation. One of these, CG7461, is homologous to two 
genes in mammals, ACAD9 and ACADVL. In addition to its function as an acyl-CoA 
dehydrogenase, ACAD9 was recently shown to be required for complex I activity in 
mammals (Haack et al., 2010; Nouws et al., 2014). This led me to assess the role of 
CG7461 in supporting complex I activity in Drosophila, revealing that this gene is an 
important target of dHNF4 to support complex I function. Complex I subunits are also 
encoded by the mitochondrial genome, suggesting that the defect in complex I activity in 
dHNF4 mutants results from the reduced expression of both mtDNA genes and CG7461. 
Although the mechanistic link between CG7461 and complex I activity was not 
examined, ACAD9 has been identified as an important assembly factor for the complex 




Evidence for mitochondrial regulation by HNF4A in mammals  
 As an initial approach to determine whether the role for dHNF4 in supporting 
mitochondrial function is conserved in mammals, we examined the effects on mtDNA 
gene expression upon acute deletion of HNF4A in the adult mouse liver. Similar to my 
findings in Drosophila, hepatic HNF4A is required to promote mitochondrial-encoded 
gene expression (Figure 4.5). Although we did not observe evidence for mitochondrial 
localization in hepatocytes, analysis of publically available HNF4A ChIP-seq data 
showed association with several loci encoding important genes involved in mitochondrial 
metabolism, gene expression, and other aspects of mitochondrial structure and function 
(Figure 4.5 C, 4.6, and 4.7). These findings suggest that HNF4A may indirectly promote 
expression of mtDNA genes through nuclear-encoded factors. Indeed, a critical regulator 
of mitochondrial quality control and ETC function, PINK1, was identified as a potential 
target of HNF4A and showed reduced expression upon HNF4A deletion in the liver 
(Figure 4.6 B). It will be interesting to examine the role for HNF4A in the expression of 
other putative target genes involved in mitochondrial function and the extent to which 
hepatic mitochondrial activity relies on HNF4A.   
 Although β-cell dysfunction is considered to be the primary cause of MODY1, the 
molecular function of HNF4A in this cell type is still unclear (Fajans and Bell, 2011). 
This is due, in part, to the paucity of HNF4A metabolic studies over the past decade. As a 
result, mice with pancreas-specific deletion of HNF4A were not readily available for 
analysis at the time we initiated our work in mammals. We therefore sought to examine 
the subcellular localization of HNF4A in human β-cells as a preliminary approach to 
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address a possible tissue-restricted role for HNF4A within mitochondria. In contrast to 
hepatocytes, we observed an unexpected lack of nuclear localization in human islets, but 
substantial colocalization with a subset of mitochondria. Future efforts will address the 
functional significance of this observation through genetic studies of HNF4A loss-of-
function in the mouse pancreas and the resulting consequences on mitochondrial 
function.   
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